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ABSTRACT	  This	   thesis	   evaluates	   the	   role	  of	   cardiac	  magnetic	   resonance	   (CMR)	   imaging	   in	  the	   assessment	   of	   patients	   with	   surgically	   repaired	   tetralogy	   of	   Fallot	   (TOF).	  CMR	   has	   become	   a	   powerful	   tool	   in	   the	   serial	   assessment	   of	   this	   group	   of	  patients	  and	  provides	   important	   information	  on	  cardiac	  structure	  and	   function	  long	   after	   surgical	   repair.	   Although	   there	   are	   a	   number	   of	   long-­‐term	   effects	   of	  TOF	   repair,	   chronic	   severe	   pulmonary	   regurgitation	   (PR)	   continues	   to	   be	  considered	  one	  of	  the	  most	  important	  as	  this	  has	  detrimental	  effects	  on	  cardiac	  function	  with	  a	   risk	  of	   sudden	  cardiac	  death.	  The	  optimal	   timing	  of	  pulmonary	  valve	   replacement	   remains	   controversial	   and	   although	   CMR	   has	   provided	  valuable	  information	  on	  the	  volumetric	  changes	  associated	  with	  chronic	  PR	  little	  is	   know	   about	   the	   effects	   of	   stress	   with	   pharmacological	   agents	   such	   as	  dobutamine	  on	  ventricular	  function	  and	  whether	  this	  can	  be	  correlated	  with	  the	  need	   for	   pulmonary	   valve	   intervention.	   Therefore,	   the	  main	   aim	   of	   this	   thesis	  was	  to	  determine	  whether	  dobutamine	  stress	  CMR	  (DS-­‐MR)	  has	  clinical	  utility	  in	  TOF	  patients	  with	  significant	  PR.	  Through	  this,	   it	  has	  been	  possible	   to	  evaluate	  the	   hemodynamic	   and	   volumetric	   changes	   during	   DS-­‐MR	   in	   TOF	   patients	   and	  how	   these	   relate	   to	   baseline	   characteristics.	   The	   association	   between	   great	  artery	   flow	  analysis	  and	  volumetric	  analysis	   in	  TOF	  patients	  during	  DS-­‐MR	  has	  also	  been	  assessed.	  For	  comparison	  the	  DS-­‐MR	  protocol	  was	  also	  completed	  in	  a	  group	   of	   healthy	   volunteers	   and	   this	   has	   allowed	   documentation	   of	   a	   normal	  volumetric	   and	   contractile	   reserve	   response	   to	   dobutamine	   as	   measured	   by	  CMR.	   	  The	  thesis	  concludes	  that	  DS-­‐MR	  is	  safe	  and	  feasible	  in	  TOF	  patients	  and	  that	   it	   has	   potential	   to	   demonstrate	   early	   systolic	   ventricular	   impairment	   in	  these	   patients.	   Through	   application	   of	   DS-­‐MR	   in	   a	   larger	   population	   of	   TOF	  patients	   it	   may	   be	   possible	   to	   accurately	   determine	   which	   patients	   are	   best	  suited	  for	  early	  pulmonary	  valve	  intervention.	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AO Aorta PA Pulmonary artery 
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AV Atrio-ventricular PA-FF Pulmonary artery forward flow 
AVSD Atrio-ventricular septal defect PA-RF Pulmonary artery regurgitant fraction 
BSA Body Surface Area PC-Flow Phase contrast flow  
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CNR/SNR Contrast to noise /signal to noise ratio PW/CW Pulse/Continuous wave Doppler 
CO Cardiac Output RCA Right coronary artery 
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DS-MR Dobutamine Stress Magnetic Resonance Imaging RVOT Right ventricular outflow tract 
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Summary	  of	  Chapters	  	  
Chapter	   1:	   This	   chapter	   provides	   a	   comprehensive	   review	   of	   the	   aetiology,	  pathophysiology	  and	  long-­‐term	  complications	  of	  surgically	  repaired	  tetralogy	  of	  Fallot.	   This	   is	   followed	   by	   an	   introduction	   to	   the	   common	   imaging	  modalities	  used	   in	   TOF	   patients	   and	   then	   a	   review	   of	   stress	   imaging	   in	   congenital	   heart	  disease	  with	  a	  focus	  on	  TOF.	  Finally	  there	  will	  be	  a	  summary	  of	  MR	  hazards	  and	  safety	   recommendations	   especially	   applied	   to	   stress	   imaging.	   The	   chapter	  concludes	  with	  the	  aims	  of	  the	  research	  thesis.	  
Chapter	   2:	   This	   describes	   the	   methodology	   of	   the	   patient	   based	   research	  protocols	  used.	  The	  CMR	  sequences	  used	  at	  rest	  and	  during	  dobutamine	  stress	  imaging	  will	  be	  reviewed	  and	  there	  will	  be	  an	  explanation	  of	  how	  the	  volumetric	  and	   arterial	   flow	   measurements	   were	   utilized	   to	   assess	   cardiac	   function.	   An	  explanation	   of	   the	   methods	   used	   in	   the	   development	   of	   new	   faster	   imaging	  techniques,	   which	   may	   be	   applied	   to	   stress	   imaging	   in	   the	   future	   is	   also	  described	  	  
Chapter	  3:	  This	  chapter	  explores	  the	  utility	  of	  volumetric	  assessment	  using	  MRI.	  It	  will	   look	   at	   the	   standard	   approach	  of	  multi-­‐slice	   SSFP	   imaging	   and	   compare	  this	   to	   the	   use	   of	   faster	   volumetric	   scanning	  which	   allows	   full	   cardiac	   volume	  assessment	  in	  a	  single	  breath	  hold.	  
Chapter	   4:	   This	   second	   results	   chapter	   focuses	   on	   the	   flow	   measurements	  collated	  during	  the	  DS-­‐MR	  study	  in	  TOF	  patients	  and	  healthy	  volunteers.	  Initially	  the	   focus	   is	   on	   general	   trends	   in	   flow	   in	   the	   great	   arteries	   from	   rest	   to	   peak	  dobutamine	   stress.	   Following	   this	   the	   flow	  measurements	   are	   correlated	  with	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volumetric	   parameters	   and	   the	   agreement	   or	   discrepancies	   are	   described	   in	  detail.	  
Chapter	  5:	  This	  chapter	  will	  focus	  on	  the	  accuracy	  of	  ventricular	  measurements	  at	   rest	   and	   during	   dobutamine	   stress	   imaging.	   The	   importance	   of	   this	   is	   to	  understand	   whether	   DS-­‐MR	   is	   an	   accurate	   method	   of	   assessing	   ventricular	  function	  and	  therefore	  rationalize	  its	  potential	  clinical	  utility.	  	  
Chapter	   6:	  The	   largest	   component	   of	   the	   ventricular	   data	   acquired	   from	  both	  patients	  and	  healthy	  volunteers	  is	  described	  in	  detail	  in	  this	  final	  results	  chapter.	  The	   importance	   of	   change	   in	   end-­‐diastolic	   and	   end-­‐systolic	   volumes	   of	   both	  ventricles	  during	   stress	   imaging	  and	  how	   this	   relates	   to	  ventricular	   contractile	  reserve	  is	  examined.	  
Chapter	   7:	   The	   discussion	   chapter	   pulls	   together	   the	   result	   described	   in	   the	  previous	   chapters	   and	   explores	   the	   possibility	   of	   finding	   new	   parameters	   of	  ventricular	   dysfunction	   through	   stress	   imaging.	   The	   relevance	   of	   CMR	   stress	  imaging	   in	   congenital	   patients	   and	   its	   clinical	   utility	   is	   revisited.	   This	   chapter	  concludes	  with	  an	  overview	  of	   future	  perspectives	  relative	  to	  stress	   imaging	   in	  TOF.	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CHAPTER	  1:	  TETRALOGY	  OF	  FALLOT	  
1.1	  Introduction	  to	  Tetralogy	  of	  Fallot	  	  Tetralogy	   of	   Fallot	   is	   the	   most	   common	   of	   the	   cyanotic	   congenital	   heart	  conditions	  and	  accounts	  for	  approximately	  5-­‐10%	  of	  all	  congenital	  heart	  disease,	  occurring	  in	  3	  per	  10000	  live	  births	  1-­‐4.	  	  
First	  described	  by	  Louis	  Arthur	  Etienne	  Fallot	  in	  1888	  as	  “La	  maladie	  Bleue”	  the	  final	   name	   tetralogy	   of	   Fallot	   is	   attributed	   to	   Canadian	  Maude	  Abbott	   in	   1924	  and	  reflects	  the	  classical	  tetrad	  of	  common	  features	  (i)	  ventricular	  septal	  defect,	  (ii)	  overriding	  of	  the	  aorta	  in	  association	  with	  the	  VSD,	  (iii)	  pulmonary	  stenosis	  and	  (iv),	  right	  ventricular	  hypertrophy	  1	  (Figure	  1).	  	  
In	   embryonic	   life	   the	   defect	   is	   created	   by	   a	   combination	   of	   anterior	   mal-­‐alignment	   and	   anterior	   deviation	   of	   the	   conal	   septum	   with	   infunbidular	  hypoplasia	   resulting	   in	   sub-­‐pulmonary	   obstruction.	   This	   may	   be	   worsened	  further	   by	   hypertrophy	   of	   the	   septal	   and	   parietal	   muscle	   bundles	   resulting	   in	  severe	  right	  ventricular	  outflow	  tract	  obstruction.	  The	  pulmonary	  valve	  is	  often	  abnormal	   and	   there	   may	   be	   associated	   stenoses	   of	   the	   branch	   pulmonary	  arteries	   1.	   Additional	   features	   can	   include;	   anomalous	   coronary	   arteries,	   right	  sided	   aortic	   arch,	   aortic	   root	   dilatation,	   aortic	   regurgitation	   and	   aorto-­‐pulmonary	  collaterals.	  All	  these	  may	  vary	  in	  their	  prevalence	  and	  severity	  1-­‐4.	  
The	  condition	  is	  associated	  with	  chromosomal	  abnormalities	  with	  as	  many	  as	  1	  in	  8	  patient	  having	  an	  abnormality	  such	  as	  trisomy	  21,	  18	  or	  13.	  More	  recently	  a	  strong	   link	   with	   a	   micro-­‐deletion	   on	   chromosome	   22	   has	   been	   described	  allowing	  genetic	  screening	  to	  be	  offered	  to	  families	  and	  pre-­‐natally.	  It	  is	  thought	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that	  approximately	  15%	  of	  all	  TOF	  patients	  have	  an	  abnormality	  of	  chromosome	  22	  1.	  
Diagnosis	  can	  be	  made	  pre-­‐natally	  with	  detailed	  fetal	  echocardiography	  and	  this	  allows	   for	   strategic	   surgical	  planning	   in	  early	   infancy.	  However	   the	  majority	  of	  children	  present	  with	  the	  condition	  after	  birth	  and	  symptoms	  vary	  depending	  on	  the	  degree	  of	  right	  ventricular	  obstruction	  and	  subsequent	  right	  to	  left	  shunt.	  In	  infancy	   classical	   symptoms	   are	   cyanotic	   “spells”,	   characterized	   by	   sudden	   and	  striking	  decrease	   in	  oxygen	  saturation	  due	   to	  acute	  complete	  or	  near	  complete	  pulmonary	  obstruction,	  which	  occur	  during	  feeding	  and	  on	  exertion	  1-­‐4.	  	  
Prior	   to	   the	  option	  of	  surgical	  repair,	  prognosis	  and	  survival	   for	  Fallot	  patients	  were	  poor.	  With	  progressive	  improvement	  in	  surgical	  technique	  those	  born	  with	  all	  variants	  of	  the	  disease	  can	  now	  expect	  to	  survive	  into	  adult	  life.	  Many	  of	  the	  current	   adult	   patients	   will	   have	   had	   a	   palliative	   aorto-­‐pulmonary	   shunt	   in	  childhood	   prior	   to	   complete	   repair	   and	   this	   approach	   is	   still	   offered	   by	   some	  surgical	   centers	   (Figure	   2).	   The	   disadvantage	   of	   a	   staged	   approach	   is	   the	  potential	   for	   long-­‐standing	   pressure	   overload	   of	   the	   right	   ventricle	   with	  persistent	  cyanosis	  1-­‐3.	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Figure	  1:	  Anatomical	  Arrangement	  in	  Uncorrected	  Tetralogy	  of	  Fallot	  at	  Birth	  
	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  
Figure	  2:	  Palliative	  Surgical	  Shunts	  in	  TOF	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Corrective	   surgical	   repair	   is	   now	   recommended	   in	   the	   first	   year	   of	   life	   and	  consists	   of	   a	   single	   staged	   reconstructive	   procedure.	   The	   goals	   for	   definitive	  repair	   consist	   of	   closing	   the	   VSD	   and	   relieving	   the	   RV	   outflow	   tract	   (RVOT)	  obstruction.	   Both	   trans-­‐atrial/trans-­‐pulmonary	   and	   trans-­‐ventricular	  approaches	  to	  repair	  are	  described.	  The	  earlier	  technique	  for	  repair	  of	  TOF	  used	  a	  trans-­‐ventricular	  approach,	  however	  currently	  the	  transatrial/transpulmonary	  approach	   is	   favored	   and	   has	   the	   advantage	   of	   avoiding	   a	   right	   ventricular	  incision	   emphasizing	   preservation	   of	   right	   ventricular	   structure	   and	   function	  and	   reducing	   the	   risk	   of	   scar	   related	   ventricular	   tachycardia	   (VT)	   2.	   If	   there	   is	  significant	   hypoplasia	   of	   the	   central	   pulmonary	   arteries	   staged	   reconstruction	  may	  be	  required.	  	  
The	  treatment	  of	  TOF	  has	  become	  one	  of	  the	  success	  stories	  in	  the	  management	  of	   congenital	   conditions	   and	   advances	   in	   surgical	   repair	   have	   been	   shown	   to	  improve	   life	   expectancy.	  Outcomes	  are	  generally	   excellent	  with	  early	  mortality	  less	  than	  2%	  and	  nearly	  90%	  alive	  20	  years	  after	  surgery	  3.	  	  
Despite	  these	  advances	  there	  are	  a	  number	  of	  key	  post	  repair	  issues,	  which	  affect	  this	  patient	  group	  and	  require	  additional	  surgical	  intervention	  in	  later	  life.	  Many	  of	   these	   relate	   to	   the	   state	   of	   the	   right	   ventricle	   and	   its	   interaction	   with	   the	  pulmonary	  arterial	  tree	  and	  left	  ventricle	  1,	  2,	  7,	  8.	  	  
These	  are	  summarized	  below:	  
• Residual	  ventricular	  septal	  defect	  (VSD):	  can	  be	  encountered	  from	  either	  partial	   patch	   dehiscence	   or	   failure	   of	   complete	   closure	   at	   the	   time	   of	  surgery	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• Aortic	   root	   dilatation	   and	   aortic	   regurgitation:	   during	   VSD	   closure	   the	  aortic	  valve	  can	  be	  damaged	  resulting	  in	  regurgitation.	  	  Patients	  may	  also	  have	  an	  intrinsic	  abnormality	  of	  the	  aortic	  root	  predisposing	  them	  to	  root	  dilatation	  and	  consequent	  regurgitation.	  This	   tends	   to	  be	  more	  common	  in	  TOF	  patients	  with	  pulmonary	  atresia	  and	  systemic	  to	  pulmonary	  artery	  collaterals	  4,	  5.	  
• Residual	   aorto-­‐pulmonary	   collaterals:	   resulting	   in	   increased	   pulmonary	  perfusion	  and	  therefore	  potential	  left	  ventricular	  volume	  overload.	  
• RVOT	  obstruction,	  branch	  pulmonary	  artery	  stenosis	  or	  hypoplasia	  
• Left	   ventricular	   dysfunction:	   this	   is	   multi-­‐factorial	   and	   has	   been	  associated	  with	   inadequate	  myocardial	  protection	  during	  repair,	  chronic	  LV	   overload	   due	   to	   long	   standing	   palliative	   arterial	   shunts	   and/or	  residual	  VSD.	  Both	  ventricles	  share	  a	  common	  pericardial	  space	  and	  are	  in	   continuity	   with	   each	   other	   via	   the	   septum	   and	   additional	   muscular	  structures.	   Interaction	   of	   the	   two	   ventricles	   results	   in	   alterations	   in	  systolic	   and	   diastolic	   function.	   The	   left	   ventricle	   is	   compromised	   when	  there	   is	  progressive	  right	  sided	  dilatation	  and	  this	   is	   likely	  to	  contribute	  to	  the	  risk	  of	  sudden	  cardiac	  death6,	  7.	  	  
• Atrial	  arrhythmia:	  atrial	  flutter	  and	  fibrillation	  are	  relatively	  common	  and	  contribute	  to	  significant	  late	  morbidity	  8.	  	  
• Ventricular	   tachycardia	   (VT):	   the	   risk	   of	   VT	   increases	   with	   increasing	  right	  ventricular	  size	  and	  QRS	  duration.	  The	  arrhythmia	  focus	  is	  usually	  in	  the	  RVOT	  in	  the	  area	  of	  previous	  infundibulectomy	  or	  VSD	  closure.	  A	  QRS	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duration	  exceeding	  180ms	   is	  a	  highly	  sensitive	  marker	   for	  sustained	  VT	  and	  sudden	  cardiac	  death	  in	  adult	  patients	  8.	  
• Pulmonary	   regurgitation	   (PR):	   this	   is	   associated	   with	   progressive	   right	  ventricular	  dilatation	   leading	   to	  RV	   failure.	  This	   is	   a	   common	   long-­‐term	  outcome	  of	   repaired	  TOF	  and	   the	   importance	  and	   impact	  of	   this	  will	  be	  reviewed	  in	  more	  detail	  in	  the	  next	  section.	  
The	   vast	   majority	   of	   Fallot	   patients	   surviving	   into	   adult	   life	   have	   a	   degree	   of	  pulmonary	   regurgitation	   and	   over	   time	   this	   creates	   a	   significant	   burden	   in	  respect	   to	   symptoms	   and	   potential	   for	   further	   surgical	   intervention.	   The	  importance	  of	  this	  long-­‐term	  complication	  of	  TOF	  repair	  creates	  many	  dilemmas	  for	   the	   clinician	   especially	   with	   regard	   to	   the	   timing	   of	   pulmonary	   valve	  replacement.	  Therefore	  the	  focus	  of	  the	  thesis	  will	  be	  on	  adult	  patients	  following	  surgical	   repair	   of	   tetralogy	   of	   Fallot	   who	   have	   chronic	   severe	   pulmonary	  regurgitation	  without	  other	  major	  complications	  from	  reconstructive	  surgery	  or	  complex	  TOF	  anatomy.	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1.2	  Pulmonary	  regurgitation:	  Why	  is	  it	  important?	  	  Pulmonary	  regurgitation	  (PR)	  is	  one	  of	  the	  most	  common	  long-­‐term	  outcomes	  of	  repaired	   TOF.	   Many	   patients	   require	   pulmonary	   valve	   replacement	   (PVR)	   in	  early	   adulthood	   and	   the	   timing	   of	   PVR	   is	   hotly	   debated	   and	   remains	  controversial.	  The	  following	  review	  will	  focus	  on	  the	  morbidity	  and	  mortality	  of	  this	   late	  complication	  and	  address	  the	  current	   literature	  relating	  to	  assessment	  and	  treatment	  of	  this	  condition:	  
	  
1.2.1	  Pathophysiology	  and	  haemodynamic	  effects	  	  For	  many	  years	   free	  PR	  was	  considered	  an	   inevitable	  consequence	  of	   standard	  surgical	   repair.	   Much	   more	   emphasis	   was	   placed	   on	   correction	   of	   the	   severe	  RVOTO	  in	  infancy/childhood.	  The	  early	  surgical	  techniques	  to	  reconstruct	  the	  RV	  outflow	   tract	   using	   a	   trans-­‐annular	   patch	   have	   subsequently	   resulted	   in	  significant	   PR.	   Although	   well	   tolerated	   for	   a	   number	   of	   years	   the	   long-­‐term	  deleterious	  effects	  of	  chronic	  PR	  have	  become	  more	  apparent	  in	  recent	  studies	  1,	  
9-­‐11.	  	  	  
Physiologically	   PR	   is	   driven	   by	   diastolic	   difference	   between	   the	   pulmonary	  artery	   and	   right	   ventricle.	   In	   this	   low-­‐pressure	   system	   forward	   flow	   can	   be	  maintained	   indirectly	   by	   work	   of	   the	   left	   heart	   and	   atrial	   contraction	   and	  additionally	  changes	  in	  airway	  or	  intra-­‐thoracic	  pressure	  can	  alter	  the	  degree	  of	  regurgitation.	   The	   severity	   of	   PR	   is	   determined	   by	   the	   following	   factors:	   the	  degree	  of	  valvular	  incompetence	  or	  effective	  orifice	  for	  regurgitation,	  the	  balance	  between	  RV	  diastolic	  afterload	  and	  RV	  compliance	  and	  the	  duration	  of	  diastole.	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The	   severity	   of	   regurgitation	   will	   worsen	   in	   situations	   which	   lead	   to	   raised	  pulmonary	   arterial	   pressures	   such	   as	   branch	   pulmonary	   artery	   stenosis,	   and	  these	   require	   intervention	   prior	   to	   definitive	   pulmonary	   valve	   surgery	   1,	   11-­‐13.	  Chronically	   the	   severity	   and	   haemodynamic	   impact	   of	   PR	   is	   dependant	   on	   the	  compliance	   of	   the	   RV.	   In	   a	   compliant	   ventricle	   there	   will	   be	   progressive	  dilatation	   and	   eventual	   dysfunction,	   whilst	   a	   restrictive	   RV	   may	   be	   relatively	  protective	  as	  this	  will	  raise	  the	  right	  ventricular	  diastolic	  pressure	  and	  decrease	  the	   gradient	   for	   PR.	   This	   type	   of	   physiology	   although	   related	   to	   a	   slower	  recovery	   after	   initial	   repair	   has	   been	   associated	   with	   superior	   exercise	  performance,	  less	  RV	  dilatation	  and	  fewer	  arrhythmias	  in	  later	  life	  13,	  14.	  	  
The	  continued	   increase	   in	  RV	  preload	  from	  chronic	  PR	  will	  eventually	  result	   in	  increased	  end-­‐diastolic	  volume,	   followed	  by	   increased	  end-­‐systolic	  volume	  and	  finally	  deterioration	  of	  myocardial	  function.	  The	  extent	  of	  RV	  dilatation	  and	  how	  this	  correlates	  with	  clinical	   symptoms	  and	  risk	  of	  premature	  cardiac	  death	  has	  been	   the	   focus	   of	   many	   research	   studies.	   Early	   observations	   reported	   that	  exercise	   dysfunction	  was	   related	   to	   cardiothoracic	   ratio	   (as	   a	   surrogate	   of	   RV	  dilatation)	   on	   chest	   radiography	   1.	   Subsequent	   work	   in	   animals	   and	   patients	  using	  a	  variety	  of	  imaging	  techniques	  has	  confirmed	  that	  RV	  dilation	  due	  to	  long	  standing	  PR	  has	  negative	  haemodynamic	  effects,	   reduces	  exercise	   capacity	  and	  predisposes	  patients	  to	  malignant	  cardiac	  arrhythmias	  1,	  11,	  12.	  	  
The	   ongoing	   RV	   stretch	   affects	   the	   inter-­‐ventricular	   conduction	   system	   and	  creates	   a	   mechano-­‐electrical	   substrate	   for	   re-­‐entry	   circuits	   predisposing	   to	  sustained	   ventricular	   tachycardia.	   QRS	   duration	   of	   180ms	   or	   more	   has	   been	  associated	  with	  increase	  risk	  of	  sudden	  cardiac	  death	  7,	  8.	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1.2.2	  Pulmonary	  valve	  replacement:	  When	  Is	  the	  right	  time?	  	  This	   leads	   to	   the	   much-­‐debated	   topic	   of	   pulmonary	   valve	   replacement	   (PVR).	  This	   relatively	   low	   risk	   intervention	   is	   required	   in	  many	  TOF	  patients	   in	   early	  adulthood	  but	  timing	  remains	  controversial.	  PVR	  early	  in	  adult	  life	  may	  preserve	  RV	   function	  but	   at	   the	   cost	   of	   re-­‐operation	   for	   a	   failing	  homograft	   in	   later	   life.	  The	  lifespan	  of	  pulmonary	  valve	  prostheses	  in	  adults	  ranges	  from	  15	  to	  30	  years	  and	  one	  series	  has	  reported	  that	  only	  47%	  of	  patients	  were	  free	  from	  homograft	  dysfunction	  at	  10	  years	  15.	  This	  suggests	  that	  a	  significant	  proportion	  of	  patients	  will	  require	  re-­‐intervention	  in	  later	  life.	  However	  when	  PVR	  is	  left	  too	  late	  there	  may	   be	   little	   or	   no	   improvement	   in	   RV	   size	   and	   function	   and	   resulting	   in	   the	  risks	  associated	  with	  this	  16.	  	  
Current	   guidelines	   suggest	   intervention	   based	   on	   a	   combination	   of	   clinical	  factors	   including	   symptoms	   and	   rhythm	   disturbance,	   and	   quantitative	   and	  qualitative	   measures	   such	   as	   exercise	   test,	   echocardiography	   and	   cardiac	  magnetic	   resonance	   (CMR)	   findings	   17,	   18.	  Most	  would	   agree	   that	   patients	  with	  overt	   heart	   failure	   symptoms	   or	   significant	   rhythm	   abnormality	   should	   be	  offered	   PVR,	   however	   there	   may	   be	   additional	   patients	   who	   do	   not	   fulfill	   the	  criteria	  but	  may	  be	  potential	  surgical	  candidates.	  	  
Imaging	   techniques	   will	   certainly	   help	   with	   this	   complex	   decision-­‐making	  process	   and	   CMR	   has	   become	   a	   powerful	   tool	   to	   assess	   progressive	   right	  ventricular	   dilatation	   serially.	   Not	   only	   can	   it	   provide	   accurate	   volumetric	  measurements	   but	   it	   also	   allows	   complete	   anatomical	   assessment	   pre-­‐operatively	   allowing	   visualization	   of	   additional	   late	   complications	   of	   TOF	   as	  described	  in	  section	  1.1.	  Increasingly	  RV	  end	  diastolic	  (RV-­‐EDV)	  and	  end	  systolic	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volume	   (RV-­‐ESV)	   measurements	   are	   being	   quoted	   as	   an	   indication	   for	  pulmonary	   valve	   replacement	   19-­‐21.	  More	   recently	   reviews	  have	   suggested	   that	  there	   is	  no	   threshold	  above	  which	  RV	  volumes	  will	  not	  decrease	  after	   surgery.	  Although	  normalization	  of	  volumes	  is	  seen	  below	  RV-­‐EDV	  160ml/m2	  and	  RV-­‐ESV	  82ml/m2	  it	  suggests	  that	  these	  measures	  may	  not	  provide	  enough	  information	  to	  determine	  which	  patients	  will	  benefit	  most	  from	  surgery	  22.	  	  
This	   leaves	   many	   unanswered	   questions.	   The	   impact	   of	   exercise	   testing	   and	  prediction	  of	  surgical	  outcome	  is	  still	  relatively	  unknown	  23.	  Additionally	  despite	  the	   advantages	   of	   CMR	   it	   appears	   that	   baseline	   volumetric	   and	   functional	  measurements	   do	   not	   give	   a	   complete	   picture	   of	   the	   RV	   and	   its	   potential	  response	   to	   surgery.	   The	   role	   of	   stress	   imaging	   in	   patients	  with	   significant	   PR	  and	  dilated	  RV	  may	  prove	   to	  be	   important	  and	   this	  will	  be	  explored	   further	   in	  this	  thesis.	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1.3	  Imaging	  in	  tetralogy	  of	  Fallot	  	  It	   is	   clear	   that	   imaging	  plays	   a	   crucial	   role	   in	   the	   assessment	   and	   follow	  up	  of	  patients	   with	   TOF.	   At	   the	   bedside	   and	   in	   routine	   clinical	   practice	  echocardiography	   remains	   the	   first	   line	   investigation	  of	   choice.	   	  However	  over	  the	   past	   10	   years	   CMR	   has	   become	   the	   gold	   standard	   for	   assessment	   in	  congenital	  heart	  disease	  especially	  when	   focusing	  on	   the	  right	  ventricle	   24.	  The	  following	  summary	  will	  explore	  the	  use	  of	  echocardiography	  and	  CMR	  in	  general	  and	  its	  specific	  role	  in	  TOF.	  
1.3.1	  Introduction	  to	  echocardiography	  	  	  Echocardiography	  in	  most	  centers	  remains	  the	  first	  line	  imaging	  investigation	  of	  choice	   in	   adult	   patients	   with	   surgically	   repaired	   TOF.	   It	   is	   easily	   accessible,	  inexpensive	  and	  well	   tolerated	  by	   the	  patient.	   	  The	   following	   summary	  gives	  a	  brief	  overview	  of	  the	  basic	  principles	  applied	  to	  echo	  in	  this	  patient	  group.	  
Cardiac	  function:	  This	   is	   assessed	   quantitatively	   and	   qualitatively.	   Visual	   estimation	   of	   bi-­‐ventricular	   function	   is	   common	   especially	   for	   the	   right	   ventricle	   where	  geometrical	   assumptions	   do	   not	   allow	   easy	   quantification	   of	   diameters	   or	  volumes.	   In	  TOF	  a	  ratio	   to	  RV	  dimension	  compared	  to	  LV	  dimension	  measured	  just	   below	   the	   annular	   rings	   often	   gives	   an	   impression	   of	   whether	   the	   RV	   is	  significantly	  dilated.	  A	  RV/LV	  ratio	  of	  >0.65	  suggests	   significant	  dilatation.	  The	  RV	   free	  wall	   is	   usually	  well	   seen	   in	   the	   apical	   4ch	   view	  but	   assessment	   of	   the	  RVOT	  is	  very	  difficult	  due	  to	  its	  anterior	  position	  in	  the	  mediastinum	  24.	  Recent	  study	   has	   shown	   that	   there	   is	   a	   only	   a	   weak	   correlation	   between	   the	   2D	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measures	   of	   RV	   size	   as	   recommended	   by	   the	   American	   Society	   of	  Echocardiography	  and	  similar	  2D	  dimensions	  as	  measured	  by	  CMR	  25.	  	  
These	   limitations	  of	  2D	   imaging	  have	  resulted	   in	   the	  development	  of	  surrogate	  markers	  of	   global	  RV	   function.	  A	   common	  parameter	  used	   is	   tricuspid	   annular	  plane	  systolic	  excursion	  (TAPSE),	  which	  documents	  longitudinal	  displacement	  of	  the	  annulus	  and	  is	  well	  validated	  as	  a	  marker	  of	  global	  function	  26.	  	  
In	  general	  accurate	  echo	  assessment	  of	  RV	  dimensions	  and	  volumes	  continues	  to	  be	  challenging.	  This	   is	  especially	   true	   in	  congenital	  heart	  disease	  where	  the	  RV	  can	   be	   significantly	   dilated,	   resulting	   in	   under-­‐estimation	   of	   ventricular	  dimensions.	   Figures	   3	   and	   4	   give	   an	   overview	   of	   RV	   echo	   parameters	   as	  recommended	  by	  the	  British	  Society	  of	  Echocardiography.	  
Flow	  assessment:	  Doppler	  imaging	  remains	  the	  cornerstone	  of	  quantifiable	  arterial	  and	  valve	  flow	  in	   echo.	   Application	   of	   a	   pulsed	   Doppler	   signal	   in	   the	   RVOT	   and	   then	   a	  continuous	  wave	  Doppler	  in	  the	  main	  pulmonary	  artery	  allows	  quantification	  of	  the	   degree	   of	   pulmonary	   stenosis	   in	   the	   standard	   way	   using	   the	   continuity	  equation.	   Additionally	   by	   measuring	   the	   pressure	   half	   time	   of	   the	   pulmonary	  regurgitation	   CW	   Doppler	   signal	   it	   is	   possible	   to	   measure	   the	   severity	   of	  regurgitation	  and	  classify	  this	  from	  mild	  to	  severe.	  The	  classification	  of	  severity	  of	  PR	  is	  shown	  in	  Figure	  4.	  Doppler	  indices	  are	  also	  used	  to	  determine	  the	  “Tei”	  or	   myocardial	   performance	   index.	   This	   is	   a	   ratio	   of	   RV	   inflow	   and	   outflow	  durations	   calculated	   from	   the	   PW	  Doppler	   profile	   27.	   It	   has	   been	   shown	   to	   be	  predictive	  of	  global	  RV	  function	  and	  although	  not	  used	  routinely	  may	  give	  useful	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additional	   information	   especially	  when	   the	   RV	   free	  wall	   and	   outflow	   tract	   are	  difficult	  to	  image	  such	  as	  in	  TOF.	  	  	  
	  
Figure	   3:	   Standardized	   Echo	   Parameters	   For	   The	   Right	   Ventricle	   as	   published	   by	   The	  
British	  Society	  of	  Echocardiography	  (BSE)	  
	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  
Figure	  4:	  Echo	  Assessment	  of	  Pulmonary	  Regurgitation	  (BSE)	  
	  
Tissue	  Doppler:	  Over	   recent	   years	   tissue	  Doppler	   imaging	   (TDI)	   has	   become	   a	   popular	  way	   to	  examine	  regional	  myocardial	  displacement	  and	  how	  its	  correlation	  with	  diastolic	  and	   systolic	   function.	   It	   allows	   measurement	   of	   myocardial	   activation	   and	  therefore	   can	   also	   be	   used	   to	   determine	   inter	   and	   intra-­‐ventricular	  dyssynchrony.	   	   Tissue	   velocity	   measurement	   of	   the	   tricuspid	   annulus	   gives	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measures	   of	   peak	   systolic	   (Sa)	   as	   well	   as	   peak	   early	   diastolic	   (Ea)	   and	   late	  diastolic	  myocardial	  (Aa)	  velocities.	  In	  general	  a	  peak	  S	  wave	  less	  than	  0.12m/s	  is	  thought	  to	  indicate	  an	  abnormality	  in	  function	  of	  the	  right	  ventricle	  28,	  29.	  These	  indices	  have	  been	  shown	  to	  be	  decreased	   in	  TOF	  patients	  when	  compared	  to	  a	  normal	   cohort.	   It	   is	   also	   possible	   to	   assess	   these	  measures	   during	   stress	   echo,	  allowing	   better	   characterization	   of	  RV	  performance	   under	   stress	   conditions	   30.	  TDI	  measurements	  are	  a	  more	  accurate	  way	  to	  calculate	  the	  “Tei”	  index	  with	  the	  advantage	  over	  PW	  Doppler	   that	   the	  measures	  are	   taken	   in	  same	  cardiac	  cycle	  (depending	  on	  the	  software	  available).	  
Isovolumic	  acceleration	  (IVA)	   is	  an	  additional	   load	   independent	  measure	  of	  RV	  performance	  that	  has	  been	  used	   in	  the	  assessment	  of	  TOF	  patients,	  eliminating	  the	  problems	  of	  RV	  loading	  from	  severe	  PR	  31,	  32.	  Tissue	  Doppler	  IVA	  is	  defined	  as	  the	   slope	   of	   the	   upstroke	   of	   the	   iso-­‐volumic	   contraction	   wave	   on	   myocardial	  velocity	  tracings	  and	  has	  been	  shown	  to	  be	  a	  reproducible	  measure	  of	  RV	  systolic	  function	   in	  TOF	  patients.	   It	  may	  be	  useful	   in	   the	   long	  term	  monitoring	  of	   these	  patients	  as	  well	  as	  possibly	  predicting	  preclinical	  RV	  dysfunction	  31,	  32.	  
Three-­‐dimensional	  imaging	  	  This	  has	  been	  developed	  over	   the	  past	  10	  years	   and	   is	  now	  used	   routinely	   for	  assessment	  of	   left	  ventricular	   function	  and	  aortic	  and	  mitral	  valve	   function.	  3D	  imaging	  of	   the	   right	   ventricle	   is	   theoretically	   possible	   and	   there	   are	   good	  post	  processing	   tools	   available	   to	   allow	   calculation	   of	   the	   end-­‐diastolic	   and	   end-­‐systolic	   volumes.	   However	   the	   usual	   geometrical	   limitation	   of	   RV	   imaging	  applies.	   Volumetric	   analysis	   may	   be	   hindered	   by	   the	   unique	   shape	   and	  orientation	  of	  the	  RV	  resulting	  in	  over	  or	  underestimation	  of	  volumes	  28,	  29.	  This	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is	  especially	  problematic	  in	  large	  right	  ventricles	  where	  there	  may	  be	  difficulty	  in	  imaging	   the	   whole	   area	   of	   interest,	   specifically	   a	   dilated	   RVOT,	   within	   the	   3D	  sector	   width	   33,	   34.	   This	   limits	   the	   accuracy	   of	   3D	   volumetric	   assessment	   in	  patients	  with	  repaired	  TOF	  but	  with	  continued	  improvements	  in	  technology	  and	  software	  some	  of	  these	  technical	  problems	  may	  be	  overcome	  in	  the	  future.	  
	  
Although	  this	  research	  originally	  intended	  to	  use	  echo	  in	  addition	  to	  CMR,	  due	  to	  technical	  difficulties	  and	  poor	  image	  quality	  the	  results	  have	  not	  been	  included	  in	  the	  main	  part	  of	  the	  thesis	  but	  are	  available	  for	  review	  in	  Appendix	  2.	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1.3.2	  Introduction	  to	  cardiac	  magnetic	  resonance	  imaging	  
	  Cardiovascular	  Magnetic	  Resonance	   imaging	  has	  emerged	  over	  the	  past	  decade	  as	  an	  alternative,	  complementary	  and	  frequently	  superior	   imaging	  modality	   for	  the	  evaluation	  of	  patients	  with	  congenital	  heart	  disease.	  Major	  advances	  in	  MRI	  hardware	   and	   software,	   including	   coil	   design,	   faster	   gradients,	   newer	   pulse	  sequences	   and	   faster	   image	   reconstruction	   techniques,	   allow	   rapid,	   high	  resolution	   imaging	  of	  complex	  anatomy	  and	  accurate	  assessment	  of	  physiology	  and	   function.	   In	   addition	   CMR	   offers	   several	   advantages	   over	   other	   imaging	  modalities	   including	   a	   large	   field	   of	   view,	   unrestricted	   imaging	   windows,	   a	  capacity	   for	   true	   three-­‐dimensional	   imaging,	  and	  a	   lack	  of	   ionizing	  radiation	  24.	  The	   basics	   of	   MRI	   originate	   from	   nuclear	   magnetic	   resonance	   imaging,	   an	  analytical	   technique,	   which	   has	   been	   available	   for	   over	   50	   years.	   The	   word	  nuclear	  was	  discarded	  in	  the	  1980’s	  due	  to	  the	  negative	  association	  with	  nuclear	  material.	   MRI	   is	   fundamentally	   a	   measurement	   of	   magnetism	   and	   in	   clinical	  practice	   the	   electromagnetic	   properties	   of	   the	   hydrogen	   are	   utilized	   to	   create	  images.	  	  
An	  MRI	  system	  is	  made	  up	  of	   three	  main	  components.	  Firstly	   the	  main	  magnet	  coils	   which	   generate	   a	   strong	   constant	   magnetic	   field.	   When	   a	   patient	   is	  positioned	  within	  a	  magnet	  bore	  the	  strength	  of	   this	   field	   is	  denoted	  by	  B0	  and	  this	  in	  turn	  defines	  the	  operating	  field	  strength	  of	  the	  magnet	  (Tesla).	  For	  cardiac	  MRI	  the	  most	  common	  field	  strength	  used	  is	  1.5	  or	  3	  Tesla.	  Other	  components	  of	  the	  MR	  system	  are	  the	  gradient	  coils,	  which	  create	  a	  gradient	  magnetic	  field	  and	  the	   radio	   frequency	   (RF)	   transmitter	   coil.	   The	   concept	   behind	   MRI	   is	   the	  spinning	   nuclear	   charge	   of	   the	   hydrogen	   nucleus,	   which	   produces	   a	   tiny	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magnetic	   field	   called	   a	   magnetic	   moment.	   Hydrogen	   is	   one	   of	   number	   of	  elements	   whose	   nuclei	   exhibit	   magnetic	   resonance	   properties	   and	   due	   to	   its	  abundance	   in	  the	  human	  body	  makes	   it	  particularly	   favourable	   for	   imaging.	   	   In	  the	  normal	  environment	  the	  random	  orientation	  of	  millions	  of	  these	  spins	  results	  in	   no	   magnetic	   field.	   However	   these	   align	   themselves	   parallel	   with	   the	   large	  magnetic	   field	   generated	   by	   the	   superconducting	   magnet	   (Bo).	   The	   hydrogen	  nuclei	   also	   exhibit	   a	   rotation	   frequency	   known	   as	   precession,	   which	   is	  proportional	   to	   the	   strength	   of	   the	   field.	   When	   the	   RF	   coil	   delivers	   a	  radiofrequency	  pulse	  with	  a	  frequency	  identical	  to	  the	  precession	  frequency	  over	  a	  body	  region,	  the	  magnetic	  moment	  in	  that	  region	  will	  be	  flipped	  out	  at	  an	  angle	  to	   the	  magnetic	   field	   a	  process	   called	  excitation.	  The	  magnetic	   field	  now	  has	  2	  components	  one	  aligned	  with	  the	  external	  field,	   longitudinal	  magnetization	  and	  one	  perpendicular	  to	  the	  field	  known	  as	  transverse	  magnetization.	  When	  the	  RF	  pulse	  is	  stopped	  the	  protons	  relax	  back	  to	  their	  original	  state	  (relaxation)	  during	  which	  they	  release	  a	  signal	   in	  the	  form	  of	  RF	  energy.	  This	   is	  captured	  by	  an	  RF	  receiver	   coil	   and	   is	   used	   to	   create	   the	   final	   image.	   During	   relaxation	   the	  longitudinal	  magnetization	   increases	  with	  a	  speed	  defined	  by	  the	  T1	  relaxation	  time	   and	   the	   transverse	   magnetization	   decreases	   with	   a	   speed	   defined	   by	   T2	  relaxation	  time.	  	  The	  T1	  and	  T2	  relaxation	  times	  are	  tissue	  specific	  and	  therefore	  influence	   the	   signal	   emitted.	   Spatial	   information	   of	   the	   specified	   body	   part	   is	  created	  by	  Fourier	  transformation	  of	  the	  signal	  generated	  and	  in	  turn	  images	  are	  created	  35,	  36.	  	  
An	   in-­‐depth	   knowledge	   of	   underlying	   MRI	   physics	   enhances	   the	   quality	   of	  interpretation	  of	  the	  imaging	  data	  and	  is	  necessary	  for	  understandings	  its	  pitfalls	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and	  limitations.	  A	  more	  comprehensive	  review	  and	  discussion	  of	  the	  physics	  of	  CMR	  37	  are	  outside	  the	  scope	  of	  this	  thesis.	  	  
In	  TOF	  patients,	  CMR	  allows	  accurate	  quantification	  of	  right	  ventricular	  size	  and	  function	  in	  additional	  to	  anatomical	  assessment.	  The	  following	  summary	  reviews	  the	  technical	  considerations	  and	  sequences	  required	  for	  TOF	  assessment.	  	  
	  
Motion	  compensation	  during	  Cardiac	  MRI:	  Cardiac	  and	  Respiratory	  Gating:	  	  Cardiac	   and	   respiratory	  motion	   during	  MR	   image	   acquisition	   results	   in	   image	  blurring.	  To	  achieve	  good	  quality	  imaging,	  compensation	  for	  this	  motion	  needs	  to	  be	   considered.	   Image	   acquisition	   can	   be	   synchronized	   with	   the	   cardiac	   cycle	  using	   either	   prospective	   or	   retrospective	   electrocardiographic	   gating	   38.	  Accurate	  R	  wave	  peak	  detection	  on	  ECG	  monitoring	   is	   critical	   for	   good	  quality	  scans.	   Most	   MR	   systems	   currently	   use	   advanced	   triggering	   modules	   based	   on	  vectorcardiography	  (VCG)	  to	  improve	  R-­‐wave	  detection	  in	  the	  MR	  environment.	  Movement	  of	   the	   thorax	  during	  scanning	  can	  also	  affect	   image	  quality	  and	   this	  can	  be	  avoided	  by	  acquiring	  images	  during	  an	  expiratory	  breath-­‐hold.	   	  Patients	  with	   complex	   heart	   disease	   who	   are	   symptomatically	   breathless	  may	   struggle	  with	  lengthy	  breath-­‐hold	  instructions.	  In	  these	  situations	  it	  is	  possible	  to	  obtain	  diagnostic	  quality	  cine	  images	  by	  averaging	  out	  respiratory	  motion	  artifact	  with	  the	  use	  of	  multiple	  signal	  averages	  during	  free	  breathing	  scans	  38.	  
CMR	  Sequences:	  Spin	  Echo	  	  Spin	  echo	  or	   “black	  blood”	   images	  of	   the	  heart	  and	  blood	  vessels,	   in	  which	   the	  blood-­‐pool	   has	  no	  or	   little	   signal,	   are	  used	   to	   generate	   static	   anatomic	   images.	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The	   blood	   appears	   black	   due	   to	   flowing	   spins	  moving	   out	   of	   the	   image	   plane	  between	  excitation	  and	  signal	  read-­‐out.	  These	  are	  inversion	  recovery	  sequences	  and	  by	  using	  an	  inversion	  pulse,	   it	   is	  possible	  to	  achieve	  further	  suppression	  of	  signal	   from	   the	   blood	   pool	   and	   therefore	   better	   image	   quality.	   Predominantly	  used	   for	   static	   two-­‐dimensional	   imaging,	   these	   images	   provide	   excellent	  anatomic	   detail	   of	   cardiac	   chambers,	   great	   vessels	   and	   pericardium.	   These	  sequences	  allow	  tissue	  characterization	  by	  altering	  the	  T1	  and	  T2	  weighting	  38.	  
In	   TOF	   patients	   these	   sequences	   are	   commonly	   used	   to	   assess	   stented	   vessels	  especially	  the	  branch	  pulmonary	  arteries,	  as	  they	  are	  less	  prone	  to	  artefact	  seen	  with	   turbulent	   flow	   and	  metallic	   signal	   drop	   out.	   	   An	   example	   of	   black	   blood	  imaging	  in	  a	  Fallot	  patient	  and	  a	  patient	  with	  vasculitis	  and	  multiple	  pulmonary	  artery	  stenoses	  is	  shown	  in	  Figure	  5.	  	  









Figure	  5:	  Black	  Blood	  Imaging	  
(A)	   Patient	  with	  multiple	   pulmonary	   artery	   stenoses,	   note	   the	   very	   narrow	  proximal	  
left	  pulmonary	  artery	  
(B)	  Fallot	  patient	  with	  proximal	  left	  pulmonary	  artery	  stenosis	  
(C)	  Fallot	  patient	  with	  patent	  stent	  in	  the	  proximal	  right	  pulmonary	  artery	  
	  
	   32	  
CMR	  Sequences:	  Gradient	  Echo	  	  	  These	  sequences	  have	  become	  the	  mainstay	  for	  dynamic	  and	  structural	  imaging	  in	  all	  types	  of	  heart	  disease.	  They	  have	  fairly	  low	  soft-­‐tissue	  contrast	  compared	  to	   spin	   echo	   and	   flowing	   blood	   appears	   bright	   as	   it	   has	   high	   signal	   intensity.	  Known	   as	   fast	   gradient	   echo	   (GRE)	   or	   cine	   turbo-­‐field	   echo	   (TFE)	   imaging	   (or	  steady	  state	  free	  precession	  (SSFP)	  depending	  on	  scanner	  type)	  these	  sequences	  allow	   short	   acquisition	   times	   as	   they	   utilize	   segmental	   K-­‐space	   filling.	   SSFP	  imaging	   allows	   more	   reliable	   endo-­‐myocardial	   border	   recognition	   and	   faster	  acquisition	   times	  by	  use	  of	   shorter	   repetition	   times	   (TR)	   relative	   to	   the	  earlier	  techniques	  mentioned	  39.	  Parallel	  imaging	  can	  also	  be	  applied	  to	  further	  shorten	  imaging	   time	   and	   with	   application	   of	   multiple	   signal	   averages,	   images	   can	   be	  acquired	  during	  free	  breathing	  if	  clinically	  indicated	  40.	  	  In	  TOF	  patients	  this	  type	  of	  imaging	  provides	  valuable	  information	  regarding	  structure	  and	  function	  of	  the	  ventricle	  and	  ventricular	  outflow	  tracts.	  
Cardiac	  function:	  	  The	   opportunity	   to	   create	   multi-­‐slice	   and	   multi-­‐phase	   (i.e.	   showing	   motion	  throughout	  the	  cardiac	  cycle)	  SSFP	  imaging	  provides	  a	  wealth	  of	  information	  on	  ventricular	  dimensions	  and	  function.	  Using	  this	  technique	  CMR	  has	  been	  shown	  to	   be	   highly	   accurate	   and	   reproducible	   making	   it	   the	   gold	   standard	   imaging	  technique	   41.	   In	   conditions	   such	   as	   TOF	   the	   ability	   to	   accurately	   measure	  ventricular	  size	  and	  function	  is	  essential	  for	  clinical	  decision	  making	  on	  potential	  surgical	  treatment	  such	  as	  PVR.	  The	  methodology	  and	  planning	  of	  these	  types	  of	  sequences	   and	   post	   processing	   to	   achieve	   measurements	   will	   be	   explored	  further	  in	  Chapter	  2.	  Figure	  6	  shows	  an	  example	  of	  a	  short	  axis	  slice	  at	  the	  mid-­‐
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ventricle	   level	   in	   a	   patient	   with	   corrected	   TOF.	   This	   demonstrates	   the	   “bright	  blood”	   appearance	   and	   also	   the	   significant	   RV	   dilatation	   relative	   to	   the	   LV	  secondary	  to	  chronic	  pulmonary	  regurgitation.	  
Flow	  quantification:	  	  Gradient	   echo	   imaging	   can	   also	   be	   phase	   encoded	   allowing	   non-­‐invasive	  assessment	   of	   vascular	   blood	   flow.	   Velocity	   encoded	   or	   phase	   contrast	   flow	  imaging	   allows	   quantification	   of	   total	   blood	   flow	   and	   peak	   velocities	   and	  calculation	   of	   regurgitant	   volumes	   in	   great	   vessels.	   Most	   applications	   for	  measuring	  net	  flow	  have	  the	  velocity-­‐encoding	  direction	  set	  to	  be	  through	  plane	  and	   perpendicular	   to	   the	   long	   access	   of	   the	   vessel	   of	   interest.	   In	   combination	  with	   volumetric	   assessment	   this	   creates	   specific	   information	   on	   the	  hemodynamic	   changes	   occurring	   in	   the	   heart	   and	   is	   essential	   for	   follow	   up	   of	  patients	  with	  significant	  valve	  insufficiency	  as	  in	  repaired	  TOF	  40.	  An	  example	  of	  a	   flow	   imaging	  velocity–time	  curve	  generated	   from	  post	  processing	  of	   the	   flow	  data	  is	  shown	  in	  Figure	  7.	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Figure	  6:	  SSFP	  Imaging	  of	  the	  Ventricles	  
Short	   axis	   SSFP	   imaging	   at	   mid	   ventricular	   level	   of	   an	   adult	   patient	   with	   surgically	  
corrected	   TOF.	   CMR	   assessment	   showed	   a	   significantly	   dilated	   right	   ventricle	   with	  
preserved	  systolic	  function	  and	  severe	  pulmonary	  regurgitation	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  
Figure	  7:	  Flow	  Velocity-­‐Time	  Curve	  in	  Tetralogy	  of	  Fallot	  
This	  graph	  shows	  the	  velocity-­‐time	  curve	  for	  flow	  in	  the	  pulmonary	  artery	  in	  a	  patient	  
with	   corrected	  TOF.	   There	   is	   significant	  backward	   flow,	  which	   correlates	  with	   severe	  
pulmonary	  regurgitation	  in	  this	  patient.	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Three-­‐dimensional	  imaging:	  	  Morphological	   assessment	   of	   the	   heart	   and	   thoracic	   vessels	   can	   be	   achieved	  without	   contrast	   injection	   using	   ECG-­‐triggered	   3D	   SSFP	   sequence	   with	  respiratory	  navigator	  gating.	  Initially	  developed	  for	  coronary	  artery	  imaging	  it	  is	  allows	   near	   isotropic	   imaging	   of	   the	   entire	   cardiac	   volume	   (Figure	   8).	   This	  technique	  allows	  accurate	  multi-­‐planar	  reformatting	  of	  any	  desired	  image	  plane	  during	   post-­‐processing	   and	   is	   particularly	   useful	   in	   complex	   congenital	   heart	  disease	   42.	   In	   TOF	   patients	   this	   allows	   visualization	   of	   the	   coronary	   arteries	  clearly.	  In	  some	  TOF	  patients	  coronary	  artery	  morphology	  is	  abnormal	  and	  it	  is	  not	  uncommon	  for	  the	  right	  or	  left	  coronary	  artery	  to	  traverse	  the	  RVOT.	  When	  patients	  are	  being	  considered	  for	  pulmonary	  valve	  intervention	  this	  is	  extremely	  important	   as	   aberrant	   coronary	   anatomy	   may	   preclude	   certain	   therapeutic	  options	   such	   as	   trans-­‐catheter	   pulmonary	   valve	   implantation.	   Additionally	   the	  option	   of	   reconstructing	   the	   whole	   heart	   volume	   in	   any	   plane	   enables	   the	  clinician	   to	   exclude	   abnormal	   pulmonary	   venous	   drainage	   or	   aorto-­‐pulmonary	  collaterals,	   again	   important	   features	   that	   may	   be	   overlooked	   in	   functional	   2D	  scanning.	   Figure	   8	   shows	   an	   example	   of	   an	   isotropic	   data	   set	   from	   a	   neonatal	  TOF	  patient	  showing	  an	  aberrant	  left	  coronary	  artery	  traversing	  the	  RVOT.	  
Angiography:	  	  The	   administration	   of	   intra-­‐venous	   CMR	   contrast	   agents	   based	   on	   gadolinium	  chelates	   allows	   the	   performance	   of	   3D	   contrast	   enhanced	   CMR	   angiography	  providing	   high	   spatial	   and	   contrast	   resolution	   data	   of	   complex	   vascular	  structures.	  Post	  processing	  algorithms	   including	   surface	  volume	   rendering	  and	  curved	   multi-­‐planar	   reformation	   of	   the	   raw	   data	   help	   to	   delineate	   vascular	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anatomy.	   The	   sequence	   is	   a	   3D	   acquisition	   of	   T1-­‐weighted	   turbo	   field	   echo	   or	  fast	  gradient	  echo	  with	  flip	  angle	  of	  40-­‐45	  degrees	  and	  very	  short	  echo	  times	  and	  repetition	  times.	  It	  can	  be	  performed	  in	  a	  time	  resolved	  or	  dynamic	  fashion	  with	  multiple	   short	   acquisitions	   that	   cover	   the	   entire	   volume	  of	   interest	   40.	   	   In	  TOF	  patients	  this	  type	  of	  imaging	  allows	  visualization	  of	  the	  right	  ventricular	  outflow	  tract,	  main	  and	  branch	  pulmonary	  arteries	  and	  helps	  to	  determine	  the	  presence	  of	  any	  aorto-­‐pulmonary	  collaterals	  or	  associated	  aortopathy.	  Figure	  9	  shows	  an	  example	  of	  RVOT	  and	  pulmonary	  artery	  angiography	  in	  a	  patient	  with	  repaired	  TOF.	  	  
In	   summary	   CMR	   offers	   a	   huge	   amount	   of	   clinical	   data	   in	   congenital	   heart	  disease.	   In	   these	   patients,	   imaging	   should	   be	   undertaken	   by	   an	   experienced	  clinical	   team	   so	   that	   all	   aspects	   of	   abnormal	   anatomy	   can	   be	   considered	  throughout	  the	  scanning	  process.	  An	  example	  of	  a	  typical	  scanning	  protocol	  for	  a	  congenital	  patient	  is	  shown	  in	  Table	  1.	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Figure	  8:	  3D	  SSFP	  Imaging	  of	  the	  Coronary	  Arteries	  
This	   data	   set	   was	   acquired	   in	   a	   neonatal	   patient	   with	   TOF.	   The	   left	   anterior	  
descending	   artery	   (LAD)	   arises	   form	   the	   right	   coronary	   cusp	   and	   traverses	   the	   right	  
ventricular	  outflow	  tract	  (RVOT).	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  
	  
Figure	  9:	  MR	  Angiogram	  of	  Pulmonary	  Arteries	  
Right	  ventricle,	  outflow	  tract,	  main	  and	  branch	  pulmonary	  arteries	  in	  an	  adult	  patient	  
with	  repaired	  TOF.	  Large	  caliber	  branch	  pulmonary	  arteries	  are	  seen	  with	  no	  evidence	  
of	  stenosis.	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Table	  1:	  A	  Typical	  CMR	  Protocol	  
	  
 SUGGESTED MRI PROTOCOL FOR CONGENITAL HEART DISEASE 
1. Scouts	  and	  reference	  scans	  (parallel	  imaging)	  
2. Interactive	  imaging	  	  
	  	  	  	  	  	  	  	  	  For	  acquisition	  of	  scan	  plane	  geometries	  including:	  Four-­‐chamber,	  short-­‐axis,	  RVOT,	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  LVOT,	  pulmonary	  trunk	  through-­‐plane,	  aorta	  through-­‐plane,	  aortic	  arch,	  branch	  	  	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Pulmonary	  arteries	  2	  orthogonal	  in-­‐plane	  views	  and	  through-­‐plane	  
3. 2D	  multi-­‐slice	  b-­‐SSFP	  cine	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Whole	  ventricle	  in	  short-­‐axis	  or	  axial	  plane	  
4. 2D	  single-­‐slice	  b-­‐SSFP	  cine	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Four-­‐chamber	  view	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  RVOT	  (1-­‐2	  planes)	  and	  LVOT	  (1-­‐2	  planes)	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Branch	  pulmonary	  arteries	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Aortic	  arch	  
5. Phase-­‐contrast	  velocity	  mapping	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Main	  PA	  through-­‐plane	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Ascending	  aorta	  through-­‐plane	  	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Vascular	  stenosis	  in-­‐plane	  or	  through-­‐plane	  	  
6. 2D	  multi-­‐slice	  black-­‐blood	  imaging-­‐	  specifically	  to	  examine	  stenosis/stents	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Branch	  pulmonary	  arteries	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Aortic	  arch	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Vascular	  stenosis	  
7. 3D	  contrast-­‐enhanced	  MRA	  of	  the	  thoracic	  great	  vessels	  (1-­‐3	  dynamics)	  
8. Balanced-­‐SSFP	  3D	  ”whole-­‐heart”	  volume	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1.4	  Stress	  Imaging	  	  Stress	  imaging	  has	  been	  used	  for	  over	  25	  years	  and	  has	  become	  widely	  accepted	  as	  an	  important	  diagnostic	  tool	  in	  the	  assessment	  of	  coronary	  artery	  disease.	  Not	  only	  can	  wall	  motion	  abnormalities	  be	  appreciated	  in	  greater	  detail	  than	  at	  rest	  but	   information	   regarding	   perfusion	   can	   also	   be	   acquired	   43,	   44.	   This	   type	   of	  imaging	  is	  now	  being	  applied	  to	  congenital	  patients,	  as	  in	  addition	  it	  is	  possible	  to	   demonstrate	   changes	   in	   contractile	   reserve	   and	   diastolic	   function	   45.	   The	  following	  review	  considers	  the	  role	  of	  stress	  imaging	  in	  patients	  with	  surgically	  corrected	  TOF.	  
Exercise	  capacity	  and	  achievement	  of	  maximal	  heart	  rate	  has	  been	  shown	  to	  be	  abnormal	  in	  TOF	  patients	  and	  there	  is	  a	  negative	  correlation	  with	  the	  severity	  of	  pulmonary	   regurgitation.	   Diller	   et	   al	   also	   showed	   that	   in	   a	   variety	   of	   patients	  with	  congenital	  heart	  disease	  abnormal	  heart	  rate	  response	  to	  exercise	  predicted	  survival	  46,	  47.	  However	  more	  information	  is	  required	  about	  the	  functional	  cardiac	  changes	  and	  this	  has	  led	  to	  the	  development	  of	  combined	  imaging	  with	  physical	  stress.	  CMR	   imaging	  has	  proved	   to	  be	   the	  modality	  of	   choice.	  Study	  has	  shown	  that	  assessment	  of	  biventricular	  function	  and	  PR	  by	  CMR	  immediately	  following	  maximal	  exercise	  revealed	  an	  abnormal	  RV	  response	  (increase	   in	  RV-­‐EDV	  with	  exercise)	  in	  a	  TOF	  patient	  group	  compared	  to	  controls	  48.	  Although	  physiological,	  exercise	   CMR	   is	   limited	   by	   patient	   motivation,	   difficulties	   with	   breathing	  techniques	   and	   lack	   of	   exercise	   during	   image	   acquisition,	  which	  may	   result	   in	  inaccuracies	  in	  volumetric	  and	  flow	  analysis	  49	  45.	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Pharmacological	   stress	   with	   agents	   such	   as	   dobutamine,	   which	   mimic	   the	  cardiovascular	   oxygen	   demands	   of	   exercise,	   have	   been	   widely	   used	   in	   the	  assessment	   of	   ischemic	   heart	   disease	   with	   good	   reproducibility	   and	   safety	  profiles	   50.	  Dobutamine	   is	   a	   positive	   inotrope	   and	  while	   it	   increases	  heart	   rate	  and	   blood	   pressure	   significantly,	   in	   healthy	   volunteers	   the	   volumetric	   changes	  are	  characterized	  by	  a	  decrease	  in	  ESV	  with	  stable	  EDV.	  This	  results	  in	  a	  marked	  increase	  in	  stroke	  volumes	  (SV)	  and	  ejection	  fraction	  (EF)	  51-­‐53.	  	  
Dobutamine	   effects	   in	   normal	   healthy	   volunteers	   have	   been	   extensively	  reported.	  Echo	  study	  has	  shown	  that	  in	  healthy	  volunteers	  being	  exposed	  to	  up	  to	   10	   μg/kg/min	   of	   dobutamine	   there	   is	   a	   gradual	   decrease	   in	   left	   ventricular	  end-­‐systolic	  diameters	  with	  no	  significant	  change	  in	  end-­‐diastolic	  diameters	  53	   .	  This	   explains	   the	   increase	   in	   LV	   stroke	   volume	   and	   ejection	   fraction	   and	  demonstrates	  normal	  contractile	  reserve	  52-­‐54.	  However	  with	  dobutamine	  levels	  greater	   than	   20μg/kg/min	   ESV	   continues	   to	   decrease	   and	   EDV	   also	   decreases	  resulting	   in	  minimal	  change	  in	  SV	  but	  continued	  increase	   in	  EF	  at	  each	  level	  58.	  Dobutamine	   stress	   magnetic	   resonance	   (DS-­‐MR)	   studies	   have	   shown	   similar	  trends	   in	   normal	   individuals	   59	   although	   only	   data	   to	   a	   maximal	   dose	   of	  15μg/kg/min	   are	   available.	   Tulevski	   et	   al	   reported	   that	   at	   this	   dose	   there	   is	  equivalent	   response	   to	   that	   seen	  with	   echo	  with	  minimal	   change	   in	   both	   right	  and	  left	  ventricular	  EDV	  but	  significant	  reduction	  in	  biventricular	  ESV	  55,	  56.	  Study	  of	  patients	  with	  congenital	  heart	  disease	  has	  shown	  the	  potential	  of	  DS-­‐MR	  in	  the	  assessment	  of	  diastolic	  and	  systolic	  function	  57.	  Tetralogy	  of	  Fallot	  patients	  with	  dilated	   right	   ventricles	   and	   significant	   PR	  have	  been	   shown	   to	   have	  preserved	  ventricular	  functional	  reserve	  with	  dobutamine	  concentrations	  of	  7.5μg/kg/min	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58.	   However	   there	   is	   also	   evidence	   of	   impaired	   ventricular	   relaxation	   in	   these	  patients	  59.	  How	  this	  impaired	  diastolic	  function	  correlates	  with	  need	  for	  PVR	  is	  yet	  to	  be	  determined.	  In	  TOF	  patients	  resting	  RV	  volumes	  are	  used	  in	  addition	  to	  clinical	   symptoms	   and	   exercise	   capacity	   to	   determine	   timing	   of	   PVR	   18.	   As	   yet	  there	  is	  limited	  data	  to	  determine	  whether	  these	  volumetric	  parameters	  during	  stress	   provide	   any	   additional	   information.	   Ubeing	   et	   al	   observed	   that	   RV-­‐ESV	  may	   be	   the	  more	   valuable	   parameter,	   reflecting	   both	   RV	   volume	   load	   and	   RV	  myocardial	   contractility	   60.	   In	   a	   population	   of	   TOF	   patients	   undergoing	  dobutamine	   stress	   conductance	   catheter	   studies	   (10μg/kg/min	   dobutamine	  peak	   dose),	   larger	   RV-­‐ESV	  was	   associated	  with	   reduced	   end-­‐systolic	   elastance	  (Ees),	  a	  marker	  of	  load-­‐independent	  myocardial	  contractility.	  RV-­‐ESV	  correlated	  more	  closely	  with	  Ees	  than	  either	  RV-­‐EDV	  or	  RV-­‐EF.	  Hence,	  this	  showed	  that	  RV-­‐ESV	   reflected	   not	   only	   RV	   volume	   loading	   but	   also	   intrinsic	   myocardial	  contractility	  and	  may	  be	  regarded	  as	  a	  non-­‐invasive	  marker	  of	  contractility	  60.	  	  Therefore	   DS-­‐MR	   imaging	   is	   likely	   to	   be	   valuable	   in	   the	   assessment	   of	   TOF	  patients	  with	  significant	  pulmonary	  regurgitation.	  Previous	  study	  has	  cautiously	  used	  low	  dose	  dobutamine	  protocols	  (up	  to	  7.5μg/kg/min)	  61	  and	  this	  may	  miss	  important	  hemodynamic	  and	  volumetric	  changes,	  which	  become	  more	  evident	  at	  higher	   doses.	   Parameters	   such	   as	   RV-­‐ESV	  may	   also	   provide	  more	   information	  about	   early	   RV	   systolic	   dysfunction	   especially	   in	   TOF	   patients	   and	   in	  combination	  with	  DS-­‐MR	  this	  may	  prove	  to	  have	  clinical	  utility	  in	  the	  future.	  
The	  clinical	  utility	  of	  DS-­‐MR,	  optimal	  protocol	  and	  volumetric	  and	  hemodynamic	  results	  in	  healthy	  volunteers	  and	  TOF	  patients	  will	  be	  fully	  described	  in	  Chapters	  2	  and	  5.	  Safety	  considerations	  of	  CMR	  imaging	  and	  of	  DS-­‐MR	  are	  explored	  in	  the	  next	  section	  of	  this	  chapter.	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1.5	  CMR	  Safety	  CMR	  has	  many	  advantages	  over	   alternative	   imaging	  modalities;	   in	  particular	   it	  does	  not	  require	  ionizing	  radiation	  and	  allows	  imaging	  of	  the	  heart	  in	  any	  plane.	  However	   it	   is	  not	   completely	   risk	   free	   and	   there	   are	  many	   safety	   issues	  which	  still	  need	  to	  be	  addressed	  when	  considering	  a	  patient	   for	  CMR.	   	  A	  great	  deal	  of	  literature	  on	  MRI	  hazards	  and	  safety	  issues	  66-­‐70	  is	  available	  and	  a	  comprehensive	  review	  and	  discussion	  of	  the	  subject	  is	  outside	  the	  scope	  of	  this	  thesis.	  However	  when	  considering	  any	   research	  protocol	   involving	  patients	  and	  volunteers	   it	   is	  essential	  to	  minimize	  hazards	  relating	  to	  MRI.	  	  	  
Magnetic	  Field	  An	  MRI	  scanner	  such	  as	  the	  1.5T	  scanner	  used	  in	  this	  study	  is	  superconducting	  and	   therefore	   continuously	   on	   field	   i.e.	   the	   magnetic	   field	   of	   the	   scanner	   is	  present	   at	   all	   times	   even	   when	   no	   scanning	   is	   taking	   place.	   This	   presents	   a	  significant	  potential	  hazard.	  Any	  ferromagnetic	  object	  such	  as	  an	  oxygen	  cylinder	  or	  dobutamine	   infusion	  pump	  will	  be	  attracted	   to	   the	  scanner	  and	   the	   force	  of	  attraction	  increases	  the	  closer	  you	  get	  to	  the	  magnet.	  	  Therefore	  a	  ferromagnetic	  object	  which	  may	  be	  easily	  controlled	  by	  a	  person	  at	  a	  distance	  from	  the	  scanner	  becomes	  impossible	  to	  control	  close	  to	  the	  magnet	  bore	  and	  consequently	  can	  be	  pulled	  uncontrollably	  into	  the	  magnet	  causing	  damage,	  injury	  or	  even	  death	  43,	  69,	  
70.	   It	   is	   therefore	   essential	   that	   the	   all	   staff	   involved	   in	   MRI	   scanning	   are	  appropriately	   trained	   and	   that	   safety	   procedures	   are	   adhered	   to	   at	   all	   times.	  Patients	   and	   accompanying	   relatives	   must	   be	   carefully	   screened	   for	   metallic	  objects	   or	  metal	   devices	   before	   entering	   the	  MRI	   suite.	  Most	   implants	   used	   in	  patients	   with	   heart	   disease	   e.g.	   sternal	   wires;	   heart	   valves,	   stents,	   occluding	  devices	   and	   coils	   are	   not	   considered	   contraindications	   to	   MRI	   (although	   an	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artefact	   local	   to	   the	   implant	  may	  be	  present).	  All	  patients	  complete	  a	  screening	  checklist	  prior	  to	  entering	  the	  MRI	  scanner	  to	  risk	  assess	  for	  contraindications	  to	  MRI	  and	  the	  strict	  exclusion	  criteria	  applied	  to	  our	  patients	  and	  volunteers	  are	  listed	  in	  section	  2.2.1.	  
Pacemakers,	   and	   internal	   cardiac	   defibrillators	   (ICD),	   are	   considered	   strong	  relative	   contraindications	   to	  MRI	   although	   some	   reports	  of	   success	  do	  exist.	   In	  recent	   years	   CMR	   compatible	   pacemakers	   and	   ICD’s	   have	   been	   developed	   and	  are	  now	  commercially	  available.	  
Thermal	  injury	  The	  electro-­‐magnetic	  RF	   fields	  used	   in	  magnetic	  resonance	   lie	   in	   the	   frequency	  range	  of	   radio	  waves.	  There	   is	   a	  potential	   risk	  of	   thermal	   injury	   to	   the	  patient	  and	  equipment	  due	  to	  the	  fact	  that	  the	  currents	  generated	  by	  the	  RF	  wave	  leads	  to	   tissue	   warming.	   Usually	   the	   increase	   in	   temperature	   is	   less	   than	   1	   degree	  Celsius.	  The	   specific	   absorption	   rate	   (SAR)	   is	   the	  RF	  output	   absorbed	  per	   time	  unit	  and	  kilogram.	  For	  safety	  reasons,	  the	  RF	  power	  emitted	  by	  the	  system	  into	  the	   body	   is	   monitored	   and	   the	   respective	   SAR	   values	   are	   limited	   accordingly.	  SAR	  limits	  are	  incorporated	  in	  the	  design	  of	  commercial	  MR	  pulse	  sequences	  to	  ensure	  that	  maximum	  changes	  in	  tissue	  temperature	  are	  kept	  below	  regulatory	  guidelines	  69,	  70.	  The	  RF	  field	  may	  induce	  AC	  currents	  in	  metal	  implants	  or	  cables	  routed	  close	  to	  the	  patient	  (e.g.,	  ECG	  cables),	  resulting	  in	  local	  warming.	  	  	  
Nephrogenic	  systemic	  fibrosis	  	  Nephrogenic	   systemic	   fibrosis	   (NSF)	   is	  a	  potentially	   fatal	  multisystem	  disorder	  primarily	  affecting	  the	  skin	  and	  has	  been	  associated	  with	  the	  use	  of	  gadolinium	  based	   contrast	   agents	   in	   patients	   with	   severe	   renal	   impairment	   (glomerular	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filtration	   rate	   <30	   mL/min/1.73m2).	   The	   use	   of	   gadolinium	   based	   contrast	  agents	  for	  MRA	  must	  be	  avoided	  in	  these	  patients	  62.	  
	  
Dobutamine	  stress	  imaging	  	  In	   addition	   to	   the	   hazards	   of	   MRI	   scanning	   there	   is	   the	   additional	   concern	   of	  using	  a	  pharmacological	  stress	  agent,	  dobutamine,	  with	  potential	  significant	  side	  effects.	   Patient	   safety	   in	   cardiac	   stress	  MRI	   is	   a	  major	   concern	   and	   requires	   a	  good	   understanding	   of	   contraindications,	   termination	   criteria,	   possible	  complications,	   and	   side	   effects.	   The	   MRI	   unit	   must	   be	   equipped	   with	  resuscitation	  equipment.	  The	  presence	  of	  a	  physician	  with	  experience	  in	  cardiac	  stress	   imaging,	   and	   advanced	   cardiac	   life	   support	   is	   required	   for	   such	   studies.	  Patient	  monitoring	  with	  continuous	  ECG	  and	  blood	  pressure	  is	  essential	  and	  use	  of	   pulse	   oximetry	   should	   be	   considered,	   especially	   in	   patients	  with	   congenital	  heart	  disease	  who	  may	  have	  shunts	  resulting	  in	  resting	  hypoxia.	  It	  must	  also	  be	  appreciated	   that	   dobutamine	   may	   predispose	   patients	   to	   arrhythmia	   most	  commonly	   ectopic	   beats,	   which	   may	   interfere	   with	   the	   R-­‐R	   interval,	   and	   thus	  affect	  image	  acquisition	  with	  certain	  MRI	  sequences.	  Additionally	  although	  not	  a	  significant	   concern	   in	   the	   congenital	   patient	   group	   the	   presence	   of	   ischaemic	  changes	  on	  the	  ECG	  should	  be	  interpreted	  with	  care	  as	  ST	  segment	  abnormalities	  are	  often	  significantly	  affected	  by	  the	  magnetic	  field	  and	  therefore	  abnormalities	  may	  not	  be	  reliably	  detected	  50	  63	  .	  	  	  
Recent	   studies	   have	   demonstrated	   high-­‐dose	   dobutamine	   MRI	   to	   be	   safe	   and	  feasible	  in	  patients	  with	  suspected	  coronary	  artery	  disease	  (CAD)	  and	  with	  a	  low	  incidence	  of	  side	  effects	  50,	  64.	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In	  congenital	  heart	  disease	  there	  has	  been	  a	  more	  cautious	  approach	  to	  the	  use	  of	   dobutamine	   and	   currently,	   a	   dobutamine	   dose	   of	   7.5μg/kg/min	   has	   been	  considered	   to	   be	   the	   safest	   and	  most	   effective	   65.	   Previous	   echo	   study	   of	   TOF	  patients	   has	   used	   higher	   doses	   of	   dobutamine	   up	   to	   40μg/kg/min	   and	   only	  reported	   one	   case	   of	   non-­‐sustained	   ventricular	   tachycardia	   at	   a	   dose	   of	  20μg/kg/min	  66,	  67.	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1.6	  Thesis	  Aims	  The	  purpose	  of	  this	  research	  was	  to	  determine	  whether	  DS-­‐MR	  has	  clinical	  utility	  in	  TOF	  patients	  with	  significant	  PR.	  	  
The	  following	  aims	  were	  defined:	  
1:	  To	  define	  the	  safety	  and	  feasibility	  of	  DS-­‐MR	  up	  to	  a	  dose	  of	  20μg/kg/min	  of	  dobutamine	  in	  TOF	  patients	  and	  a	  healthy	  volunteer	  group.	  
2:	  To	  determine	  the	  haemodynamic	  and/or	  volumetric	  changes	  during	  DS-­‐MR	  in	  TOF	  patients	  and	  how	  these	  relate	  to	  baseline	  characteristics.	  
3:	   To	   determine	   whether	   the	   volumetric	   response	   during	   DS-­‐MR	   seen	   in	   TOF	  patients	  is	  normal	  compared	  to	  a	  group	  of	  healthy	  volunteers.	  
4:	  To	  examine	  the	  association	  between	  great	  artery	  flow	  analysis	  and	  volumetric	  analysis	  in	  TOF	  patients	  during	  DS-­‐MR.	  
5:	   To	   establish	   whether	   image	   analysis	   during	   DS-­‐MR	   is	   accurate	   and	  reproducible.	  
6:	   To	   assess	   the	   utility	   of	   fast	   3D	   volumetric	   assessment	   and	   its	   role	   in	   stress	  imaging.	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CHAPTER	  2:	  IMAGING	  PROTOCOLS	  AND	  METHODS	  	  CMR	   continues	   to	   be	   the	   gold	   standard	   imaging	  modality	   in	   the	   assessment	   of	  patients	  with	   congenital	  heart	  disease.	  The	  previous	   chapter	  has	  discussed	   the	  merits	  of	  CMR	   in	  assessment	  of	   the	   right	  ventricle	  with	  particular	   reference	   to	  patients	  with	  surgically	  repaired	  TOF.	  Volumetric	  assessment	  in	  cardiac	  patients	  provides	   valuable	   information	   regarding	   volumes,	   regional	   wall	   motion	  abnormality	  and	  systolic	  function.	  	  
This	   chapter	  will	  document	   the	  protocols	   and	  methods	  used	   to	  assess	  patients	  with	  congenital	  heart	  disease	  especially	  those	  with	  surgically	  corrected	  TOF.	  The	  first	  part	  of	   the	  chapter	  will	   focus	  on	  bi-­‐ventricular	  volumetric	  assessment	   in	  a	  variety	  of	  congenital	  patients	  and	  the	  comparison	  of	  standard	  approach	  of	  multi-­‐slice	   2D	   imaging	   to	   single	   breath	   hold	   3D	   volume	   acquisition.	   Following	   this	  there	  will	  be	  a	  review	  of	  the	  CMR	  protocols	  used	  in	  the	  assessment	  of	  volumes	  and	   great	   arterial	   flows	   in	   TOF	   patients	   at	   rest	   and	   during	  DS-­‐MR	   imaging.	   In	  addition	   the	  methods	   used	   in	   volumetric	   analysis	   and	  post-­‐processing	   and	   the	  importance	  of	  observer	  variance	  are	  explored.	  The	  final	  sections	  of	  this	  chapter	  describe	  the	  Echo	  protocol	  performed	  in	  the	  TOF	  patients	  followed	  by	  a	  review	  of	  the	  statistical	  methods	  utilized	  in	  data	  analysis.	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2.1	  Volumetric	  Assessment	  3D	  vs.	  2D Volumetric	  assessment	  of	  the	  cardiac	  ventricles	  has	  become	  an	  essential	  part	  of	  any	  CMR	  study	  68-­‐73.	  Traditionally,	  cine	  images	  are	  acquired	  in	  the	  short	  axis	  (SA)	  orientation	  with	  multiple	  slices	  through	  the	  ventricles.	  Although	  well	  validated,	  this	   technique	   requires	   the	   acquisition	  multiple	   slices	   covering	   both	   ventricles	  requiring	  multiple	  breath	  holds.	  	  3D	  imaging	  of	  the	  ventricles	  could	  circumvent	  these	  limitations	  and	  a	  number	  of	  techniques	   have	   been	   tried	   in	   recent	   years	   74,	   75	   76.	   One	   problem	   with	   these	  techniques	   especially	   using	   self-­‐respiratory	   gating	   is	   long	   scanning	   times.	   For	  improved	  patient	  comfort	  and	  reduced	  scan	  time,	  assessment	  of	  cardiac	  function	  within	   one	   breath	   hold	   would	   be	   ideal.	   Functional	   studies	   of	   the	   heart	   under	  different	  patient	  conditions	  such	  as	  in	  stress	  MRI	  would	  also	  then	  be	  possible.	  	  Therefore,	  we	  sought	   to	  evaluate	  a	  single	  breath-­‐hold	  3D	  cine	  b-­‐SSFP	  protocol.	  To	   allow	  acquisition	  of	   a	   full	   ventricular	   volume	   in	  one	  breath-­‐hold	  we	  used	  a	  32-­‐channel	   coil	   allowing	   for	   SENSE	   under	   sampling	   in	   both	   phase-­‐encoding	  directions	   combined	   with	   further	   acceleration	   by	   partial	   Fourier	   encoding	  reconstruction.	  	  The	  protocol	  allowed	  assessment	  of	  the	  impact	  of	  injection	  of	  an	  extracellular	  contrast	  agent	  on	  contrast-­‐to-­‐noise	  ratio	  (CNR)	  between	  blood	  and	  myocardium,	  image	  quality	  with	  respect	  to	  endocardial	  blurring	  and	  accuracy	  of	  3D	  cine	  b-­‐SSFP	  as	  compared	  with	  cardiac	  volumes	  assessed	  by	  standard	  multi-­‐slice	  cine	  SSFP	  used	  as	  a	  reference.	   	  The	  CMR	  sequences	  and	  study	  will	  now	  be	  discussed	  further.	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3D	  Imaging	  Patient	  Population	  	  Fifteen	  patients	  (mean	  age	  35±13	  years,	  5	  female,	  10	  male)	  attending	  for	  routine	  CMR	   were	   prospectively	   recruited.	   Twelve	   patients	   were	   referred	   for	  assessment	   of	   a	   cardiac	   congenital	   abnormality	   and	   three	   for	   assessment	   of	  suspected	  or	  known	  ischemic	  heart	  disease	  (Table	  2).	  All	  patients	  gave	  written	  consent.	  Exclusion	  criteria	  were	  contraindications	  for	  CMR.	  
2.1.1	  Data	  Acquisition	  	  The	  patients	  were	  scanned	  using	  1.5T	  MR-­‐scanner	  (Achieva,	  Philips	  Healthcare,	  Best,	   The	   Netherlands)	   with	   a	   32-­‐element	   cardiac	   coil	   (16	   anterior	   and	   16	  posterior	   elements	   with	   a	   4x4	   configuration,	   Philips	   Healthcare).	   Cardiac	  synchronization	  was	   performed	  with	   vector	   electrocardiography	   (VECG).	   After	  localization	   and	   a	   coil	   sensitivity	   reference	   scan,	   an	   interactive	   scan	   was	  performed	  in	  order	  to	  determine	  the	  geometry	  of	  the	  short	  axis	  (SA)	  view.	  This	  was	  used	   for	   planning	   the	  multiple	   slice	   2D	   (M2D)	   and	  3D	  ventricular	   volume	  scans.	  All	  patients	  underwent	  standard	  M2D	  cine	  b-­‐SSFP	  sequence	  with	  multiple	  breath	  holds	  (2	  slices	  per	  breath-­‐hold,	  12.3-­‐17.2	  seconds	  per	  breath	  hold,	  mean	  total	   scan	   duration	   4.9mins)	   for	   volumetric	   and	   functional	   ventricular	  assessment.	   Additionally,	   in	   each	   patient	   a	   single	   breath	   hold	   3D	   cine	   b-­‐SSFP	  sequence	   pre	   and	   1	   minute	   post	   administration	   of	   Gd-­‐DTPA	   (Gadolinium	  diethylenetriamine	  penta-­‐acetic	  acid,	  0.1mmol/kg)	  was	  performed	  (breath	  hold	  18-­‐26	   seconds).	   The	   contrast	   agent	   was	   given	   as	   part	   of	   a	   first-­‐pass	   MR	  angiogram,	  which	  was	  clinically	  indicated.	  Administration	  of	  gadolinium	  contrast	  agent	  at	  this	  timing	  interval	  allowed	  good	  mixing	  of	  the	  agent	  while	  maintain	  a	  high	   concentration	   in	   the	   blood	   pool.	   The	   3D	   cine	   b-­‐SSFP	   acquisition	   was	  
	   51	  
accelerated	   using	   a	   SENSE	   factor	   of	   2	   in	   both	   phase	   encoding	   directions	   (AP	  being	   the	   first	   phase	   encoding	   direction,	   and	   right-­‐left	   (RL)	   being	   the	   second	  phase	  encoding	  direction)	  and	  partial	  Fourier	  reconstruction	  (factor	  of	  0.625)	  in	  the	   first	   phase	   encoding	   direction,	   resulting	   in	   a	   net	   acceleration	   factor	   of	   6.4.	  Comparative	  parameters	  for	  the	  M2D	  and	  3D	  b-­‐SSFP	  scans	  are	  shown	  in	  Table	  3.	  
2.1.2	  Image	  Quality	  Analysis	  Accuracy	   of	   volumetric	   assessment	   tends	   to	   be	   dictated	   by	   the	   clarity	   of	   the	  endocardial	   border	   definition.	   If	   there	   is	   motion	   artefact	   due	   to	   breathing	   or	  arrhythmia	   this	   may	   significantly	   affect	   endocardial	   border	   by	   eye	   or	   by	  computer	  generated	  semi-­‐automated	  software.	  McConnell	  et	  al	  devised	  a	  scoring	  system	   to	   evaluate	   image	   quality	   and	   this	  was	   used	   to	   determine	  whether	   the	  data	   collected	  by	  both	   the	  conventional	  multi-­‐slice	  2D	   imaging	  and	   the	   fast	  3D	  volume	  were	  of	  adequate	  quality	  to	  allow	  volumetric	  analysis.	  	  	  
To	   do	   this	   the	   images	   were	   scored	   by	   independent	   observers.	   Using	   a	   mid	  ventricular	  reference	  image	  window	  and	  level	  settings	  were	  chosen	  to	  optimize	  contrast	  between	  blood	  pool	  and	  myocardium	  and	  these	  settings	  were	  applied	  to	  all	   images	   77.	   10	   patient	   data	   sets	   containing	   an	   example	   diastolic	   image	   from	  each	   of	   the	   3	   imaging	   types	   were	   randomly	   ordered	   and	   imaged	   scored	   by	   4	  experience	   independent	   observers.	   Image	   quality	   of	   2D	   and	   3D	   images	   was	  graded	   on	   a	   4	   point	   scale	   based	   on	   the	   visibility	   of	   the	   endocardial	   border	  (modified	   from	  McConnell	   et	   al	   78)	   .	   Score	   (1)	  Poor:	   endocardial	  border	  poorly	  visible	   or	   not	   visible	   (non-­‐diagnostic),	   (2)	   moderate	   blurring	   of	   endocardial	  border,	   (3)	  good	  endocardial	  border	  visibility,	   (4)	  excellent	   image	  quality.	  This	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method	   of	   scoring	  was	   also	   used	   for	   the	   volume	   assessments	   in	   the	   TOF	   CMR	  protocol	  described	  in	  the	  next	  section	  of	  this	  chapter.	  
Table	  2:	  Fast	  3D	  Imaging	  –	  Demographics	  
	  
Patient Age Diagnosis 
1 22 Aortic coarctation 
2 52 AVSD repair 
3 35 Aortic coarctation 
4 60 Ischaemic heart disease 
5 28 Tetralogy of Fallot 
6 56 Ischaemic heart disease 
7 71 Ischaemic heart disease 
8 19 Aortic coarctation 
9 38 Aortic coarctation 
10 31 Aortic regurgitation 
11 34 Ebstein anomaly 
12 40 Aortic stenosis 
13 29 Tetralogy of Fallot 
14 34 Aortic coarctation 
15 36 Pulmonary regurgitation and VSD 	  
Table	   3:	   Comparison	   of	   M2D	   SSFP	   sequence	   with	   the	   Single	   Breath	   Hold	   3D	   SSFP	  
sequence	  
Parameter M2D SSFP 3D SSFP 
Field of view (mm) 360-410 310-363 
Spatial Resolution (mm) 2.1 x 2.14 x 10 2.13 x 2.26 x 10 
Number of slices 10-12 10-12 
Number of breath holds 5-6 1 
Breath hold duration (s) 12.3-17.2 18-26 
SENSE Factor 




(2 AP x 2 RL) 
TFE factor 7-12 12-18 
Temporal Resolution (ms) 21-38 44-65 
Cardiac Phases 20-30 20 
TR / TE (ms) 1.6 / 3.2 1.8 /3.6 	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Contrast	  to	  Noise	  Assessment	  	  Visual	   image	   scoring	   allows	   qualitative	   assessment	   but	   it	   is	   also	   necessary	   to	  perform	  a	  quantitative	  measure	  of	  image	  quality	  and	  this	  can	  be	  done	  using	  the	  contrast	   to	   noise	   ratio.	   This	   helps	   to	   determine	   whether	   the	   presence	   of	  gadolinium	   contrast	   agent	   significantly	   affects	   image	   quality	   and	   also	  whether	  there	   is	   a	   significant	   difference	   between	   the	   two	   different	   non-­‐contrast	   scans.	  Contrast	   to	   noise	   ratio	   (CNR)	   for	   M2D,	   3D	   pre	   contrast	   (3DNC)	   and	   3D	   post	  contrast	   (3DC)	   was	   evaluated	   by	   measuring	   the	   mean	   pixel	   value	   (signal	  intensity	  SI)	  within	  a	  region	  of	  interest	  (ROI)	  for	  blood	  and	  a	  separate	  ROI	  for	  the	  myocardium.	  The	  blood	  pool	  ROI	  was	  drawn	   in	   the	   centre	   of	   the	   left	   ventricle	  and	   myocardium	   ROI	   the	   mid	   septum.	   All	   measurements	   were	   made	   at	   end-­‐diastole.	  Mean	  and	  standard	  deviation	  (SD)	  signal	  intensity	  was	  also	  collected	  in	  the	  background	  (estimation	  of	  noise)	  in	  a	  region	  close	  to	  the	  chest	  wall.	  The	  2D	  and	  3D	  scans	  were	  acquired	  using	  SENSE,	  and	  it	  is	  therefore	  difficult	  to	  obtain	  an	  absolute	  measure	   of	   noise.	   However,	   for	   the	   3D	   scans	   all	   imaging	   parameters	  (including	  coil	   sensitivity	  maps)	  were	   identical	  and	  the	  same	  region	  of	   interest	  was	  used.	  Contrast	  to	  noise	  was	  then	  calculated	  by:	  	  
(mean	  SI	  blood-­‐	  mean	  SI	  myocardium)	  /	  SD	  background	  noise	  
The	  results	  of	  the	  CNR	  measurements	  for	  the	  3	  different	  sequences	  and	  how	  this	  related	   to	   visual	   scoring	   and	   accuracy	   of	   volume	   assessment	   will	   be	   explored	  further	  in	  chapter	  3.	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Volumetric	  Analysis	  The	  final	  comparative	  measure	  in	  this	  patient	  group	  was	  volumetric	  assessment	  of	  left	  and	  right	  ventricles.	  Volumetric	  analysis	  was	  performed	  in	  all	  patients	  for	  the	  M2D	  multi-­‐slice	  stack	  and	  the	  pre	  and	  post	  contrast	  3D	  volume.	  Endocardial	  borders	  were	  manually	  drawn	  for	  the	  three	  data	  sets	  allowing	  segmentation	  of	  both	   ventricle	   in	   systole	   and	   diastole	   using	   commercially	   available	   software	  (Philips,	   Viewforum).	   Papillary	   muscles	   were	   excluded	   for	   the	   left	   and	   right	  ventricles.	  End-­‐diastolic	   (EDV)	  and	  end-­‐systolic	   (ESV)	  volumes	  were	  calculated	  for	  the	  left	  (LV)	  and	  right	  ventricle	  (RV),	  from	  which	  the	  stroke	  volume	  (SV)	  and	  ejection	   fraction	   (EF)	   were	   derived.	   A	   detailed	   review	   of	   methods	   used	   to	  quantify	  ventricular	  volumes	  is	  available	  in	  section	  2.2.	  	  	  To	   further	   validate	   the	   methods,	   two	   experienced	   independent	   observers	  analyzed	  ten	  of	  the	  data	  sets	  to	  assess	  inter-­‐observer	  variability.	  	  The	   volumes	  measured	   by	   the	   3	  methods	  were	   compared	   using	   Bland	  Altman	  analysis	  to	  determine	  whether	  the	  fast	  3D	  imaging	  is	  as	  accurate	  as	  conventional	  multi-­‐slice	   2D	   imaging.	   The	   results	   of	   this	   analysis	  will	   be	   described	   in	   full	   in	  Chapter	  3.	  This	  small	  study	  highlights	  the	  complexity	  of	  components	  involved	  in	  volumetric	  assessment.	   Although	   post-­‐processing	   software	   used	   to	   measure	   cardiac	  volumes	  is	  semi-­‐automated,	  accurate	  volume	  assessment	  requires	  experience	  to	  ensure	   that	   important	   factors	   that	   may	   affect	   image	   quality	   are	   taken	   into	  consideration.	  The	  following	  section	  will	  focus	  on	  volumetric	  assessment	  in	  TOF	  patients	  and	  healthy	  volunteers	  and	   introduce	  the	  methods	  used	   in	  stress	  CMR	  imaging.	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2.2	  CMR	  assessment	  in	  tetralogy	  of	  Fallot	  	  CMR	   imaging	   in	   TOF	   patients	   incorporates	   assessment	   of	   anatomy,	   systolic	  function	  and	  arterial	   flow	  patterns	   in	  order	   to	  give	  a	   comprehensive	   review	  of	  the	  post	  surgical	  repair	  status.	  From	  previous	  studies	  we	  have	  seen	  that	  resting	  right	  ventricular	  volumes	   in	  TOF	  patients	  with	   severe	  PR	  do	  not	  easily	  predict	  which	  patients	  require	  PVR	  most	  urgently	  and	  have	  limited	  clinical	  application	  in	  terms	  of	  predicting	   improvement	   in	  RV	   function	  post	  PVR.	  Stress	   imaging	  with	  CMR	  and	  Echo	  has	  been	  limited	  to	  date	  partly	  due	  to	  concern	  about	  side	  effects	  with	  higher	  dose	  pharmacological	  agents	  such	  as	  dobutamine.	  In	  addition	  image	  quality	  tends	  to	  be	  compromised	  when	  using	  pharmacological	  or	  physical	  stress	  with	  either	  imaging	  modality.	  	  
The	  main	  focus	  of	  this	  thesis	  was	  to	  evaluate	  the	  volumetric	  response	  to	  stress	  using	  dobutamine	  as	  a	  surrogate	  for	  exercise.	  This	  was	  achieved	  using	  a	  staged	  CMR	   dobutamine	   protocol	   with	   the	   assessment	   of	   bi-­‐ventricular	   volumes	   and	  great	   arterial	   flows	   at	   each	   stage.	   The	   following	   section	   details	   the	   CMR	  sequences	  and	  the	  dobutamine	  protocols	  used	  in	  TOF	  patients	  and	  in	  a	  group	  of	  healthy	  volunteers.	  
2.2.1	  DS-­‐MR	  Study	  Demographics	  Between	   March	   2007	   and	   October	   2009,	   28	   adult	   patients	   with	   surgically	  repaired	   TOF	   referred	   for	   CMR	   as	   part	   of	   their	   standard	   clinical	   care	   were	  recruited	   prospectively.	   Patients	   were	   selected	   based	   on	   echocardiographic	  findings	   of	   moderate	   to	   severe	   pulmonary	   regurgitation	   and	   dilated	   right	  ventricle.	  	  For	  comparison,	  we	  collaborated	  with	  a	  second	  centre	  (S.K.,	  Nebraska,	  USA)	   and	   recruited	   ten	   healthy	   volunteers	   in	   2010	   for	   CMR	   assessment	   of	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ventricular	   function	   at	   rest	   and	   dobutamine	   stress.	   This	   collaboration	   allowed	  utility	   of	   the	   same	   type	   of	   1.5T	   Philips	   scanner,	   32	   channel	   coil	   and	   therefore	  identical	  sequences.	  The	  stress	  protocols	  were	  also	  identical.	  	  	  
2.2.2	  Inclusion	  and	  exclusion	  criteria.	  	  	  The	  exclusion	  criteria	  were:	  
• Patients	   and	   volunteers	   with	   contraindications	   for	   CMR	   including	  incompatible	  metallic	  implants	  or	  claustrophobia.	  	  
• Patients	  with	  contraindications	  to	  dobutamine	  administration	  (history	  of	  ventricular	   tachycardia,	   documented	   ischemic	   heart	   disease,	   poor	   left	  ventricular	   systolic	   function,	   severe	   aortic	   valve	   disease	   or	   significant	  pulmonary	  stenosis).	  	  
• Patients	  with	  more	   than	   trivial	  aortic	  and	   tricuspid	  regurgitation	  or	  any	  residual	  left-­‐to-­‐right	  shunt.	  
• Patient	  currently	  taking	  beta-­‐blocker	  treatment.	  	  
• Volunteers	  with	  any	  cardiac	  history	  or	  history	  of	  any	  chronic	  illness	  Medical	   records	   were	   reviewed	   for	   patient	   characteristics	   and	   anatomic	   and	  operative	   details	   and	   these	   together	   with	   volunteer	   characteristics	   are	  summarized	  in	  Table	  4.	  	  The	   local	   research	   ethics	   committees	   in	   each	   centre	   approved	   the	   study	   and	  informed	   consent	   was	   obtained	   from	   all.	   Details	   of	   the	   patient	   information	  leaflet,	  ethics	  approval	  and	  consent	  forms	  are	  available	  in	  Appendix	  1.	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Table	  4:	  Study	  Population	  
	  
	  
2.2.3	  Cardiac	  magnetic	  resonance	  study	  	  Patients	  and	  volunteers	  were	  scanned	  using	  1.5T	  MR-­‐scanner	   (Achieva,	  Philips	  Healthcare,	   Best,	   The	   Netherlands)	   with	   a	   32	   channel	   cardiac	   coil	   (Philips	  Healthcare).	   Cardiac	   synchronization	   was	   performed	   with	   vector	  electrocardiography	   (VECG).	   A	   full	   clinical	   protocol	   was	   performed	   on	   each	  patient	   (see	   chapter	  1,	   table	  1	   for	  details).	  This	   commenced	  with	  a	   survey	  and	  reference	   scan.	  Anatomical	   planes	  were	   created	  using	   a	   real	   time	   “Interactive”	  sequence	  which	  allowed	  pre-­‐scan	  planning	  of	   specific	  geometries	   such	  as	   right	  ventricular	  outflow	  tract	  view	  (RVOT),	   through	  plane	  ascending	  aorta	  (Ao)	  and	  pulmonary	  artery	  (PA)	  and	  branch	  pulmonary	  artery	  cross	  sections	  (required	  for	  flow	   quantification).	   This	   was	   followed	   by	   sequences	   required	   to	   assess	  ventricular	   function	  and	  flow	  and	  these	  will	  be	  explained	  in	  more	  detail	  below.	  	  
Demographics Fallot Patients Healthy Volunteers 
Study population  n=28 n=10 
Gender Male=14 (50%) Male=5 (50%) 
Age at CMR (y) 32.1 (16.2-60.1) 40.6 (23.9-51.8) 
Age at TOF repair (y) 4.9 (1.0-31.1)  
Interval since TOF repair (y) 25.1 (14.1-47.3)  
Palliations prior to TOF repair 7/28  
TOF repair type   
• Trans-annular repair 13/28  
• Non-trans annular repair 3/28  
• Unknown 12/28  
NYHA classification 1.8 ± 0.6  
QRS duration (ms) 151 ± 7.7  
Baseline RV-EDV (ml/m2) 134.5±31.4 76.6±14.3 
Baseline RV-ESV(ml/m2) 64.4±22.1 32.1±8.6 
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The	  final	  component	  of	  the	  clinical	  scan	  was	  an	  MR	  angiogram	  of	  the	  RVOT	  and	  pulmonary	  arteries	  and	  an	  isotropic	  3D	  cardiac	  volume	  for	  anatomical	  review.	  
Volumetric	  Assessment	  As	   discussed	   above	   cardiac	   volume	   assessment	   is	   a	  major	   component	   of	   CMR	  assessment.	   Good	   quality	   imaging	   is	   required	   to	   ensure	   accurate	   volume	  quantification.	  In	  TOF	  patients	  with	  severe	  PR	  there	  is	  often	  dilatation	  of	  the	  RV	  and	   RVOT.	   Conventionally	   volumes	   are	   measured	   using	   the	   short	   axis	   (SA)	  orientation,	  as	  this	  is	  optimal	  for	  the	  shape	  of	  the	  left	  ventricle.	  	  SA	  assessment	  of	  volumes	   in	   TOF	   patients	   has	   been	   validated	   and	   used	   routinely	   in	   clinical	  practice	  although	  it	  has	  been	  shown	  that	  assessment	  using	  axial	  slices	  is	  superior	  in	   terms	   of	   accuracy	   and	   observer	   variance	   79.	   This	   axial	   orientation	   allows	  better	  appreciation	  of	  the	  right-­‐sided	  valve	  planes	  and	  right	  ventricular	  outflow	  tract	   dilatation.	   Therefore	   for	   the	   TOF	   patients	   the	   volume	   assessment	   was	  performed	   using	   the	   axial	   orientation	   rather	   than	   SA.	   In	   contrast	   in	   healthy	  volunteers	  we	  chose	  to	  assess	  ventricular	  function	  in	  the	  conventional	  way	  using	  SA	   slices.	   The	   impact	   of	   this	   change	   in	   orientation	  between	   the	   groups	  will	   be	  further	  explained	  in	  chapter	  5.	  	  
In	   this	   research	   study	   the	   conventional	  multi-­‐slice	   SSFP	   sequence	  was	  used	   to	  assess	   cardiac	   volumes.	   This	   multi-­‐phase,	   multi-­‐slice	   volumetric	   data	   set	   was	  acquired	   using	   a	   fast	   2-­‐dimensional	   balanced	   steady	   state	   free	   precession	  sequence	   (b-­‐SSFP).	   Continuous	   slices	   (12-­‐14,	   i.e.	   6-­‐7	   breath-­‐holds)	   were	  acquired	   in	   an	   axial	   orientation	   (transverse)	   for	   the	  TOF	  patients	   and	   in	   short	  axis	   orientation	   for	   the	   volunteers	   to	   cover	   the	   ventricles	   in	   accordance	   with	  standardized	  imaging	  protocols	  79.	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Imaging	   parameters	   were	   as	   follows:	   TR/TE=3.0ms/1.5ms,	   flip	   angle	   60°,	   30	  cardiac	   phases	   per	   average	   heart	   beat,	   field	   of	   view	   360x480	  mm,	  matrix	   size	  196x172,	   slice	   thickness	   8-­‐10	   mm,	   no	   intersection	   gap,	   sensitivity	   encoding	  (SENSE)	  for	  spatial	  under	  sampling	  (factor	  2).	  	  
Flow	  In	  addition	  to	  volumetric	  assessment	  all	  patients	  and	  volunteers	  had	  pulmonary	  artery	  and	  aortic	   flow	   	   (PC-­‐flow)	  quantified	  at	   rest	   and	  during	  DS-­‐MR.	  All	  TOF	  patients	   studied	   had	   a	   degree	   of	   pulmonary	   regurgitation	   and	   the	   inclusion	   of	  flow	   assessment	   in	   the	   protocol	  was	   to	   determine	   how	   flow	   dynamics	   change	  during	  DS-­‐MR	  and	  whether	  derived	  volumetric	  and	  flow	  parameters	  can	  be	  used	  interchangeably	  in	  the	  assessment	  of	  ventricular	  function	  in	  TOF	  patients.	  Both	  modalities	  are	   likely	   to	  suffer	   from	  some	  reduced	   image	  quality	  during	  DS-­‐MR.	  Flow	  imaging	  in	  particular	  may	  also	  suffer	  from	  inaccuracy	  due	  to	  increased	  flow	  turbulences	  at	  higher	  blood	  flow	  rates	  80	  and	  be	  sensitive	  to	  errors	  from	  cardiac	  arrhythmia	  such	  as	  ventricular	  ectopics	  81.	  Hence,	  the	  focus	  was	  to	  examine	  the	  flow	   dynamics	   during	   DS-­‐MR,	   how	   these	   effect	   the	   amount	   of	   pulmonary	  regurgitation	   and	   whether	   this	   has	   any	   bearing	   on	   the	   volumetric	   changes	  observed.	   Phase	   contrast	   (PC)	   flow-­‐derived	   measures	   of	   right	   and	   left	  ventricular	   (LV)	   stroke	   volumes,	   absolute	   pulmonary	   artery	   backward	   flow	  volumes	   (PA-­‐BF)	   and	   pulmonary	   artery	   regurgitant	   fraction	   (PA-­‐RF)	   should	  agree	  with	   analogous	   volumetric-­‐derived	   parameters	   at	   rest.	   However	   little	   is	  known	  about	  how	  this	  relationship	  changes	  with	  stress	  and	  this	  has	  been	  further	  evaluated	  in	  chapter	  4.	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Pulmonary	  artery	  (PA)	  and	  aortic	  (AO)	  flows	  were	  performed	  perpendicular	  to	  the	   vessel	   flow	   using	   a	   retrospective	   2D	   phase	   contrast	   sequence	   during	   free	  breathing.	  Image	  planes	  were	  located	  for	  pulmonary	  artery	  flow	  at	  the	  midpoint	  of	  the	  main	  PA	  and	  just	  above	  the	  level	  of	  the	  sinus	  of	  the	  aorta	  and	  for	  the	  aorta	  within	  the	  ascending	  aorta	  at	  the	  level	  of	  pulmonary	  artery	  bifurcation.	  	  Imaging	   parameters	   were	   as	   follows:	   TR/TE=4.4ms/2.4ms,	   flip	   angle	   10°,	  velocity	   encoded	   value	   (VENC)	   set	   to	   200-­‐350	   m/s,	   40	   cardiac	   phases	   per	  average	  heart	  beat,	   field	  of	  view	  350x300,	  matrix	  size	  256x256,	   slice	   thickness	  8mm,	  duration	  (depending	  on	  heart	  rate)	  usually	  between	  1.0	  and	  2.5	  minutes.	  	  	  PC-­‐flow	   rates	   were	   calculated	   as	   area	   (semi-­‐automated	   tracing	   the	   cross	  sectional	   area	   of	   the	   vessel	   of	   interest	   in	   the	  magnitude	   images)	  multiplied	  by	  the	  mean	  velocity	  (derived	  from	  the	  phase	  images)82.	  Flow	  parameters	  (forward	  flow,	  backward	  flow,	  stroke	  volume,	  regurgitant	  fraction,	  cardiac	  output)	   in	  the	  pulmonary	  artery	  and	  ascending	  aorta	  were	  normalized	  to	  the	  body	  surface	  area.	  	  
2.2.4	  Dobutamine	  Stress	  Imaging	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Table	  5:	  DS-­‐MR	  Safety	  Checklist	  
	  
Stress	  Protocol	  A	   full	   anatomical	   and	   functional	   assessment	   including	   great	   artery	   flows	   and	  ventricular	   volumes	   was	   completed	   for	   each	   of	   the	   TOF	   patients	   at	   rest	   as	  previously	   described.	   	   On	   completion	   of	   the	   clinical	   scan,	   dobutamine	  hydrochloride	   (Hameln	   pharmaceuticals	   ltd,	   Gloucester,	   UK)	  was	   administered	  by	   continuous	   infusion	   into	   a	   large	   antecubital	   vein.	   An	   initial	   infusion	   of	  10μg/kg/min	  (stage	  1	  DS-­‐MR)	  of	  dobutamine	  was	  allowed	  to	  reach	  steady	  state	  over	   3-­‐5	   minutes,	   with	   monitoring	   of	   the	   heart	   rate	   and	   blood	   pressure.	   At	  steady	   state,	   phase	   contrast	   flow	   imaging	   of	   aortic	   and	   pulmonary	   artery	   flow	  was	  completed	  followed	  by	  a	  b-­‐SSFP	  axial	  multi-­‐slice	  stack	  to	  assess	  ventricular	  function.	  Providing	  the	  patient	  remained	  asymptomatic,	  the	  dobutamine	  infusion	  was	  increased	  to	  20μg/kg/min	  for	  a	  further	  3-­‐5	  minutes	  (stage	  2	  DS-­‐MR)	  and	  the	  CMR	  stress	  protocol	  repeated.	  Dobutamine	  was	  then	  discontinued	  and	  patients	  removed	  from	  the	  MR	  scanner	  to	  allow	  for	  a	  period	  of	  recovery.	  	  Each	   volunteer	   had	   a	   quantitative	   volume,	   aortic	   and	   pulmonary	   flow	  assessment	  at	  rest	  and	  during	  dobutamine	  stress	  using	  the	  same	  stress	  protocol	  as	   detailed	   above.	   However	   volumetric	   assessment	   was	   performed	   using	   the	  standard	  short	  axis	  orientation.	  This	  allowed	  the	  opportunity	  for	  further	  analysis	  
Checklist 
1. Resuscitation equipment 
2. Blood pressure, O2 saturation and ECG monitoring 
3. MR compatible syringe driver for dobutamine administration 
4. 12 lead ECG machine 
5. Access to emergency drugs especially atropine 
6. Clinician with Advanced Life Support training 
	   62	  
of	  circumferential	  motion	  of	  a	  normal	  left	  ventricle	  under	  stress	  conditions	  and	  further	  information	  regarding	  this	  can	  be	  found	  in	  the	  appendix.	  	  Dobutamine	   infusion	   was	   discontinued	   if	   systolic	   blood	   pressure	  reached>180mmHg,	   heart	   rate	   >75%	   predicted	   (220	   -­‐	   age),	   or	   if	   patients	  experienced	  other	  significant	  side	  effects,	  such	  as	  dyssrhythmia	  or	  hypotension.	  
2.2.5	  Volumetric	  and	  Flow	  Analysis	  -­‐	  Post-­‐processing	  
Volumetric	  Analysis	  Both	   ventricles	  were	   segmented	   in	   systole	   and	   diastole	   using	   semi-­‐automated	  commercially	  available	  software	  (ViewForum,	  Philips	  Medical	  Systems,	  Best,	  The	  Netherlands)	   with	   endocardial	   borders	   drawn	   manually	   by	   two	   independent	  observers.	  Papillary	  muscles	  were	  excluded	  for	  the	  left	  and	  right	  ventricles.	  End-­‐diastolic	   (EDV)	  and	  end-­‐systolic	   (ESV)	  volumes	  were	  calculated	   for	   the	  RV	  and	  (LV),	   from	  which	  the	  stroke	  volume	  (SV)	  and	  ejection	  fraction	  (EF)	  and	  cardiac	  output	   (CO)	   were	   derived.	   All	   volume	   measurements	   were	   indexed	   for	   body	  surface	   area	   and	   expressed	   as	  ml/m2.	    Contractile	   reserve	  was	   defined	   as	   the	  percentage	   change	   in	   ventricular	   EF	   at	   each	   stage	   of	   dobutamine	   infusion	  compared	   with	   resting	   EF	   91.	   Volumetric	   assessment	   was	   completed	   for	   all	  patients	   at	   each	   stage	   of	   the	   dobutamine	   stress	   protocol.	   These	   results	   of	   this	  analysis	  will	  be	   fully	  explained	   in	  chapter	  6	  which	  will	   focus	  on	   the	  changes	   in	  ventricular	   volumes	   that	   occur	   under	   stress	   and	   how	   this	   relates	   to	   resting	  cardiac	  function	  in	  TOF	  patients	  and	  healthy	  volunteers.	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Flow	  Analysis	  Flow	   measurements	   were	   calculated	   by	   use	   of	   semi-­‐automated	   vessel	   edge	  detection	   algorithm	   (Extended	  MR	  work	   space	   version	   2.5.3.1,	   Philips	  Medical	  Systems,	  Best,	  The	  Netherlands.).	  	  Flows	  were	  documented	  in	  the	  following	  way:	  1. Total	  aortic	  forward	  flow	  Ao-­‐FF	  (total)	  2. Total	  pulmonary	  forward	  flow	  PA-­‐FF	  (total)	  3. Total	  pulmonary	  regurgitant	  volume	  of	  backward	  flow	  PA-­‐BF	  4. Pulmonary	  stroke	  volume	  or	  effective	  forward	  flow	  PA-­‐SV(eff	  FF)	  calculated	  by:	  (PA-­‐FF)	  –	  (PA-­‐BF)	  5. Pulmonary	  artery	  regurgitant	   fraction	  PA-­‐RF:	  expressed	  as	  a	  percentage	  of	  	  (PA-­‐BF/	  PA-­‐FF	  (total))	  x	  100	  All	   flow	  measurements	   were	   indexed	   for	   body	   surface	   area	   and	   expressed	   as	  ml/beat/m2.	  
LV	  and	  RV	  stroke	  volumes	  comparison	  with	  flow	  The	  LV	  and	  RV	  SV	  were	  calculated	  from	  the	  volumetric	  analysis	  as	  SV=EDV-­ESV	  
83.	  In	  the	  absence	  of	  atrioventricular	  valve	  incompetence	  or	  intracardiac	  shunts,	  the	  ventricular	  SV	  should	  match	  the	  forward	  flow	  in	  its	  connected	  great	  artery	  83.	  	  
Therefore	  the	  systemic	  antegrade	  output	  or	  LV	  stroke	  volume	  can	  be	  compared	  to	   the	   forward	   blood	   flow	   entering	   the	   aorta	   (Ao-­‐FF)	   after	   each	   ventricular	  contraction.	  	  
Likewise	  the	  pulmonary	  antegrade	  output	  or	  RV-­‐SV	  was	  compared	  with	  the	  total	  pulmonary	  artery	  forward	  flow	  (PA-­‐FF).	  	  
Further	   comparisons	   between	   flow	   and	   derived	   volumetric	   parameters	   can	  therefore	  be	  made	  using	  the	  SV	  difference	  method	  as	  detailed	  below.	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Pulmonary	  Backward	  Flow	  	  The	   pulmonary	   artery	   backward	   flow	   (PA-­‐BF)	   was	   defined	   as	   the	   absolute	  regurgitant	  volume	  (ml/m2)	  across	  the	  pulmonary	  valve.	  In	  the	  absence	  of	  aortic	  valve	  incompetence	  or	  intra-­‐cardiac	  shunts,	  the	  volumetric	  derived	  PA-­‐BF	  can	  be	  calculated	  by	  the	  SV	  difference	  method	  83	  as:	  	  	  
PA-­BF	  =	  RVSV	  –	  LVSV	  
We	  compared	  this	  volumetric	  derived	  parameter	  with	  the	  PA-­‐BF	  as	  assessed	  by	  PC-­‐flow.	  
Pulmonary	  Regurgitant	  Fraction	  	  Pulmonary	   artery	   regurgitant	   fraction	   (PA-­‐RF)	   is	   commonly	   defined	   as	   the	  proportion	   of	   the	   regurgitant	   pulmonary	   flow	   per	   total	   forward	   flow/stroke	  volume.	  	  
The	  PA-­‐RF	  can	  be	  calculated	  from	  the	  PC-­‐flow	  83	  analysis	  as:	  	  
PA-­RF	  [%]	  =	  (PA-­BF	  /	  PA-­FF)	  x	  100	  By	   use	   of	   the	   SV-­‐difference	   method	   as	   described	   above,	   the	   PA-­‐RF	   can	   be	  calculated	  from	  the	  volumetric	  analysis	  as	  83:	  	  
PA-­RF	  [%]	  =	  (RVSV-­LVSV	  /	  RVSV)	  x	  100	  We	   compared	   the	   PA-­‐RF	   assessed	   by	   PC-­‐flow	   analysis	   with	   the	   volumetric	  derived	  parameter.	  	  
The	   above	   parameters	   were	   compared	   at	   rest	   and	   during	   stress	   for	   all	   TOF	  patients	  and	  further	  details	  of	  the	  results	  are	  available	  in	  chapter	  4.	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2.3	  Observer	  Variance	  As	   we	   have	   already	   seen	   in	   the	   early	   aspects	   of	   this	   chapter	   volumetric	  assessment	   of	   cardiac	   ventricle	   is	   complex	   and	   requires	   experience	   both	   to	  acquire	   good	   quality	   images	   and	   in	   the	   post	   processing	   analysis	   to	   ensure	  accuracy.	  Volumetric	  assessment	  by	  CMR	  has	  been	  shown	  to	  be	  highly	  accurate	  and	  reproducible	  especially	  for	  the	  left	  ventricle	  and	  in	  healthy	  volunteers.	  When	  applying	  new	  techniques	  to	  groups	  of	  patients	  or	  analyzing	  volumes	  or	  flows	  in	  different	   physiological	   conditions	   it	   is	   important	   to	   establish	   whether	   these	  methods	  are	  robust.	  It	  is	  apparent	  that	  for	  RV	  assessment	  the	  axial	  imaging	  plane	  tends	   to	   give	   more	   accurate	   and	   reproducible	   volumes	   and	   this	   certainly	  influenced	   our	   protocol.	   The	   accuracy	   of	   volume	   assessment	   during	   DS-­‐MR	   is	  less	  well	  described.	  Dobutamine	  stress	  magnetic	  cardiac	  resonance	  imaging	  (DS-­‐MR)	   is	   widely	   used	   in	   the	   assessment	   of	   adult	   patients	   with	   ischemic	   heart	  disease	  84	  with	  good	  reproducibility	  and	  safety	  data	  50.	  However	  there	  is	  limited	  volume	  data	  in	  his	  group	  as	  the	  focus	  of	  these	  studies	  tend	  to	  be	  on	  regional	  wall	  motion	   abnormalities	   relating	   to	   underlying	   ischaemia.	   In	   congenital	   heart	  disease	  there	  is	  limited	  data	  related	  to	  volume	  assessment	  (see	  Chapter	  1.4)	  but	  tends	   to	  be	  at	   a	   lower	  dose	   than	   the	  protocol	  we	  used	   65.	  Currently	  a	  maximal	  dose	  of	  7.5mcg/kg/min	  dobutamine	  is	  considered	  safe	  and	  reproducible	  61.	  	  Section	  2.1	  describes	   the	   elements	   taken	   into	   consideration	  when	  evaluating	   a	  technique	  for	  accuracy.	  In	  order	  to	  determine	  the	  reproducibility	  and	  accuracy	  of	  the	  data	  collected	  during	  DS-­‐MR	  similar	  analysis	  was	  completed	  at	  each	  level	  of	  stress	  testing	  in	  TOF	  patients	  and	  volunteers.	  The	  results	  of	  this	  will	  be	  available	  in	  chapter	  4.	  The	  methods	  used	  are	  described	  below:	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Volumetric	  Observer	  Variance	  
For	  inter-­‐observer	  variability	  two	  observers	  (VP	  and	  IV)	  with	  over	  three	  years	  of	  CMR	  experience	  analyzed	  all	  TOF	  and	  volunteer	  data	  sets	  as	  described	  above	  at	  rest	   and	   both	   levels	   of	   dobutamine.	   Both	   observers	   also	   analyzed	   flow	  quantification	  for	  the	  PA	  and	  AO.	  Additionally,	  ten	  data	  sets	  for	  the	  TOF	  patients	  and	  all	  of	  the	  volunteer	  data	  sets	  were	  re-­‐analyzed	  by	  a	  single	  observer	  (VP)	  to	  document	  intra-­‐observer	  variability	  for	  volume	  and	  flow	  assessment.	  
Image	  Quality	  Assessment	  
Image	   qualitative	   analysis	  was	   performed,	   (as	   in	   Section	   2.1)	   by	   two	   pediatric	  cardiologists	  with	  over	  five	  years	  experience	  in	  CMR.	  From	  10	  randomly	  chosen	  TOF	  patient	  data	  sets,	  and	  10	  volunteer	  DS-­‐MR	  data	  sets	  a	  mid-­‐ventricular	  slice	  was	  chosen	  in	  end-­‐systole	  and	  end-­‐diastole.	  Reference	  image	  window	  and	  level	  settings	  were	  used	  to	  standardize	  contrast	  between	  blood	  pool	  and	  myocardium	  in	  all	   images.	  Observers	  were	  blinded	  to	  the	  stage	  of	  DS-­‐MR.	  Image	  quality	  was	  scored	   based	   on	   the	   visibility	   of	   the	   endocardial	   border,	   as	   reported	   by	  McConnell	  et	  al	  85.	  	  
All	  measures	  of	  variability	  between	  observers	  or	  methods	  were	  compared	  either	  using	  the	  coefficient	  of	  variation	  or	  Bland	  Altman	  analysis.	  
The	  accuracy	  and	  reproducibility	  of	  these	  techniques	  will	  be	  discussed	  at	  length	  in	  Chapter	  4.	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2.4	  Echocardiography	  Protocol	  in	  Tetralogy	  of	  Fallot	  One	   of	   the	   initial	   aims	   of	   this	   thesis	   was	   to	   evaluate	   the	   utility	   of	  echocardiography	   in	   addition	   to	   CMR	   in	   the	   assessment	   of	   the	   cohort	   of	   TOF	  patients	  with	  PR	  at	  rest	  and	  during	  dobutamine	  stress.	  A	  baseline	  echo	  protocol	  was	   performed	   prior	   to	   each	   study	   and	   this	   included	   all	   of	   the	   standardized	  parameters	   of	   left	   and	   right	   ventricular	   function,	   valve	   assessment	   as	   well	   as	  tissue	  Doppler	  imaging	  and	  3D	  volumetric	  assessment	  of	  the	  right	  ventricle.	  On	  completion	   of	   the	   baseline	   echo	   the	   patients	   completed	   the	   CMR	   and	   DS-­‐MR	  protocols	  described	  above.	  	  
	  The	   echo	   assessment	   was	   performed	   within	   the	   MR	   scanner	   room.	   It	   was	  possible	  to	  use	  an	  XMR	  facility,	  which	  combines	  an	  X-­‐ray	  table	  and	  MRI	  scanner	  (Figure	   10).	   The	   patient	  was	   initially	   positioned	   on	   the	   X-­‐ray	   part	   of	   the	   XMR	  system	  to	  allow	  the	  echo	  machine	  to	  be	  used	  within	  the	  scanning	  room	  (outside	  of	  the	  specified	  Gauss	  safety	  line).	  This	  allowed	  echo	  assessment	  to	  be	  performed	  on	   exactly	   the	   same	   day	   and	   within	   the	   same	   environment	   as	   the	   CMR	  assessment.	   Once	   complete	   the	   patient	  was	  moved	   along	   the	   XMR	   system	   and	  positioned	  within	  the	  MR	  scanner.	  	  
Prior	   to	  discontinuation	  of	   the	  dobutamine	   the	  patient	  was	  mobilized	   to	   the	  X-­‐ray	  portion	  of	   the	  XMR	  table	  as	  described	  above	  and	  a	   limited	  stress	  echo	  was	  performed	   which	   included	   TDI	   assessment	   and	   3D	   volume	   of	   the	   RV.	   A	  description	  of	  the	  echo	  protocol	  and	  specifics	  are	  detailed	  below.	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Figure	  10:	  XMR	  Facility	  
A	  combined	  X-­‐ray	  and	  MRI	  scanner	  within	  interlocking	  table	  to	  enable	  imaging	  of	  the	  
patient	   on	   the	   X-­‐ray	   table	   initially	   then	   positioning	   of	   the	   patient	   within	   the	   MRI	  
scanner	  	  
	  
Resting	  Echo	  Assessment	  Echocardiographic	   examination	   performed	   by	   a	   single	   sonographer	   (VP)	   in	   all	  study	  patients	  using	  IE33	  machine	  (Philips	  Healthcare).	  For	  standardized	  2D	  and	  TDI	  imaging	  a	  S5-­‐1	  sector	  array	  transducer	  with	  5	  to	  1	  MHz	  extended	  operating	  frequency	  range	  was	  used.	  The	  resting	  echo	  examination	  included	  assessment	  of	  the	  ventricles	  and	  cardiac	  valves	  according	  BSE	  standards.	  	  
Tissue	  Doppler	  	  Tissue	  Doppler	  PW	  Doppler	  was	   recorded	   for	   the	  RV	   free	  wall	   (just	   inferior	   to	  the	   tricuspid	   annulus),	   septum	   and	   LV	   lateral	   wall	   in	   the	   apical	   four-­‐chamber	  view.	  This	  allowed	  quantification	  of	  the	  peak	  systolic	  (S),	  early	  diastolic	  (E)	  and	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late	  diastolic	  (A)	  wave	  velocity	  was	  measured	  for	  the	  basal	  segment	  of	  each	  wall.	  Measurements	   were	   taken	   by	   one	   investigator	   and	   obtained	   by	   averaging	   3	  consecutive	  beats.	  
3D	  assessment	  of	  the	  right	  ventricle	  3DE	   was	   performed	   using	   the	   IE	   33	   (Philips,	   Andover,	   MA,	   USA)	   ultrasound	  machine	   with	   X3–1	   matrix-­‐array	   transducers	   (Philips).	   Image	   acquisition	   was	  performed	   from	   an	   apical	   window	   with	   the	   RV	   as	   the	   region	   of	   interest.	   To	  encompass	  the	  complete	  RV	  into	  the	  3D	  dataset,	  a	  full	  volume	  scan	  was	  acquired	  in	   harmonic	   mode	   from	   four	   R-­‐wave	   triggered	   sub-­‐volumes.	   This	   scan	   was	  carried	   out	   during	   an	   end-­‐expiratory	   breath-­‐hold	   lasting	   5	   seconds	   when	  possible.	   The	   3D	   dataset	   was	   stored	   in	   a	   DICOM	   format	   on	   a	   CD-­‐ROM	   and	  transferred	   to	   separate	   workstations	   for	   off-­‐line	   data	   analysis. Automated	  border	  detection	  and	  volume	  computation	  algorithm	  analysis	  of	  original	  raw	  was	  performed	   using	   dedicated	  RV	   analysis	   software	   (TomTEC,	  Munich,	   Germany).	  The	  3D	  dataset	  could	  be	  manipulated	  offline	  to	  allow	  the	  best	  visualization	  of	  the	  RV	  inflow	  and	  outflow	  tracts.	  End-­‐diastolic	  and	  end-­‐systolic	  phases	  were	  defined	  and	   contours	   were	   manually	   drawn	   in	   end-­‐diastolic	   and	   end-­‐systolic	   images.	  These	   were	   propagated	   throughout	   the	   data	   set	   and	   in	   order	   to	   generate	  volumetric	  measures	  and	  ejection	  fraction.	  	  
Stress	  Echo	  Imaging	  This	  aspect	  of	  the	  study	  was	  performed	  immediately	  after	  the	  completion	  of	  CMR	  stress	   protocol.	   The	   dobutamine	   infusion	  was	   continued	   at	   20	   μg/kg/min	   and	  limited	   echo	   parameters	   were	   collected.	   The	   intention	   was	   to	   assess	   TDI	   PW	  Doppler	  and	  a	  3D	  RV	  volume,	  as	  per	   the	  protocol	  documented	  above.	  However	  this	   aspect	   of	   the	   protocol	   proved	   to	   be	   challenging	   due	   to	   significant	  motion	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artefacts	   secondarily	   to	   tachycardia	  at	   this	  dose	  of	  dobutamine,	  which	  affected	  the	  3D	  image	  acquisition	  and	  later	  analysis	  on	  the	  post	  processing	  software	  (see	  appendix	  2).	  	  
	  
2.4	  Statistics	  Statistical	   analysis	   was	   performed	   using	   Statistical	   Analysis	   Software	   (SASW)	  version	  18.	  All	   data	  with	   a	   normal	   distribution	   are	  described	   as	  mean	  +/-­‐	   one	  standard	  deviation.	  Comparison	  of	  volumes	  and	  flows	  from	  one	  level	  of	  stress	  to	  the	  next	  was	  evaluated	  using	  the	  3	  way	  ANOVA	  followed	  by	  paired	  student	  t	  test,	  as	   were	   the	   differences	   between	   sub-­‐groups	   (defined	   by	   response	   in	   RV-­‐ESV)	  with	  p<0.05,	   level	  of	  significance.	  Regression	  analysis	  was	  used	  to	  correlate	  the	  percentage	  change	  in	  volumes	  against	  EF.	  Inter	  and	  intra-­‐observer	  variance	  was	  assessed	   using	   the	   coefficient	   of	   variance	   for	   the	   volumetric	  measurements	   at	  each	   level	   of	   DS-­‐MR.	   The	   Bland-­‐Altman	   analysis	   was	   used	   for	   comparison	   of	  volumetric	   versus	   PC-­‐flow-­‐derived	   analogous	   cardiovascular	   functional	  parameters	   and	   also	   to	   compare	   the	   volumetric	   assessment	  measured	   in	  M2D	  scan	  versus	  3D	  volumes	  (pre	  and	  post	  contrast)	  61	  86.	  Image	  quality	  comparison	  was	  evaluated	  with	  Friedman	  ranks	  analysis.	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CHAPTER	  3:	  FAST	  3D	  VOLUMETRIC	  IMAGING	  
3.1	  Overview	  	  The	   previous	   chapter	   discussed	   the	   protocols	   and	   techniques	   used	   for	   the	  evaluation	   of	   cardiac	   volumes	   in	   patients	   with	   congenital	   heart	   disease	   in	  particular	  repaired	  TOF	  and	  also	  in	  healthy	  volunteers.	  In	  this	  chapter	  the	  use	  of	  faster	  volumetric	  scanning	  is	  explored	  and	  data	  relating	  to	  a	  single	  breath	  hold	  volumetric	  assessment	  is	  discussed.	  	  There	   is	   a	   move	   to	   produce	   faster	   MR	   sequences,	   which	   will	   allow	   rapid	   full	  volume	   assessment	   in	   a	   single	   breath-­‐hold	   or	   during	   free	   breathing	   scanning.	  This	  would	   be	   preferable	   in	   sick	   patients	  who	   find	   the	   repetitive	   breath	   holds	  challenging.	   One	   approach	   to	   circumvent	   these	   limitations	   would	   be	   the	  acquisition	  of	  a	  3D	  cine	  data	  covering	  both	  ventricles.	  Single	  breath-­‐hold	  3D	  cine	  techniques	  have	  been	  proposed	  by	  using	  either	  highly	  parallel	   imaging	  87	  or	  by	  exploiting	   the	   spatial-­‐temporal	   correlations	   with	   kt-­‐techniques	   88,	   89.	  Unfortunately	   a	   major	   disadvantage	   of	   3D	   cine	   acquisitions	   is	   reduced	   blood-­‐myocardial	   contrast,	   which	   hampers	   clear	   delineation	   of	   endocardial	   borders.	  This	  has	  been	  demonstrated	  to	  be	  mainly	  due	  to	  the	  lack	  of	  blood	  inflow	  in	  large	  3D	  volumes	  90.	  Application	  of	  a	  contrast	  agent	  was	  shown	  to	  improve	  the	  image	  contrast	   for	   3D	   volumetric	   assessment	   using	   a	   kt-­‐technique.	   However,	   this	  approach	   suffers	   from	   endocardial	   blurring	   related	   to	   the	   reconstruction	  algorithm,	  leading	  to	  an	  underestimation	  of	  end-­‐diastolic	  volumes	  due	  to	  partial	  volume	   effects	   88,	   91.	   Furthermore,	   as	   kt-­‐techniques	   usually	   require	   a	   training	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period	   either	  with	   an	   additional	   breath-­‐hold,	   with	   the	   diaphragm	   in	   the	   same	  position	  or	  a	  longer	  breath-­‐hold	  this	  requires	  considerable	  patient	  cooperation.	  Recently,	   self-­‐respiratory	  navigated	   techniques	   74,	   75	   and	  highly	  under	   sampled	  reconstruction	  techniques	  have	  been	  proposed	  to	  acquire	  whole	  heart	  cine	  data	  sets	   76.	   One	   problem	   using	   self-­‐respiratory	   gating	   techniques	   is	   long	   scanning	  times.	   Therefore,	   for	   improved	   patient	   comfort	   and	   reduced	   scan	   time	  assessment	   of	   cardiac	   function	  within	   one	   breath	   hold	  would	   be	   ideal.	   Such	   a	  technique	   could	   then	   be	   used	   during	   stress	   imaging	   which	   would	   limit	   the	  duration	  of	  stress	  and	  possible	  side	  effects	  that	  patients	  have	  to	  experience.	  	  	  In	  order	  to	  determine	  whether	  such	  a	  novel	  technique	  could	  be	  applied	  to	  stress	  imaging	   it	   was	   necessary	   to	   first	   apply	   the	   sequence	   in	   patients	   at	   rest	   and	  compare	  the	  accuracy	  of	  cardiac	  volume	  evaluation.	  	  The	  methodology	  of	  3D	  imaging	  of	  the	  ventricles	  and	  the	  patient	  cohort	  used	  has	  been	   fully	   explained	   in	   the	   previous	   chapter.	   How	   this	   approach	   performs	  compared	  to	  the	  standard	  multi-­‐slice	  acquisition	  will	  now	  be	  discussed.	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3.2	  Results	  of	  3D	  compared	  with	  2D	  imaging	  The	   patient	   population	   and	   demographics	   have	   been	   described	   in	   chapter	   2.1.	  Data	  were	  successfully	  acquired	  in	  all	  patients.	  The	  patients	  were	  predominantly	  adult	   congenital	   patients	   who	   had	   had	   corrective	   surgery	   of	   a	   structural	  abnormality	  in	  childhood.	  Volume	  data	  was	  acquired	  in	  the	  short	  axis	  orientation	  and	   three	   sets	   of	   volume	   data	   generated	   for	   each	   patient.	   The	   first	   data	   set	  corresponds	   to	   the	   conventional	  multi-­‐slice	   2D	   (M2D).	   The	   3D	   SSFP	   full	   heart	  volume	   was	   performed	   immediately	   prior	   to	   and	   post	   contrast	   injection	   (see	  methods	   chapter	   2)	   and	   these	   data	   sets	   were	   therefore	   classified	   as	   3D	   non-­‐contrast	   (3DNC)	   or	   3D	   contrast	   (3DC).	   Images	   for	   the	   multi-­‐slice	   2D	   (M2D)	  images	  and	  the	  pre	  and	  post	  contrast	  images	  are	  shown	  in	  figure	  11.	  
3.2.1	  Scan	  duration	  One	  of	  the	  most	  important	  features	  of	  the	  3D	  approach	  is	  the	  reduction	  of	  total	  scan	  time.	  The	  mean	  breath	  hold	  (BH)	  duration	  for	  the	  acquisition	  of	  2	  slices	  for	  the	  M2D	  approach	  was	  14.9s	  (12.3-­‐17.2	  for	  2	  slices),	  resulting	  in	  approximately	  4	   to	   5	   minutes	   for	   the	   complete	   ventricular	   volume	   data	   acquisition.	   In	  comparison	  3D	  scans	  required	  a	  mean	  single	  BH	  of	  20s	  (Table	  3	  Chapter	  2).	  	  
3.2.2	  Image	  Quality	  M2D	   images	   provided	   the	   best	   visualization	   of	   the	   endocardial	   border	   with	   a	  mean	   score	   of	   3.9.	   The	   3D	   images	   pre	   contrast	   (3DNC)	   only	   achieved	   a	  mean	  visual	   score	   of	   2.2	   due	   to	   reduced	   contrast	   between	   blood	   pool	   and	   the	  endocardial	   border	   in	   the	   majority	   of	   images.	   The	   administration	   of	   contrast	  agent	   resulted	   in	   improvement	   in	   image	   quality	   with	   a	   mean	   score	   of	   3.2.	  Friedman’s	  ranks	  analysis	  showed	  the	  difference	   in	   image	  quality	   for	   the	   three	  scan	  types	  to	  be	  significant	  p<0.01	  (Mean	  rank	  M2D	  2.8,	  3DC	  2.02,	  3DNC	  1.18).	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Figure	  11:	  Mid-­‐ventricular	  images	  for	  M2D	  and	  3D	  Sequence	  
M2D	  images	  (a)	  diastolic	  phase	  (d)	  systolic	  phase	  
3D	  images	  post	  contrast	  (b)	  diastolic	  phase	  (e)	  systolic	  phase	  
3D	  images	  pre	  contrast	  (c)	  diastolic	  phase	  (f)	  systolic	  phase	  
	  
	  





Contrast to Noise Measurements 
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3.2.3	  Blood-­‐Myocardial	  Contrast	  Contrast	  to	  noise	  results	  for	  all	  three	  image	  types	  are	  shown	  in	  Table	  6.	  The	  M2D	  and	  3D	   images	  post	  gadolinium	  showed	  greater	  contrast	  between	  myocardium	  and	  blood	  pool	  than	  the	  3D	  images	  pre	  contrast.	  These	  had	  the	  least	  contrast	  and	  therefore	   the	  worst	   delineation	  of	   the	   endocardial	   border	   as	   supported	  by	   the	  visual	  scoring	  results.	  
3.2.4	  Ventricular	  volume	  analysis	  Left	  and	  right	  ventricular	  parameters	  for	  all	  three	  scan	  groups	  are	  shown	  in	  table	  7.	   Statistical	  analysis	   (t-­‐test)	   showed	  no	  significant	  difference	   for	  measured	  LV	  and	  RV-­‐EDV	  and	  ESV	  between	  the	  M2D	  and	  3DC	  images.	  However,	  Bland	  Altman	  plots	   showed	   greater	   bias	   and	   standard	   deviation	   (Figs.	   12	   and	   13)	   when	  comparing	  the	  M2D	  with	  3DNC	  images.	  	  Range	  and	  mean	  of	  intra	  and	  inter	  observer	  variability	  using	  the	  3D	  and	  the	  M2D	  method	  are	  shown	  in	  Tables	  8	  and	  9.	  For	  inter-­‐observer	  variability	  no	  statistical	  differences	  were	   found	  comparing	  the	  mean	  values	   for	   the	  3D	  data	  and	  for	   the	  M2D	  data	  for	  both	  ventricles.	  Additionally	  the	  coefficient	  of	  variance	  (COV)	  was	  calculated	   for	   all	   parameters	   to	   further	   assess	   inter-­‐observer	   agreement.	   This	  confirmed	   good	   inter-­‐observer	   agreement	   with	   COV	   of	   less	   than	   10.	   The	   only	  exceptions	   to	   this	   was	   for	   RV-­‐ESV	   3DNC	   images	   where	   the	   COV	   was	   13.2,	  suggesting	   less	   good	   agreement	   in	   the	   measurement	   of	   the	   volumes	   in	   this	  group.	  	  For	  intra-­‐observer	  variability,	  using	  the	  3D	  method	  there	  was	  also	  no	  statistical	  difference,	  confirming	  good	  reproducibility	  for	  these	  techniques.	  Intra-­‐observer	  was	  only	  completed	  for	  the	  LV	  measurements.	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Table	  7:	  Right	  and	  Left	  Ventricular	  Parameters	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  CMR	  technique	  	   M2D	   3DNC	   3DC	  
Volume	  (ml)	   Mean±SD	   Range	   Mean±SD	   Range	   Mean±SD	   Range	  
LV-­EDV	   159.3±52.1	   94-­‐320	   151.1±45.4	   93-­‐283	   162.7±54.4	   93-­‐332	  
LV-­ESV	   66.8±45.6	   27-­‐187	   64.6±46.4	   23-­‐189	   70.2±49.5	   28-­‐208	  
LV-­SV	   92.5±21.4	   62-­‐133	   86.5±20.8	   48-­‐127	   92.5±22.5	   55-­‐130	  
RV-­EDV	   161.0±47.8	   71-­‐277	   149.2±48.5	   48-­‐258	   163.0±46.5	   69-­‐268	  
RV-­ESV	   70.7±33.3	   14-­‐146	   67.0±30.9	   14-­‐140	   74.7±33.8	   17-­‐147	  
RV-­SV	   90.3±18.9	   57-­‐131	   82.2±20.9	   34-­‐118	   88.3±18.6	   52-­‐121	  	  	  
	  




Table	  9:	  Intra-­‐Observer	  Variability	  for	  M2D	  and	  3D	  Imaging	  
Intra-­observer	  variability	  	  	   Range	  Difference	  %	   Mean	  difference	  %	  	   LV-­EDV	   LV-­ESV	   LV-­EDV	   LV-­ESV	  
M2D	   [-­‐1.1	  ;	  3.6]	   [-­‐2.0	  ;	  3.0]	   0.34	   0.52	  
3DC	   [-­‐2.1	  ;	  3.4]	   [-­‐1.3	  ;	  3.5]	   -­‐0.01	   1.31	  
3DNC	   [-­‐3.0	  ;	  3.3]	   [-­‐3.1	  ;	  2.4]	   -­‐0.33	   -­‐0.22	  
Inter-­observer	  variability	  	  	   Range	  Difference	  %	   Mean	  difference	  %	  	  	   LV-­EDV	   LV-­ESV	   RV-­EDV	   RV-­ESV	   LV-­EDV	   LV-­ESV	   RV-­EDV	   RV-­ESV	  
M2D	   [-­‐12.1	  ;	  8.3]	   [-­‐9.7	  ;	  17.6]	   [-­‐10.6	  ;	  10.2]	   [-­‐9.5	  ;	  8.0]	   -­‐2.1	   0.86	   1.12	   -­‐0.53	  
3DC	   [-­‐10.7	  ;	  14.1]	   [-­‐13.8	  ;	  16.5]	   [-­‐13.8	  ;	  3.6]	   [-­‐9.2	  ;	  9.5]	   -­‐2.75	   1.05	   -­‐2.89	   0.59	  
3DNC	   [-­‐28.3	  ;	  29.9]	   [-­‐2.7	  ;	  10.7]	   [-­‐6.1	  ;	  11.0]	   [-­‐8.4	  ;	  19.7]	   -­‐0.86	   3.21	   2.17	   2.69	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Figure	  12:	  Bland	  Altman	  Plots	  for	  Left	  Ventricular	  Parameters	  
	  
Figure	  13:	  Bland	  Altman	  Plots	  for	  Right	  Ventricular	  Parameters	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3.3	  Summary	  This	  small	  study	  illustrated	  that	  fast	  ventricular	  volume	  assessment	  is	  achievable	  in	  a	  variety	  of	  patients	  with	  structural	  heart	  disease.	  The	  comparative	  volumetric	  results	  showed	  that	  whilst	  multi-­‐slice	  SSFP	  imaging	  of	  the	  ventricles	  has	  the	  best	  image	  quality	   it	   is	   possible	   to	   obtain	   good	  quality	   images	  with	   faster	   scanning	  but	   that	   the	   addition	   of	   contrast	   significantly	   improved	   endocardial	   definition	  and	  therefore	  accuracy	  of	  volumetric	  measurements.	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CHAPTER	   4:	   DISPARITY	   BETWEEN	   FLOW	   AND	   VOLUMETRIC	  
ASSESSMENT	  
4.1	  Overview	  Flow	   assessment	   of	   the	   great	   arteries	   has	   also	   become	   an	   essential	   CMR	   tool	  especially	   in	   patients	   with	   structural	   heart	   disease	   where	   shunts	   and	  regurgitation	   fractions	   will	   guide	   intervention	   for	   specific	   abnormalities.	   In	  patients	   with	   repaired	   TOF	   pulmonary	   regurgitation	   is	   an	   important	  determinant	  of	   late	  outcome.	  The	  degree	  of	  regurgitation	  is	  either	  described	  as	  the	  pulmonary	  reverse/back	  flow	  or	  the	  back	  flow	  is	  expressed	  as	  a	   fraction	  of	  the	  forward	  flow,	  known	  as	  the	  regurgitant	  fraction	  (RF).	  This	  measurement	  may	  now	  contribute	  to	  the	  recommendations	  for	  pulmonary	  valve	  intervention	  92.	  	  PC	  flow	   assessment	   of	   valve	   function	   has	   been	   shown	   to	   be	   reproducible	   and	  accurate	  and	   there	   is	  also	  data	  which	  shows	   that	  at	   rest	   functional	  parameters	  such	   as	   ventricular	   stroke	   volume	   derived	   from	   MR	   volumes	   measurements	  correlate	  well	  with	  analogous	  parameters	  measured	  by	  PC	   flow	   93,	   94.	  However	  there	   is	   relatively	   limited	  data	  on	  how	   flow	  measurements	  may	   change	  during	  stress	   imaging.	  Additionally	   the	  robustness	  and	  relative	  agreement	  of	   flow	  and	  volumetric	   parameters	   during	   stress	   imaging	   and	   under	   different	   levels	   of	  dobutamine	  stress	  is	  yet	  to	  be	  explored	  104,	  105.	  	  
The	  following	  chapter	  will	  review	  the	  accuracy	  of	  flow	  measurements	  compared	  to	   volumetric	   assessment	   in	   repaired	   TOF	   patients	   and	   in	   normal	   volunteers.	  Initially	  there	  is	  an	  explanation	  of	  the	  inclusion	  and	  exclusion	  criteria	  of	  patients	  during	   DS-­‐MR.	   This	   is	   followed	   by	   review	   of	   the	   heart	   rate	   changes	   observed	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during	  DS-­‐MR	  and	  whether	  this	  may	  impact	  on	  comparative	  cardiac	  parameters.	  There	  will	  also	  be	  full	  explanation	  of	  the	  flow	  measurements	  collected	  during	  the	  study	   and	   how	   these	   are	   affected	   by	   stress.	   The	   final	   part	   of	   this	   chapter	  will	  focus	   on	   flow	  versus	   volumetric	  measurements	   and	  how	   closely	   they	   compare	  during	  DS-­‐MR.	  	  
4.2	  Results	  of	  Phase	  contrast	  flow	  during	  DS-­‐MR	  
4.2.1	  Study	  Population	  Flow	  and	  volumetric	  measurements	  were	  completed	   in	  all	  TOF	  patients	  and	   in	  10	  volunteers.	  A	  total	  of	  28	  patients	  (chapter	  2,	  table	  4)	  with	  repaired	  TOF	  were	  included	   in	   the	   DS-­‐MR	   part	   of	   the	   study.	   Of	   these	   only	   18	   patients	   completed	  both	  stages	  of	  the	  DS-­‐MR	  protocol.	  	  Details	  of	  the	  exclusions	  are	  described	  below	  and	  schematically	  represented	  in	  figure	  14.	  
Of	   the	   28	   patients	   recruited	   into	   the	   study,	   24	   completed	   stage	   1	   dobutamine	  (10μg/kg/min).	  Four	  patients	  were	  excluded,	  2	  due	  to	  claustrophobia	  later	  in	  the	  scan	   and	   2	   due	   to	   frequent	   ventricular	   ectopics	   which	   were	   not	   seen	   during	  baseline	   scanning.	   Twenty	   patients	   continued	   to	   stage	   2	   dobutamine	  (20μg/kg/min),	   four	  patients	  were	  excluded	   following	   stage	  one:	  Two	  patients	  due	  to	  minor	  side	  effects	  and	  intolerance	  of	  dobutamine	  (nausea,	  headache)	  and	  2	   due	   to	   attainment	   of	   	   >75%	  of	  maximal	   predicted	   heart	   rate	   during	   stage	   1.	  Two	  further	  data	  sets	  were	  not	  included	  in	  the	  final	  analysis	  due	  to	  incomplete	  volumetric	  data	   at	   stress.	   For	  both	  of	   these	  patients	   the	  data	   set	  was	   acquired	  with	   the	   most	   basal	   slice	   starting	   too	   high	   within	   the	   ventricle,	   therefore	   a	  portion	  of	  the	  ventricle	  could	  not	  be	  included	  in	  the	  volumetric	  analysis.	  This	  is	  probably	   due	   to	   a	   change	   in	   diaphragm	   position	   due	   to	   increasing	   breathing	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activtity	  during	  stress.	  It	  was	  not	  possible	  to	  repeat	  the	  volumetric	  stack	  during	  DS-­‐MR	  as	   this	  would	   result	   in	   significantly	   prolonged	   exposure	   to	   dobutamine	  and	  the	  risks	  associated	  with	  this.	  	  
Comparative	   data	   analysis	   was	   performed	   on	   the	   18	   patients	   who	   completed	  both	   stages	   of	   DS-­‐MR.	   Therefore	   the	   results	   presented	   from	   this	   point	   will	  describe	  trends	  and	  observations	  documented	  in	  the	  18	  patients	  who	  completed	  both	  levels	  of	  the	  DS-­‐MR	  protocol.	  Population	  details	  relative	  to	  the	  18	  included	  are	  shown	  in	  Table	  10.	  All	  10	  volunteers	  completed	  the	  protocol	  without	  side	  effects	  or	  complications.	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  
Figure	  14:	  Exclusion	  criteria	  for	  Fallot	  patients	  during	  DS-­‐MR	  
A	  total	  of	  18	  patients	  completed	  the	  full	  stress	  protocol	  with	  complete	  ventricular	  and	  
flow	   data	   collated.	   There	   were	   no	   documented	   serious	   side	   effects	   of	   dobutamine.	  
Minor	  side	  effects	  included	  headache,	  nausea	  and	  awareness	  of	  tachycardia.	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Table	  10:	  DS-­‐MR	  Study	  Population	  
	  Demographics	   Fallot	  Patients	   Healthy	  Volunteers	  
Study	  population	  	   n=18	   n=10	  
Gender	   Male=10	  (56%)	   Male=5	  (50%)	  
Age	  at	  CMR	  (y)	   31.9	  (16.2-­60.1)	   40.6	  (23.9-­51.8)	  
Age	  at	  TOF	  repair(y)	   4.6	  (1.3-­20.2)	   	  
Palliations	  prior	  to	  TOF	  repair	   7/18	   	  
TOF	  repair	  type	   	   	  
• Trans-­annular	  repair	   8/18	   	  
• Non-­transannular	  repair	   3/28	   	  
• Unknown	   7/18	   	  
NYHA	  classification	   1.8	  ±	  0.6	   	  
QRS	  duration	  (ms)	   151	  ±	  7.7	   	  
Baseline	  RV-­EDV	  (ml/m2)	   126.4±27.2	   76.6±14.3	  
Baseline	  RV-­ESV(ml/m2)	   57.2±18.8	   32.1±8.6	  
Baseline	  RV-­EF	  (%)	   55±7	   59±4	  
Baseline	  LV-­EDV	  (ml/m2)	   73.0±12.4	   76.9±12.5	  
Baseline	  LV-­ESV	  (ml/m2)	   31.1±8.2	   33.4±7.5	  
Baseline	  LV-­EF	  (%)	   58±6	   57±4	  
Pulmonary	  Regurgitant	  Fraction	  (%)	   43±15	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4.2.2	  Haemodynamic	  effects	  of	  dobutamine	  stress	  	  There	  was	  a	  significant	  and	  sustained	  increase	  in	  heart	  rate	  for	  both	  the	  control	  and	   the	  TOF	  patients	  during	  dobutamine	   stress	   (p<0.05)	   and	   these	   results	   are	  explained	  in	  chapter	  6.	  It	  is	  also	  important	  to	  ensure	  that	  heart	  rate	  changes	  are	  similar	   during	   flow	   and	   volume	  measurements	   as	   if	   vastly	   different	   this	   could	  lead	   to	   considerable	   error	   when	   comparing	   analogous	   volumetric	   and	   flow	  parameters.	  	  The	  PC-­‐flow	  sequence	  used	  was	  free	  breathing	  and	  was	  performed	  prior	  to	  the	  volumetric	  SSFP	  multi-­‐slice	  stack	  being	  completed	  for	  both	  patients	  and	   volunteers.	   Comparative	   heart	   rates	   in	   the	   Fallot	   group	   for	   each	   level	   of	  stress	   and	   sequence	   used	   are	   shown	   in	   Figure	   15.	   This	   shows	   that	   there	  was	  little	   variability	   in	   heart	   rate	   during	   flow	   assessment	   in	   contrast	   to	   volume	  assessment	  and	   therefore	   it	   felt	   that	   this	   is	  unlikely	   to	  have	   caused	  bias	   in	   the	  comparison	  between	  volumetric	  and	  flow	  derived	  hemodynamic	  parameters.	  
4.2.3	  Quantitative	  Analysis	  –	  Flow	  Measurements	  Although	   the	   focus	   of	   this	   chapter	   is	   the	   comparison	   of	   volumetric	   and	   flow	  parameters	  it	  is	  important	  to	  understand	  some	  of	  the	  changes	  observed	  in	  flow	  measurements	   especially	   in	   the	   TOF	   patients	   during	   DS-­‐MR.	   The	   following	  section	  will	   focus	   on	   the	   general	   flow	   findings	   in	   volunteers	   and	   TOF	   patients	  and	   this	  will	   be	   followed	   by	   the	   comparison	   between	   flow	  measurements	   and	  volumetrically	  derived	  analogous	  parameters.	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Figure	  15:	  Heart	  Rate	  Changes	  during	  Stress	  Conditions	  
The	   above	   figure	   shows	   the	   heart	   rate	   in	   Fallot	   patients	   at	   rest	   and	   during	  
dobutamine	   stress	   imaging.	   The	   coloured	   bars	   represent	   the	   different	   type	   of	  
assessment	  made,	  either	  flow	  or	  volumetric	  and	  the	  associated	  heart	  rate	  during	  that	  
assessment.	  	  
	  
Table	  11:	  Flow	  Parameters	  for	  Fallot	  Patients	  during	  DS-­‐MR	  
 
Ao-­FF:	   Aortic	   forward	   flow,	   PA-­SV:	   pulmonary	   artery	   stroke	   volume	   or	   effective	   forward	   flow,	   PA-­FF:	   total	   pulmonary	  
forward	  flow,	  PA-­BF:	  pulmonary	  back	  flow,	  PA-­RF:	  pulmonary	  regurgitant	  fraction,	  PA-­CI:	  pulmonary	  cardiac	  index	  
Parameter	  
(ml/beat/m2)	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Stage	  of	  DS-­MR	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Significance	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  (Paired	  t	  test)	  p	  value	  	  	   Rest	   10	   20	   Rest-­10	   Rest-­20	   10-­20	  
AO-­FF	   39.5±5.5	   44.1±8.7	   38.2±8.1	   <0.05	   0.3	   <0.05	  
PA-­SV	  (eff	  FF)	   39.0±9.8	   42.3±7.4	   35.6±10.3	   0.2	   0.3	   <0.05	  
PA-­FF	  (total)	   69.7±15.1	   74.7±17.3	   62.2±16.5	   0.05	   <0.05	   <0.05	  
PA-­BF	   30.7±14.2	   32.3±16.3	   26.6±13.5	   0.31	   <0.05	   <0.05	  
PA-­RF	  (%)	   42.6±14.6	   41.1±14.6	   41.4±15.5	   0.43	   0.53	   0.83	  
PA-­CI	  (l/min/m2)	   2.6±0.7	   3.6±0.7	   4.1±1.1	   <0.05	   <0.05	   <0.05	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Table	  12:	  Flow	  Parameters	  for	  Normal	  Volunteers	  during	  DS-­‐MR	  
	  
Ao-­FF:	  Aortic	  forward	  flow,	  PA-­FF:	  total	  pulmonary	  forward	  flow	  
	  
Flow	  Parameters	  Flow	  measurements	  were	  obtained	  as	  described	  in	  Chapter	  2.	  Tables	  11	  and	  12	  shows	  flow	  measurements	  for	  aortic	  and	  main	  pulmonary	  artery	  flow	  at	  rest	  and	  during	  DS-­‐MR	   in	  Fallot	  patients	   (the	  statistical	  analysis	  performed	  on	   this	  data	  comprised	  of	  a	  series	  of	  multiple	  t-­‐tests;	  in	  retrospect	  it	  would	  have	  been	  more	  accurate	   to	   analyse	   the	   data	   using	   ANOVA	   for	   repeated	   measures	   with	  Bonferroni	   post	   hoc	   testing	   and	   this	   is	   considered	   as	   a	   limitation	   of	   the	   data	  presented).	  
For	   all	   flow	   parameters	   from	   rest	   to	   stage	   1	   of	   the	   DS-­‐MR	   protocol	   there	   is	   a	  small	  increase	  in	  arterial	  forward	  flow.	  This	  is	  a	  statistically	  significant	  increase	  in	  the	  normal	  group	  and	  for	  the	  aortic	  forward	  flow	  in	  the	  TOF	  group.	  	  Following	  this	  there	  generally	  appears	  to	  be	  a	  reduction	  in	  stroke	  volumes	  at	  higher	  levels	  of	  DS-­‐MR	  and	  this	  probably	  reflects	  the	  shorter	  cardiac	  cycle	  due	  to	  rapid	  heart	  rates	   at	   DS-­‐MR	   stage	   2.	   Overall	   as	   can	   be	   seen	   in	   the	   TOF	   group	   despite	   the	  reduction	  in	  pulmonary	  artery	  total	   forward	  flow	  there	  is	  a	  significant	   increase	  in	   derived	   pulmonary	   artery	   cardiac	   index	   as	   a	   result	   in	   the	   increase	   in	   heart	  
Parameter	  
(ml/beat/m2)	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Stage	  of	  DS-­MR	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Significance	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  (Paired	  t	  test)	  p	  value	  	  	   Rest	   10	   20	   Rest-­10	   Rest-­20	   10-­20	  
AO-­FF	   43.7±6.3	   55.0±9.5	   49.8±8.3	   <0.05	   <0.05	   <0.05	  
PA-­FF	  	   43.4±6.1	   54.6±11.4	   48.9±9.2	   <0.05	   <0.05	   <0.05	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rate.	   Interestingly	   pulmonary	   artery	   backward	   flow	   initially	   increases	   in	   line	  with	   the	  other	   flow	  measurements	  but	   then	  decreases	  again	  at	  higher	   levels	  of	  DS-­‐MR.	   Despite	   this	   there	   is	   no	   change	   in	   the	   calculated	   pulmonary	   artery	  regurgitant	   fraction	   and	   this	   highlights	   how	   this	   measure	   of	   pulmonary	  regurgitation	  may	  be	   limited,	  as	   it	  does	  not	  give	  a	   true	  reflection	  of	  volumetric	  change	  through	  the	  pulmonary	  valve.	  
4.3	  Accuracy	  Of	  Flow	  Versus	  Volumetric	  Derived	  Parameters	  A	   variety	   of	   studies	   have	   looked	   at	   the	   correlation	   of	   flow	   derived	   stroke	  volumes	  with	  volumetric	  derived	  parameters	  with	  good	  agreement	  between	  the	  different	   methods.	   This	   has	   results	   in	   flow	   and	   volume	   measurements	   being	  interchangeable	   and	   complimentary	   especially	   when	   evaluating	   patients	   with	  complex	   structural	   heart	   disease	   with	   shunts	   and	   regurgitant	   valves.	   Little	   is	  known	   about	   whether	   this	   accuracy	   is	   maintained	   during	   dobutamine	   stress.	  Whilst	  evaluating	  the	  volumes	  and	  flow	  it	  became	  clear	  that	  for	  the	  TOF	  patients	  at	  higher	  levels	  of	  stress	  there	  were	  inconsistencies	  in	  the	  comparative	  flow	  and	  volumetric	  stroke	  volumes.	  This	  is	  further	  explored	  in	  the	  next	  section.	  	  
Flow	  vs.	  Volumes	  	  Aortic	   forward	   flow	  (antegrade	  systemic	  stroke	  volume)	  and	  pulmonary	  artery	  forward	   flow	   (antegrade	   pulmonary	   stroke	   volume)	  measured	   by	   PC-­‐flow	   and	  derived	   from	  volumetric	  measurements	  were	  compared	  at	   rest	  and	  during	  DS-­‐MR	   All	   TOF	   patients	   had	   a	   degree	   of	   pulmonary	   regurgitation.	   There	   was	   no	  evidence	   of	   pulmonary,	   aortic	   or	   atrio-­‐ventricular	   (AV)	   valve	   regurgitation	   in	  any	  of	  the	  volunteers.	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The	   Bland-­‐Altman	   analysis	   and	   Pearson	   correlation	   coefficient	   were	   used	   for	  comparison	   of	   volumetric	   versus	   PC-­‐flow-­‐derived	   analogous	   cardiovascular	  functional	  parameters,	  as	  shown	  in	  Table	  12	  and	  13	  and	  Figures	  16	  and	  17.	  	  
4.3.1	  Systemic	  Antegrade	  Output	  
Volumetric	  LVSV	  vs.	  PC-­‐Flow	  AO-­‐FF	  
	  Volunteers	  	  At	   rest	   there	   is	   good	   agreement	   for	   stroke	   volumes	   measured	   by	   flow	   and	  volumes	  for	  the	  systemic	  circulations.	  The	  correlation	  between	  flow	  and	  volume	  derived	   antegrade	   output	   continues	   to	   be	   good	   throughout	   stress	   with	   good	  limits	   of	   agreement	   and	   Pearson’s	   correlation	   of	   0.94,	   0.78	   and	   0.93	   for	   rest,	  dobutamine	  10	  and	  dobutamine	  20	  respectively.	  This	  is	  confirmed	  in	  the	  Bland	  Altman	  plots	  (Figure	  16).	  	  
TOF	  Patients	  	  Within	  the	  TOF	  group,	  two	  patients	  were	  excluded	  from	  this	  analysis	  as	  aliasing	  was	   found	   in	   the	   flow	   analysis	   of	   the	   aorta.	   Aliasing	   occurred	   in	   a	   number	   of	  patients	  and	  this	   is	  due	  the	  velocity	  PC-­‐flow	  sequence	  being	  set	   lower	  than	  the	  peak	  velocity	  achieved	  during	  stress.	   In	   the	   remaining	  16	  patients	  an	  excellent	  agreement	  was	  found	  at	  rest	  (mean	  ±	  limits	  of	  agreement,	  -­‐0.8	  ±5.7	  ml/beat/m2).	  During	  stress	   imaging,	  however,	   the	  agreement	  deteriorated	  at	  Dobutamine-­‐10	  (-­‐3.1±17.9	   ml/beat/m2)	   and	   even	   further	   at	   Dobutamine-­‐20	   (5.2±30.6	  ml/beat/m2)	   as	   shown	   in	   Table	   13	   and	   Figure	   17.	   	   The	   correlation	   between	  volumetric	   and	   PC-­‐flow	  was	   excellent	   at	   rest	   (Pearson=0.88)	   but	   deteriorated	  progressively	   at	   dobutamine-­‐10	   (Pearson=0.41)	   and	   dobutamine-­‐20	  (Pearson=0.32).	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4.3.2	  Pulmonary	  Antegrade	  Output	  	  
Volumetric	  RVSV	  vs.	  PC-­‐Flow	  PA-­‐FF	  
Volunteers	  	  In	   this	  group	   there	  was	  good	  correlation	  between	  volumetric	  and	   flow	  derived	  parameters	  at	  rest	  and	  during	  stress.	  There	  is	   little	  scatter	  in	  the	  Bland	  Altman	  analysis	   and	  Pearson	   correlation	  was	   above	  0.90	   for	   all	   3	   stages	   of	   the	  DS-­‐MR	  protocol.	  
TOF	  Patients:	  For	   this	   parameter	   of	   total	   RV	   output	   per	   heartbeat,	   there	   was	   excellent	  agreement	  at	  rest	  (mean	  ±	  limits	  of	  agreement,	  -­‐0.1	  ±	  7.6	  ml/beat/m2)	  although	  still	   not	   as	   good	   as	   the	   agreement	   of	   LVSV	   and	  AO-­‐FF	   (see	   Figure	   17).	   During	  stress	  imaging	  however,	  the	  agreement	  and	  correlation	  was	  again	  reduced	  with	  large	   scatter	   during	   Dobutamine-­‐10,	   but	   this	   did	   not	   further	   deteriorate	   at	  dobutamine-­‐20	   (see	  Table	   13	   and	  Figure	  17).	   The	   correlation	  was	   excellent	   at	  rest	   (Pearson=0.96)	   and	   kept	   moderately	   strong	   even	   during	   Dobutamine-­‐10	  (Pearson=0.75)	  and	  Dobutamine-­‐20	  (Pearson=0.83)	  
4.3.3	  Pulmonary	  Regurgitant	  Volume	  
Volumetric	  RVSV-­‐LVSV	  vs.	  PC-­‐Flow	  PA-­‐BF	  Three	   patients	   had	  mild	   aortic	   regurgitation	   (>10%)	   and	  were	   excluded	   from	  this	  particular	  analysis	  for	  consistency.	  A	  reasonably	  good	  agreement	  was	  found	  at	   rest	   (mean	   ±	   limits	   of	   agreement,	   -­‐3.6	   ±	   15.1	   ml/beat/m2).	   During	   stress	  imaging,	  the	  agreement	  deteriorated	  at	  Dobutamine-­‐10	  (-­‐1.7	  ±	  23.9	  ml/beat/m2)	  and	  remained	  on	  this	  level	  at	  Dobutamine-­‐20	  (5.4	  ±	  24	  ml/beat/m2)	  as	  shown	  in	  Table	  13	  and	  Figure	  18.	  The	  correlation	  was	  excellent	  at	  rest	  (Pearson=0.85)	  and	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kept	   moderately	   strong	   even	   during	   Dobutamine-­‐10	   (Pearson=0.81)	   and	  Dobutamine-­‐20	  (Pearson=0.78).	  
4.3.4	  Pulmonary	  Regurgitant	  Fraction	  
Volumetric	  RVSV-­‐LVSV/	  RVSV	  vs.	  PC-­‐Flow	  PA-­‐BF	  /PA-­‐FF	  Three	   patients	   had	   mild	   aortic	   regurgitation	   (>10%,	   see	   above)	   and	   were	  excluded	  also	   in	   this	  particular	  comparative	  analysis	   for	  consistency.	  As	  shown	  in	  the	  Bland-­‐Altman	  plots	  (Figure	  18),	  there	  was	  only	  limited	  agreement	  at	  rest	  with	   some	  bias	   and	  wide	   scatter	   (-­‐5.6	  ±	   22.8%),	   resulting	   in	   an	   increased	  bias	  and	  wider	   limits	  of	  agreement	  compared	   to	   the	  pulmonary	  regurgitant	  volume	  (see	  above).	  	  The	  agreement	  did	  not	  further	  deteriorate	  during	  Dobutamine-­‐10	  (-­‐3.8	   ±	   19.2%)	   and	   Dobutamine-­‐20	   (3.2	   ±	   21.8%,	   see	   also	   Table	   13).	   The	  correlation	   was	   strong	   during	   rest,	   dobutamine-­‐10	   and	   dobutamine-­‐20	  (Pearson=0.88,	  0.84	  and	  0.84	  respectively).	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Table	  13:	  Mean	  and	  Limits	  of	  Agreement	  in	  Normal	  Volunteers	  for	  Flow	  vs.	  Volumetric	  
Parameters	  
Bland-Altman Category  
 
 
Systemic antegrade output 
 
LVSV vs. AO-FF 
(ml/beat/m2) 
Pulmonary antegrade output  
 
RVSV vs. PA-FF 
(ml/beat/m2) 
REST   
• Mean difference -0.30 0.97 
• Upper limit of agreement  4.19 3.73 
• Lower limit of agreement  -4.78 -1.79 
   
DOBUTAMINE-10   
• Mean difference -2.14 -0.48 
• Upper limit of agreement  11.23 7.18 
• Lower limit of agreement  -15.51 -8.14 
   
DOBUTAMINE-20   
• Mean difference -0.53 1.35 
• Upper limit of agreement  5.60 5.65 
• Lower limit of agreement  -6.66 -8.35 	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Table	   14:	   Mean	   and	   Limits	   of	   Agreement	   in	   Fallot	   Patients	   for	   Flow	   vs.	   Volumetric	  
Parameters	  
	  
















































(PA-BF / PA-FF) 
 
(%) 
REST     
• Mean difference -0.8 -0.1 -3.6 -5.6 
• Upper limit of agreement  4.9 7.5 11.5 17.2 
• Lower limit of agreement  -6.4 -7.2 -18.7 -28.3 
• Upper confidence interval 2.4 to 7.4  4.2 to 10.7 4.1 to 19 5.9 to 28.3 
• Lower confidence interval -8.9 to -3.9 -10.4 to -3.9 -26.1 to -11.2 -39.5 to -17 
     
DOBUTAMINE-10     
• Mean difference -3.1 2.4 -1.7 -3.8 
• Upper limit of agreement  14.8 26.3 22.3 15.5 
• Lower limit of agreement  -20.9 -21.4 -25.6 -23 
• Upper confidence interval 6.3 to 23.2 15.7 to 36.8 10.4 to 34.1 5.95 to 25 
• Lower confidence interval  -29.4 to -12.4 -31.9 to -10.8 -37.4 to -13.8 -32.5 to -13.5 
     
DOBUTAMINE-20     
• Mean difference 5.2 6.8 5.4 3.2 
• Upper limit of agreement  35.8 28.3 29.4 25 
• Lower limit of agreement  -25.5 -14.7 -18.6 -18.3 
• Upper confidence interval 21.2 to 50.3 18.7 to 37.8 17.6 to 41.3 14.2 to 35.8 







	   93	  




LV	   SV	  V






RV	   SV	  v




Figure	  16:	  Systemic	  and	  Antegrade	  Flow	  Agreement	  between	  PC-­‐Flow	  and	  Volumetric	  
parameters	  in	  normal	  volunteers	  
 
 
Figure	  17:	  Systemic	  And	  Antegrade	  Flow	  Agreement	  Between	  PC-­‐Flow	  And	  Volumetric	  
Parameters	  In	  Fallot	  Patients	  
	  
Bland-­‐Altman	   plots	   of	   the	  mean	   bias	   (MB)	   and	   95%	   confidence	   limits	   of	   agreement	  
(LOA)	   between	   the	   volumetric	   vs.	   PC-­‐flow	   assessment	   of	   the	   systemic	   antegrade	  
output	   (A,B,C)	   and	   the	   pulmonary	   antegrade	   output	   (D,E,F)	   at	   the	   three	   different	  
stages:	   rest	   (A,	   D),	   dobutamine-­‐10	   (B,	   E)	   and	   dobutamine-­‐20	   (C,	   F).	   Values	   are	  
expressed	  as	  ml/beat/m2.	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Figure	   18:	   Pulmonary	   regurgitant	   volume	   and	   regurgitant	   fraction	   agreement	  
between	  volumetric	  and	  PC-­‐flow	  parameters	  
Bland-­‐Altman	   plots	   of	   the	  mean	   bias	   (MB)	   and	   95%	   confidence	   limits	   of	   agreement	  
(LOA)	   between	   the	   volumetric	   vs.	   PC-­‐flow	   assessment	   of	   the	   pulmonary	   regurgitant	  
volume	   (A,B,C)	   and	   the	   pulmonary	   regurgitant	   fraction	   (D,E,F)	   at	   the	   three	   different	  
stages:	   rest	   (A,	   D),	   dobutamine-­‐10	   (B,	   E)	   and	   dobutamine-­‐20	   (C,	   F).	   Values	   are	  
expressed	   as	   ml/beat/m2	   for	   the	   pulmonary	   regurgitant	   volume	   and	   as	   percentage	  
[%]	  for	  the	  pulmonary	  regurgitant	  fraction.	  
	  
4.4	  Summary	  The	   results	   documented	   above	   clearly	   show	   that	   ventricular	   stroke	   volume	   at	  rest	   correlated	   extremely	   well	   with	   analogous	   PC-­‐flow	  measurements.	   This	   is	  true	  even	  in	  the	  TOF	  patients	  who	  have	  a	  significant	  degree	  of	  regurgitation	  and	  is	   in	   line	   with	   previously	   published	   data.	   	   Of	   concern	   is	   how	   this	   agreement	  significantly	  deteriorated	  during	  stress	  in	  the	  TOF	  group	  although	  it	  appears	  to	  be	   maintained	   in	   the	   volunteers	   with	   normal	   cardiac	   anatomy.	   	   There	   are	   a	  number	   of	   factors,	   which	   are	   likely	   to	   influence	   the	   differences	   observed	  especially	  in	  the	  TOF	  group.	  All	  of	  the	  TOF	  patients	  had	  pulmonary	  regurgitation	  and	   are	   therefore	   more	   susceptible	   to	   abnormalities	   in	   flow	   dynamics	   and	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conceivably	   this	   will	   be	   more	   pronounced	   at	   higher	   heart	   rates.	   Additionally	  image	  quality	  and	  accuracy	  of	  analysis	  needs	  to	  be	  considered	  specifically	  for	  the	  volumetric	  assessment.	  This	  will	  be	  explored	  further	  in	  the	  next	  chapter.	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CHAPTER	  5:	  ACCURACY	  OF	  CMR	  VOLUMETRIC	  ASSESSMENT	  
5.1	  Overview	  	  The	   previous	   chapters	   have	   shown	   the	   importance	   of	   volumetric	   and	   flow	  assessment	  during	  a	  CMR	  study	  70,	  73,	  95,	  96.	  Conventionally	  volumes	  are	  measured	  using	  the	  short	  axis	  orientation,	  as	  this	   is	  optimal	   for	  the	  ellipsoid	  shape	  of	   the	  left	  ventricle.	  In	  patients	  with	  congenital	  heart	  disease,	  pathology	  often	  involves	  the	   right	   ventricle	   which	   in	   conditions	   such	   as	   surgically	   repaired	   TOF	   can	  become	   significantly	   dilated	   due	   to	   chronic	   volume	   loading	   from	   severe	  pulmonary	  regurgitation	  (PR).	  In	  these	  patients	  the	  ability	  to	  accurately	  measure	  ventricular	  size	  and	  function	  is	  essential	  for	  clinical	  decision	  making	  21,	  24,	  108,	  109.	  Short	  axis	  assessment	  of	  volumes	  in	  these	  patients	  has	  been	  validated	  and	  used	  routinely	   in	   clinical	   practice.	   However	   it	   has	   been	   shown	   that	   assessment	   of	  volumes	   in	  TOF	  patients	  using	  axial	   slices	   is	   superior	   in	   terms	  of	  accuracy	  and	  observer	   variance	   79.	   This	   axial	   orientation	   allows	   better	   appreciation	   of	   the	  right-­‐sided	  valve	  planes	  and	  right	  ventricular	  outflow	  tract	  dilatation.	  Although	  the	  assessment	  of	  RV	  volumes	  may	  contribute	  to	  the	  assessment	  of	  TOF	  patients	  with	   severe	   PR	   they	   do	   not	   fully	   predict	   which	   patients	   require	   PVR	   most	  urgently	   and	   or	   which	   patients	   with	   have	   the	   greatest	   improvement	   in	   RV	  function	   post	   PVR	   21.	   	   Volumetric	   assessment	   under	   stress	   testing	   conditions	  using	   agents	   such	   as	   dobutamine	   may	   provide	   new	   parameters	   of	   early	   right	  ventricular	  dysfunction	  48,	  65,	  110,	  111.	  Short	  axis	  volumetric	  assessment	  during	  low	  dose	  dobutamine	  stress	  MR	  in	  a	  variety	  of	  congenital	  patients	  has	  been	  shown	  to	  be	  accurate	  and	  reproducible	  61.	  There	  are	  no	  data	  on	  the	  utility	  of	  axial	  volume	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assessment	  during	  DS-­‐MR	   imaging	   in	   volunteers	   or	  TOF	  patients.	   This	   chapter	  assesses	   the	   accuracy	   and	   reproducibility	   of	   axial	   and	   short	   axis	   volume	  assessment	   during	   dobutamine	   stress	   MR	   in	   the	   TOF	   patients	   and	   healthy	  volunteers.	   If	   significant	   changes	   in	   volumetric	   response	   are	   seen	   in	   either	  patients	  or	  volunteers	   it	   is	  essential	   to	  know	  whether	   these	  measurements	  are	  accurate	  and	  reproducible	  so	  that	  the	  information	  gained	  from	  stress	  imaging	  in	  patients	  can	  be	  used	  to	  guide	  clinical	  decision-­‐making.	  
We	  also	  hypothesized	  that	  strict	  intra-­‐institutional	  image	  reading	  training	  would	  yield	   acceptable	   observer	   agreement	   94	   underscoring	   the	   potential	   diagnostic	  value	  of	  higher	  dose	  DSMR	   in	   the	  early	  detection	  of	   right	  ventricular	   failure	   in	  this	  group	  of	  patients.	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5.2	  Accuracy	  of	  Volumetric	  Assessment	  Left	  and	  right	  ventricular	  volumes	  were	  measured	  at	  rest	  and	  during	  stress	  MR	  for	   the	   TOF	   patients	   and	   normal	   healthy	   volunteers	   using	   the	   imaging	  parameters	  and	  exclusion	  criteria	  described	  in	  Chapters	  2	  and	  4.	  The	  following	  description	   of	   quantitative	   and	   qualitative	   analysis	   will	   focus	   on	   the	   18	   TOF	  patients	  and	  10	  healthy	  volunteers	  who	  completed	  both	  levels	  of	  DS-­‐MR,	  i.e.	  10	  and	   20μg/kg/min	   of	   dobutamine	   (Chapter	   4,	   Table	   10).	   The	   detailed	  hemodynamic	  and	  volumetric	  response	  to	  dobutamine	  will	  be	  further	  described	  in	  Chapter	  6.	  
5.2.1	  Volumetric	  Quantitative	  Analysis	  Volumetric	   analysis	  was	   performed	   as	   described	   in	   the	  methods	   of	   Chapter	   2.	  For	   inter-­‐observer	  analysis	   two	   independent	  experienced	  observers	  performed	  volumetric	  analysis	  on	   the	  TOF	  patients	  and	   the	  volunteers.	  For	   intra-­‐observer	  analysis	   data	   was	   re-­‐analyzed	   by	   a	   single	   observer	   6	   months	   after	   the	   initial	  assessment	  was	  performed.	  	  
Accuracy	   of	   volumetric	   assessment	   for	   both	   ventricles	   was	   analyzed	   by	  comparing	   the	   mean	   difference	   between	   the	   two	   observers	   together	   with	   the	  range	   of	   difference	   for	   each	   volumetric	   parameter.	   Further	   analysis	   by	  coefficient	   of	   variance	   (COV)	   showed	   there	   is	   good	   inter	   and	   intra-­‐observer	  agreement	   for	   all	   parameters	   at	   rest	   observations	  with	   coefficient	   of	   variance	  <10%	   in	   both	   the	   volunteers	   and	   TOF	   patients	   (Figure	   19&20,	   Table	   15&16).	  With	  increasing	  concentration	  of	  dobutamine	  there	  continued	  to	  be	  good	  inter-­‐observer	  agreement	   for	  end-­‐diastolic	  volumes	  with	  a	  coefficient	  of	  variance	  for	  the	  LV-­‐EDV	  in	  TOF	  patients	  of	  1.6%	  and	  4.6%	  (10,	  20	  respectively)	  and	  for	  RV-­‐
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EDV	   4.2%	   and	   3.7%	   (10,	   20	   respectively).	   However	   there	   was	   notably	   higher	  inter-­‐observer	  variability	   for	  LV-­‐ESV	  at	   stage	  2	  DS-­‐MR.	  This	   is	  most	   significant	  for	   the	  LV-­‐ESV	   in	   the	  TOF	  patients	  with	  a	  COV	  of	  14.9%	  compared	  to	  8.6%	  for	  RV-­‐ESV	  for	  the	  same	  dobutamine	  stage	  (Figure	  19,	  Table	  15).	  	  Intra-­‐observer	  variability	  showed	  coefficient	  of	  variance	  levels	  below	  10%	  for	  all	  ventricular	  parameters	  suggesting	  good	  reproducibility	  (Figure	  20,	  Table	  16).	  
	  
	  








Coefficient	  of	  Variance	  (%)	  
Mean	  Difference	  
	  [Range	  difference	  min;	  max]	  
	   	   Rest	   10	   20	   Rest	   10	   20	  
LV-­EDV	  
































































Table	   15:	   Agreement	   between	   the	   two	   observers	   for	   left	   and	   right	   ventricular	  
volumes.	   Fallot	   patients:	   axial	   volume.	   Normal	   volunteers:	   short	   axis	   volume.	  
Agreement	  was	  determined	  by	  coefficient	  of	  variance	  with	  levels	  of	  <10	  considered	  to	  
show	  good	  agreement.	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[Range	  difference	  min;	  max]	  
	   	   	   	   	  
	   DS-­MR	  Stage	   DS-­MR	  Stage	  
	   	   Rest	   10	   20	   Rest	   10	   20	  
LV-­EDV	   Fallot	   2.7	   1.7	   1.8	   -­0.1	  
[-­6.8	  ;	  6.5]	  
0.2	  
[-­3.4	  ;	  3]	  
0.7	  
[-­2.2	  ;	  4.1]	  







LV-­ESV	   Fallot	   5.8	   6.2	   6.4	   -­0.5	  
[-­	  7.0	  ;	  5.5]	  
-­0.6	  
[-­5.3	  ;	  2.6]	  
-­0.6	  
[-­3.6	  ;	  2.36]	  







RV-­EDV	   Fallot	   1.7	   2.4	   2.1	  
0.1	  
[-­5.8	  ;	  8.1]	  
0.2	  
[-­3.9	  ;	  14.78]	  
2.1	  
[-­6.78	  ;	  11.8]	  







RV-­ESV	   Fallot	   1.7	   2.3	   3.8	   -­0.3	  




[-­4.6	  ;	  6.7]	  







	   	   	   	   	   	   	   	  
	  
Agreement	   between	   left	   and	   right	   ventricular	   parameters	   measured	   by	   a	   single	  
observer	  6	  months	  apart.	  Fallot	  patients:	  axial	  volume.	  Normal	  volunteers:	  short	  axis	  
volume.	   Agreement	   was	   determined	   by	   coefficient	   of	   variance	   with	   levels	   of	   <10	  
considered	  to	  show	  good	  agreement.	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Figure	  19:	  Inter-­‐observer	  variability	  
Coefficient	  of	   variance	   calculated	   for	   right	  and	   left	   ventricular	  volumes	  at	  each	   level	  
of	   dobutamine	   stress.	   	   Good	   agreement	   between	   observers	   was	   seen	   for	   all	  
parameters	  except	  LV-­‐ESV	  in	  the	  TOF	  patients	  at	  dobutamine	  20ug/kg/min.	  
	  	  	  
	  	  	  
Figure	  20:	  Intra-­‐observer	  variability	  
Coefficient	   of	   variance	   results	   for	   intra-­‐observer	   variance	   of	   ventricular	   volumes	   at	  
each	   level	   of	   dobutamine	   stress.	   Good	   agreement	   (single	   observer)	  was	   seen	   for	   all	  
parameters	  in	  TOF	  patients	  and	  volunteers.	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5.2.2	  Image	  Quality	  Assessment	  Image	  quality	   scores	  were	  assessed	  as	  described	   in	  Chapter	  2.	   In	  TOF	  patients	  and	   healthy	   volunteers	   image	   quality	   scores	   at	   baseline	   were	   excellent	   with	  mean	  score	  greater	  than	  3	  for	  both	  ventricles.	  There	  was	  a	  trend	  towards	  a	  small	  reduction	  in	  image	  quality	  with	  each	  stage	  of	  DS-­‐MR	  and	  LV	  image	  quality	  scores	  in	  the	  TOF	  patients	  were	  slightly	  lower	  than	  the	  analogous	  RV	  scores,	  but	  these	  changes	  in	  image	  score	  did	  not	  reach	  statistical	  significance.	  
Volunteer	   Group:	   The	   mean	   score	   based	   on	   the	   visibility	   of	   the	   endocardial	  borders	  decreased	  85	  marginally	  with	  increase	  in	  DS-­‐MR	  stage.	  In	  both	  ventricles	  scores	  at	  baseline	  were	  excellent	  with	  a	  mean	  quality	  score	  of	  3.62	  for	  the	  LV	  and	  3.57	  for	  the	  RV.	  There	  was	  a	  small	  reduction	  in	  image	  quality	  with	  each	  stage	  of	  DS-­‐MR	   and	   scores	   of	   3.23	   and	   3.15	   for	   the	   LV	   and	  RV	   respectively	   by	   stage	   2	  dobutamine	   (Figure	   21).	   These	   changes	   in	   image	   score	   were	   not	   statistically	  significant.	  
Fallot	   patient	   group:	   In	   this	   group	   there	  was	   also	   a	   decrease	   in	   image	   quality	  with	  escalation	  of	  the	  dobutamine	  protocol.	  At	  rest	  the	  mean	  image	  quality	  score	  for	  the	  RV	  was	  3.56	  and	  this	  reduced	  to	  3.17	  at	  stage	  1	  dobutamine	  and	  3.11	  at	  stage	   2	   dobutamine	   (Figure	   21).	   The	   LV	   scores	  were	   slightly	   lower	   compared	  with	  the	  analogous	  RV	  scores.	  At	  dobutamine	  stage	  2	  for	  the	  LV	  the	  mean	  image	  quality	  score	  was	  2.71	  compared	  to	  3.0	  at	  rest.	   	  However,	   these	  changes	   in	   the	  image	   quality	   during	   DS-­‐MR	   did	   not	   reach	   statistical	   significance	   using	   the	  Friedman’s	  test,	  neither	  for	  the	  RV	  (p=0.23)	  nor	  the	  LV	  (p=0.53).	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Figure	  21:	  Image	  Quality	  Assessment	  
Volumetric	   image	  quality	  assessment	   for	  TOF	  patients.	  Mid-­‐ventricular	  axial	   slices	  at	  
rest,	  dobutamine-­‐10	  and	  dobutamine-­‐20.	  The	  2D-­‐SSFP	   images	  were	  scored	  on	  a	  four-­‐
point	  scale	  based	  on	  the	  visibility	  of	  the	  endocardial	  borders	  for	  the	  right	  (*)	  and	  left	  
(arrow)	   ventricles.	   Progressive	   (albeit	   not	   statistically	   significant)	   decrease	   of	   the	  
image	  quality	  score	  (=	  extent	  of	  blurring	  of	  the	  endocardial	  borders)	   for	  the	  RV	  (blue	  
bar)	  and	  LV	  (red	  bar),	  from	  rest	  to	  dobutamine-­‐20.	  	  
	  
5.3	  Summary	  
This	  chapter	  has	  presented	  the	  assessment	  of	  accuracy	  of	  volumetric	  analysis	  in	  patients	   with	   corrected	   TOF	   and	   healthy	   volunteers	   both	   in	   the	   conventional	  short	   axis	   geometry	   and	   also	   axial	   geometry	   the	   preferred	   method	   for	  quantification	   of	   the	   right	   ventricle.	   Even	   at	   high	   doses	   of	   dobutamine,	   image	  quality	   is	   maintained	   and	   volumes	   can	   be	   quantified	   with	   fairly	   good	   inter-­‐observer	   agreement	   and	   very	   good	   intra-­‐observer	   agreement.	   	   However	   it	   is	  clear	  that	  at	  higher	  doses	  of	  DS-­‐MR	  LV-­‐ESV	  is	  susceptible	  to	  error.	  There	  are	  two	  potential	  causes	  for	  this	  poor	  agreement.	  Firstly	  the	  ventricular	  end-­‐systolic	  size	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is	   much	   smaller	   at	   this	   higher	   level	   of	   DS-­‐MR.	   Small	   discrepancies	   between	  observers	   in	   volume	  measurement	  will	   be	   amplified	  when	   calculating	   the	  COV	  (as	   seen	   in	   previous	   study	   61).	   Therefore	   even	   a	   small	   difference	   between	  observers	  will	   result	   in	   a	  much	   greater	   variance	   and	   suggest	   poor	   agreement.	  Secondly	   the	   images	   in	   TOF	   patients	   were	   acquired	   in	   the	   axial	   plane	   and	  although	   this	   is	  known	   to	  allow	  better	  visualization	   for	   the	  RV	   this	   is	  prone	   to	  error	   in	   the	   LV	   due	   to	   partial	   volume	   effect	   in	   the	   most	   apical	   slices	   of	   the	  ventricle	   79.	   In	   comparison	   the	   normal	   group	   have	   better	   agreement	   between	  observers	  at	  higher	  DS-­‐MR	  stages	  with	  a	  COV	  of	  10.5	  at	  stage	  2	  DS-­‐MR	  and	  these	  images	   were	   acquired	   using	   a	   short-­‐axis	   geometry.	   Although	   volumetric	  assessment	   of	   the	   LV	   using	   transverse	   slices	   has	   been	   validated	   79,	   95	   and	   is	  thought	   to	   be	   comparable	   to	   short	   axis	   imaging	   at	   rest	   it	   is	   likely	   that	   the	  potential	  for	  error	  is	  greater	  during	  DS-­‐MR.	  
	  In	  the	  RV	  the	  ESV	  in	  both	  TOF	  patients	  and	  the	  normal	  volunteers	  showed	  good	  agreement	  suggesting	  good	  reproducibility.	  In	  the	  TOF	  group	  this	  superiority	  in	  comparison	  to	  the	  LV-­‐ESV	  is	  likely	  to	  be	  due	  to	  the	  larger	  baseline	  ESV	  reducing	  the	   potential	   errors	   of	   small	   volumes.	   Additionally	   the	   axial	   geometry	   allows	  better	   visualization	   of	   the	   valve	   planes	   which	   may	   improve	   accuracy	   when	  assessing	   volumes	   as	   seen	  previously	   79.	   In	   comparison	   the	   normal	   group	   also	  showed	   good	   agreement	   between	   observers	   in	   RV-­‐ESV	   assessment	   at	   higher	  stages	  of	  DS-­‐MR	  suggesting	  that	  both	  short	  axis	  and	  axial	  assessment	  of	  the	  RV	  yield	   reproducible	   results.	   Overall	   the	   data	   show	   good	   agreement	   between	  observers	  for	  volume	  assessment	  during	  DS-­‐MR.	  This	  is	  only	  possible	  with	  good	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institutional	  training	  and	  adherence	  to	  strict	  reporting	  guidelines	  94.	  This	  should	  be	  taken	  into	  consideration	  when	  performing	  and	  analyzing	  DS-­‐MR	  volumes.	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CHAPTER	  6:	  DOBUTAMINE	  STRESS	  MR	  IN	  TETRALOGY	  OF	  
FALLOT	  
6.1	  Overview	  The	   previous	   chapters	   have	   shown	   the	   importance	   of	   volumetric	   and	   flow	  assessment	  and	  how	  these	  can	  be	  affected	  during	  stress	  imaging.	  In	  this	  chapter	  the	   focus	   is	   on	   the	   haemodynamic	   and	   volumetric	   changes	   seen	   during	  dobutamine	   stress	   MR,	   and	   how	   these	   may	   reflect	   underlying	   ventricular	  dysfunction.	  	  
In	  repaired	  TOF	  chronic	  severe	  PR	   is	  associated	  with	  progressive	  RV	  dilatation	  and	  dysfunction	  and	  an	   increased	   risk	  of	   exercise	   intolerance,	   arrhythmia,	   and	  sudden	  death	  97.	  PVR	  is	  beneficial	  in	  reducing	  RV	  size	  as	  quantified	  by	  CMR	  22,	  98	  but	  may	  not	  lead	  to	  recovery	  when	  performed	  late,	  i.e.	  in	  patients	  with	  prolonged	  and	   severe	   ventricular	   dilatation	   and	   dysfunction	   99,	   100.	   Hence,	   there	   is	  accumulating	  evidence	  to	  support	  PVR	  before	  clinical	  symptoms	  and	  ventricular	  dysfunction	  occur,	  but	  controversy	  remains	  on	  appropriate	  timing	  criteria	  22,	  101,	  
102.	  A	  recent	  CMR	  study	  has	  demonstrated	  that	  even	  moderate	  reduction	  of	  right	  (RV-­‐EF<45%)	  and	   left	  ventricular	  ejection	   fraction	  (LV-­‐EF<55%)	   in	  addition	   to	  severe	  RV	  dilatation	  (RV-­‐EDV	  z-­‐score	  >7)	  predicted	  major	  adverse	  events	  such	  as	  death,	  increase	  in	  NYHA	  class	  to	  III	  or	  IV,	  or	  sustained	  ventricular	  tachycardia	  
103.	   This	   suggests	   a	   need	   to	   focus	   on	   early	   markers	   of	   impaired	   ventricular	  systolic	  function	  when	  selecting	  asymptomatic	  TOF	  patients	  for	  early	  PVR	  103,	  104.	  
Stress	   imaging	  may	   provide	   early	  markers	   of	   ventricular	   dysfunction.	   To	   date	  low-­‐dose	  DS-­‐MR	  up	  to	  7.5	  μg/kg/min	  105	  has	  identified	  abnormalities	  of	  diastolic	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function	   in	   TOF	   with	   chronic	   PR	   59	   but	   has	   failed	   to	   identify	   RV	   systolic	  dysfunction	  not	  already	  evident	  at	  baseline	  106.	  	  
Therefore,	  this	  study	  tested	  the	  hypothesis	  that	  DS-­‐MR	  at	  a	  higher	  dose	  level	  may	  provoke	  ventricular	  systolic	  dysfunction	  amongst	  a	  group	  of	  TOF	  patients	  with	  chronic	   severe	   pulmonary	   regurgitation,	   RV	   dilatation,	   and	   preserved	   baseline	  ventricular	   systolic	   function.	   We	   also	   sought	   to	   provide	   reference	   values	   of	  ‘normal’	  ventricular	  response	  from	  healthy	  adult	  volunteers	  using	  our	  staged	  DS-­‐MR	   protocol	   (baseline,	   10	   and	   20	   μg/kg/min	   of	   dobutamine)	   for	   comparison	  with	   patient	   data.	   An	   additional	   goal	   was	   to	   define	   parameters	   of	   ventricular	  systolic	   dysfunction	   in	   response	   to	   stress	   that	   might	   be	   more	   sensitive	   than	  ejection	   fraction	   at	   rest,	   in	   order	   to	   design	   future	   clinical	   research	   in	   larger	  series.	  
The	  following	  chapter	  will	  discuss	  the	  volumetric	  changes	  seen	  in	  TOF	  patients	  and	  healthy	  volunteers	  and	  how	  this	  may	  reflect	  underlying	  RV	  dysfunction.	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6.2	  Results	  Of	  Haemodynamic	  And	  Volumetric	  Changes	  During	  DS-­‐MR	  As	  previously	  described,	  of	  the	  28	  TOF	  patients	  recruited	  for	  the	  study	  only	  24	  completed	   full	  volumetric	  and	   flow	  assessment	  at	  10μg/kg/min	  of	  dobutamine	  and	  18	   continued	   to	   complete	   the	  higher	  dose	  of	  dobutamine	  at	  20μg/kg/min,	  stage	   2	   (Chapter	   4,	   Figure	   13).	   This	   chapter	   will	   describe	   the	   haemodynamic	  consequences	  of	  dobutamine	  stress.	  The	  volumetric	  analysis	  will	  initially	  review	  the	   changes	   observed	   during	   low	   dose	   dobutamine	   as	   24	   of	   the	   patients	  completed	   this	   section.	   The	   comparative	   data	   at	   both	   levels	   of	   DS-­‐MR	   and	   the	  trends	  observed	  includes	  only	  the	  18	  patients	  who	  completed	  the	  full	  protocol.	  
6.2.1	  Haemodynamic	  Parameters	  At	  stage	  1	  DS-­‐MR	  heart	  rate	  increased	  by	  29%	  in	  the	  TOF	  patients	  and	  by	  27%	  for	  the	  control	  group.	  Heart	  rate	  continued	  to	  increase	  at	  stage	  2	  DS-­‐MR	  by	  34%	  for	   TOF	   patients	   and	   33%	   for	   controls.	   Mean	   arterial	   blood	   pressure	   also	  increased	  with	   each	   level	   of	   DS-­‐MR	   (Stage	   1	   TOF	   patients:	   10%,	   controls:	   8%,	  Stage	  2	  TOF	  patients:	  6%,	  controls:	  4%).	  	  Both	  groups	  had	  a	  significant	  (p<0.05)	  and	  similar	  increase	  in	  heart	  rate	  and	  mean	  arterial	  blood	  pressure	  at	  each	  level	  of	  dobutamine,	  confirming	  the	  reproducibility	  of	  the	  dobutamine	  stress	  protocol	  (Fig.	  22).	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Figure	  22:	  Haemodynamic	  changes	  during	  DS-­‐MR	  
Change	   in	   mean	   heart	   rate	   and	   mean	   arterial	   blood	   pressure	   related	   to	   level	   of	  
dobutamine,	   rest,	   10	   or	   20	   μg/kg/min	   for	   patients	   and	   normal	   healthy	   volunteers.	  
Values	   expressed	   as	  mean	  with	   standard	   deviation	   shown.	   There	  was	   a	   statistically	  
significant	   increase	   in	   heart	   rate	   and	   blood	   pressure	   from	  baseline	   to	   10	   μg/kg/min	  
and	   also	   between	   10	   and	   20	   μg/kg/min	   for	   both	   TOF	   patients	   and	   controls	   (all	   p-­‐
values	  <0.05)	  
	  The	  LV	  and	  RV	  cardiac	  index	  increased	  significantly	  with	  each	  dobutamine	  dose	  in	  both	  the	  TOF	  group	  and	  normal	  controls.	  The	  magnitude	  of	  this	  increase	  was	  greater	   in	   the	   control	   group	   compared	   with	   the	   TOF	   group.	   The	   percentage	  increase	   in	  RV-­‐CI	   in	   the	  control	  group	   for	  stage	  1	  and	  stage	  2	  dobutamine	  was	  56%	   and	   23%	   respectively	   compared	   with	   44%	   and	   20%	   for	   the	   TOF	   group	  (Table	   17).	   The	   RV-­‐CI	   is	   greater	   within	   the	   TOF	   group	   as	   this	   includes	   the	  additional	  volume	  from	  the	  PR	  hence	  the	  marked	  difference	  in	  CI	  for	  LV	  vs	  RV.	  	  
These	   haemodynamic	   changes	   observed	   correlate	  well	  with	   published	   data	   on	  stress	   imaging	   (echo	   and	   CMR)	   and	   confirm	   the	   physiological	   effects	   of	  dobutamine	  on	   the	  myocardium.	  This	   is	   important,	  as	   it	   is	  necessary	   to	  ensure	  effective	   stress	   conditions	   to	   enable	   interpretation	   of	   volumetric	   and	   flow	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measurements	   acquired.	   The	   volumetric	   parameters	   will	   now	   be	   further	  examined.	  
Table	  17:	  Cardiac	  Index	  During	  DS-­‐MR	  
	  
	  
Table	  17:	  Values	  are	  expressed	  as	  mean	  ±	  standard	  deviation	  for	  TOF	  patients	  (n=18)	  
and	  normal	  healthy	  volunteers	  (n=10).	  The	  significance	  of	  these	  changes	  is	  denoted	  by	  
the	   following:	   (*)	   change	   from	  rest	   to	  10	  dobutamine,	  p<0.05,	   (§)	   change	   from	  10	   to	  
20	  dobutamine,	  p<0.05,	  (⌘)	  change	  from	  rest	  to	  20,	  p<0.05.	  
	  
6.2.2	  Ventricular	  function	  Volumetric	   analysis	   included	   quantification	   of	   bi-­‐ventricular	   EDV,	   ESV,	   SV	   and	  derived	  EF	  as	  described	  in	  Chapter	  2.	  	  
6.2.2.1	  Dobutamine	  Stress	  MR	  Stage	  1	  –	  Dobutamine	  10	  μg/kg/min	  	  
Volunteers	  Previous	   study	  has	   reported	   that	  during	  dobutamine	   stress	   imaging	   in	  healthy	  volunteers	  there	  is	  little	  change	  in	  ventricular	  EDV	  and	  a	  reduction	  in	  ESV	  at	  low	  dose	  dobutamine.	  This	  pattern	  of	  ventricular	  volumetric	  change	  was	  seen	  clearly	  in	  the	  volunteer	  group	  in	  this	  study.	  
Parameter	   	   Stage	  of	  DS-­‐MR	   %	  Change	  in	  CI	  
	   	   Rest	   10	   20	   Rest-­‐10	   10-­‐20	  
LV-­CI	  (l/min/m2)	   Fallot	   2.8±0.5	   3.9±0.8*	   4.4±1.0§♯	   40	   13	  
	   Normal	   3.0±0.6	   4.8±0.8*	   5.7±0.8§♯	   60	   19	  
RV-­CI	  (l/min/m2)	   Fallot	   4.5±0.9	   6.5±1.5*	   7.8±1.9§♯	   44	   20	  
	   Normal	   3.0±0.6	   4.7±0.8*	   5.8±4.0§♯	   56	   23	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During	   stage	   1	   DS-­‐MR	   there	   was	   a	   reduction	   in	   ESV	   with	   no	   change	   in	   EDV.	  Hence,	  the	  increase	  in	  SV	  related	  to	  unchanged	  EDV,	  with	  significant	  increase	  in	  bi-­‐ventricular	  EF,	  reflecting	  normal	  contractile	  reserve.	  
	  
	   	  	  
	   	  	  
Figure	  23:	  Normal	  volunteers,	  volumetric	  parameters	  during	  Stage	  1	  DS-­‐MR	  
	  
TOF	  Patients	  	  Of	  the	  28	  TOF	  patients	  recruited,	  24	  completed	  the	  first	  stage	  of	  DS-­‐MR;	  	  data	  for	  the	   volumetric	   changes	   is	   shown	   in	   figures	   23	   and	   24	   (mean	   results	   are	  displayed	   later	   in	   this	   chapter).	   In	   the	   majority	   of	   TOF	   patients	   the	   expected	  trend	   in	   volumetric	   measurements	   is	   observed.	   	   There	   is	   a	   decrease	   in	   end-­‐systolic	  volume	  for	  the	  LV	  and	  RV	  during	  stage	  1	  of	  the	  DS-­‐MR	  protocol.	  However	  there	  are	  3	  patients,	  whose	  LV	  parameters	  do	  not	   follow	   the	   typical	  pattern	  of	  response.	  In	  the	  LV-­‐EDV	  response	  figure,	  patients	  7,19	  and	  20	  show	  an	  increase	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in	  LV-­‐EDV	  during	  stage	  1	  DSMR.	  The	  same	  patients	  also	  have	  no	  reduction	  in	  LV-­‐ESV	  during	  the	  same	  stage.	  The	  significance	  of	  this	  is	  difficult	  to	  put	  into	  context	  in	   such	   a	   small	   data	   set	   but	   may	   show	   correlation	   with	   abnormal	   ventricular	  response	  at	  stage	  2	  DS-­‐MR.	  	  
Two	   patients	   (11	   and	   12)	   show	   an	   increase	   in	   RV-­‐EDV	   increase	   during	  DSMR	  stage	   1	   and	   a	   slight	   increase	   in	   RV-­‐ESV.	   This	   data	   shows	   that	   although	   when	  averaged	   it	   appears	   the	  patient	  group	  respond	   to	  dobutamine	  10μg/kg/min	  as	  expected,	   on	   an	   individual	   basis	   there	   are	   some	   patients	   have	   an	   abnormal	  response	  even	  at	  low	  dose	  DS-­‐MR	  	  
Of	   the	   four	   patients	   who	   could	   not	   continue	   to	   stage	   2	   DS-­‐MR,	   three	   had	   an	  appropriate	   reduction	   in	   ESV	   and	   appropriate	   increase	   in	   EF	   at	   stage	   1.	   One	  patient	   had	   a	   very	   dilated	   RV	   at	   baseline	   and	   very	   abnormal	   response	   to	  dobutamine	  stage	  1	  (series	  11,	  figure	  24).	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Figure	  24:	  Fallot	  patients	  volumetric	  parameters	  during	  DSMR	  Stage	  1	  
	  
6.2.2.2	  Dobutamine	  Stress	  MR	  Stage	  2	  –	  Dobutamine	  20	  μg/kg/min	  	  	  
Volunteers	  During	  the	  second	  stage	  of	   the	  DS-­‐MR	  protocol,	  dobutamine	  concentration	  was	  increased	  to	  20μg/kg/min.	  At	  this	  level	  there	  was	  marked	  reduction	  in	  EDV	  and	  ESV	   for	   both	   ventricles	   with	   no	   significant	   change	   in	   SV	   (Figure	   25	   &	   26).	  Resulting	  in	  a	  further	  significant	  increase	  in	  EF	  -­‐	  normal	  contractile	  reserve.	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Figure	  25:	  Volumetric	  changes	  in	  Left	  Ventricle	  during	  DS-­‐MR	  
Normal	  volunteers	  (A)	  and	  Tetralogy	  of	  Fallot	  patients	  (B)	  
Mean	   ejection	   fraction	   for	   each	   ventricle	   is	   shown	   in	   the	   panel	   to	   the	   right	   of	   the	  
volumetric	  data.	  Values	  expressed	  as	  mean	  with	  standard	  deviation.	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Figure	  26:	  Volumetric	  changes	  in	  the	  Right	  Ventricle	  during	  DS-­‐MR	  
Normal	  volunteers	  (A)	  and	  the	  Tetralogy	  of	  Fallot	  patients	  (B)	  	  
Mean	   ejection	   fraction	   for	   each	   ventricle	   is	   shown	   in	   the	   panel	   to	   the	   right	   of	   the	  
volumetric	  data.	  Values	  expressed	  as	  mean	  with	  standard	  deviation.	  
P	  values	  denote	  significant	  difference	  between	  each	  level	  of	  the	  dobutamine	  protocol.	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TOF	  patients	  In	   the	   TOF	   patients	   for	   the	   LV	   (Figure	   25),	   the	   same	   pattern	   of	   response	  was	  observed	  for	  LV-­‐EDV	  and	  LV-­‐ESV	  as	  described	  above	  for	  the	  volunteers,	  although	  the	   improvement	   in	   EF	   at	   20μg/kg/min	   dobutamine	   failed	   to	   reach	   statistical	  significance.	  	  	  	  
There	  was	  a	  reduction	  in	  RV-­‐EDV,	  which	  reached	  statistical	  significance	  (Figure	  26,	  panel	  B).	  However	   the	  degree	  of	   this	   reduction	  was	   relatively	   smaller	   than	  that	  observed	  for	  the	  LV	  volumes	  (LV-­‐EDV	  18%,	  RV-­‐EDV	  9%	  at	  stage	  2	  DS-­‐MR).	  	  
The	  most	   striking	   result	  was	   the	   change	   in	   the	  RV-­‐ESV	   during	   stage	   2	  DS-­‐MR.	  The	  higher	  dose	  dobutamine	  did	  not	  universally	  result	  in	  the	  expected	  decrease	  in	   RV-­‐ESV	   in	   the	   TOF	   group,	   but	   produced	   two	   distinct	   types	   of	   response:	   A	  proportion	   of	   patients	   had	   a	   further	   decrease	   in	   RV-­‐ESV	   (responders),	   whilst	  others	  had	   increased	  or	  unchanged	  RV-­‐ESV	  (non-­‐responders)	   (Figure	  27	  panel	  A).	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Figure	  27:	  Sub-­‐group	  analysis	  determined	  by	  RV-­‐ESV	  response	  
(A)	  Dobutamine	  effect	  on	  RV-­‐ESV,	  subgroups	  defined	  by	  response	  to	  dobutamine	  from	  
10	   to	   20	   μg/kg/min.	   The	   responders	   (n=9)	   showed	   a	   further	   reduction	   of	   RV-­‐ESV	   on	  
increasing	   from	  10	  to	  20,	  which	   is	   comparable	   to	   that	  seen	   in	   the	  control	  group	   (RV-­‐
ESV	   rest	   32.1ml/m2,	   DS-­‐MR	   10:	   19.3ml/m2,	   DS-­‐MR	   20:	   14.5ml/m2,	   p<0.05).	   The	   non-­‐
responders	  showed	  either	  an	  increase	  or	  no	  change	  in	  RV-­‐ESV.	  
(B)	   Dobutamine	   effect	   on	   RV-­‐EDV	   by	   subgroups	   defined	   by	   response	   in	   RV-­‐ESV.	   The	  
responders,	   showed	  a	  minimal	   reduction	  of	  RV-­‐EDV	   from	  baseline	   to	   dobutamine	  10	  
whilst	   there	   is	   a	   more	   significant	   reduction	   in	   RV-­‐EDV	   from	   10	   to	   20.	   In	   the	   non-­‐
responders	   there	   is	   also	   only	   a	   minimal	   decrease	   in	   EDV	   from	   rest	   to	   10	   and	   little	  
further	  reduction	  from	  10	  to	  20.	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6.2.2.3	  Responders	  vs.	  non	  responders	  The	  possibility	  of	  correlating	   the	  RV-­‐ESV	  response	  with	  an	  underlying	  baseline	  characteristic	   or	   stress	   parameter	   was	   further	   explored.	   Table	   18	   shows	   a	  comparison	  of	  some	  of	  these	  parameters	  with	  t-­‐test	  analysis.	  The	  only	  parameter	  that	   showed	   a	   difference	   between	   the	   sub-­‐groups	   was	   baseline	   heart	   rate	  (p=0.04)	  with	  a	  slightly	   lower	  heart	  rate	   in	   the	  non-­‐responder	  group.	  However	  during	  DS-­‐MR	  a	   comparable	   increase	   in	  HR	  at	   each	   level	   of	   stress	  was	   seen	   in	  each	  sub-­‐group.	  The	  responders	  had	  a	  HR	  at	  rest	  of	  70bpm,	  DS-­‐MR	  10,	  89bpm	  and	  DS-­‐MR	  20,	  113bpm.	  The	  non-­‐responders	  had	  a	  heart	  rate	  at	  rest	  of	  62bpm,	  DS-­‐MR	   10,	   80bpm,	   DS-­‐MR	   20:	   114bpm.	   Therefore	   the	   abnormal	   volumetric	  response	   seen	   at	   20	   μg/kg/min	   could	   not	   be	   predicted	   from	   baseline	  characteristics.	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Table	  18:	  Baseline	  characteristics	  of	  RV-­‐ESV	  responders	  and	  non-­‐responders	  
	  










between	  2	  groups	  
(p	  values)	  
Age	  at	  CMR	  (yr)	   32.8	  (19.8-­‐60.1)	   30.7	  (16.2-­‐59.7)	   0.88	  
Sex	  	  (M/F)	   F=6	  M=4	   F=3	  M=5	   N/A	  
NYHA	  classification	   2.0±0.6	   1.8±0.4	   0.32	  
BSA	   1.77±0.16	   1.72±0.16	   0.54	  
Age	  at	  TOF	  correction	  (yr)	   4.1	  (1.3-­‐20.2)	   4.9	  (1.5-­‐15.5)	   0.73	  
QRS	  duration	  (ms)	   150±7.6	   151±7.3	   0.81	  
Heart	  rate	  (bpm)	   68.3±9.09	   63.0±8.4	   0.04	  
Mean	  BP	  (mmhg)	   86.1±7.6	   89.2±2.9	   0.34	  
LV-­EDV	   70.1±12.0	   76.7±11.1	   0.27	  
LV-­ESV	   29.4±7.2	   33.2±8.3	   0.34	  
LV-­SV	   40.6±7.3	   43.5±5.2	   0.4	  
LV-­EF	   58.2±5.3	   57.2±6.8	   0.73	  
RV-­EDV	   122.3±24.3	   131.6±28.1	   0.48	  
RV-­ESV	   57.1±17.7	   57.4±19.07	   0.97	  
RV-­SV	   65.2±11.0	   74.2±13.3	   0.16	  
RV-­EF	   54.1±7.6	   57.1±6.1	   0.41	  
 
Table	  18:	  The	  subgroups	  are	  defined	  by	  response	  of	  RV-­‐ESV	  to	  dobutamine	  from	  10	  to	  
20	   μg/kg/min,	   showing	   no	   significant	   difference	   (except	   for	   gender	   and	   heart	   rate)	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Figure	  28:	  Change	  in	  RV-­‐EF	  by	  subgroup.	  	  
The	  responders	  have	  a	  significant	  increase	  in	  RV-­‐EF	  from	  rest	  to	  10	  and	  there	  is	  a	  non-­‐
significant	  further	  small	   increase	  at	  higher	   levels	  of	  dobutamine.	  The	  non-­‐responders	  
have	   an	   initial	   increase	   in	   RV-­‐EF	   but	   with	   higher	   levels	   of	   dobutamine	   there	   is	   a	  
reduction	  in	  RV-­‐EF.	  
 
6.2.3	  Contractile	  reserve	  Contractile	  reserve	  is	  determined	  by	  change	  in	  ventricular	  EF,	  and	  can	  therefore	  be	  measured	  by	  any	  imaging	  modality	  that	  quantifies	  EF.	  An	  increase	  of	  greater	  than	   5%	   during	   stress	   is	   considered	   to	   indicate	   the	   presence	   of	   contractile	  reserve.	  The	  RV-­‐ESV	  non-­‐responders	  had	  a	  reduction	  in	  RV-­‐EF	  at	  20μg/kg/min	  indicating	  abnormal	  contractile	  reserve	  (Figure	  29).	  As	  demonstrated	   in	  Figure	  29,	  the	  changes	  in	  RV-­‐EDV	  showed	  no	  correlation	  with	  changes	  in	  RV-­‐EF	  whilst	  RV-­‐ESV	  showed	  a	  good	  relationship.	  This	  suggests	  that	  the	  response	  of	  RV-­‐ESV	  at	  20μg/kg/min	   contributed	   most	   to	   abnormal	   RV	   contractile	   reserve	   in	   this	  patient	  group.	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Figure	   29:	   Correlation	   of	   contractile	   reserve	   and	   volumetric	   changes	   in	   TOF	   patients	  
during	  DS-­‐MR.	  
Scatter	  plots	  showing	  percentage	  change	  in	  RV-­‐EF	  (=contractile	  reserve)	  compared	  to	  
percentage	   change	   in	   RV-­‐ESV	   (Panel-­‐A)	   and	   RV-­‐EDV	   (Panel-­‐B)	   from	   rest	   to	  
dobutamine	  10	  (triangles)	  and	  from	  10	  to	  dobutamine	  20	  (squares).	  
In	   Panel-­‐A,	   the	   upper	   left	   quadrant	   in	   the	   RV-­‐ESV	   vs.	   RV-­‐EF	   image	   incorporates	   the	  
abnormal	   responders,	   as	   RV-­‐ESV	   either	   increases	   or	   is	   static	   with	   a	   reciprocal	  
reduction	   in	   RV-­‐EF.	   The	   lower	   right	   quadrant	   shows	   a	   normal	   response	   with	   a	  
decrease	   in	   RV-­‐ESV	   and	   comparable	   increase	   in	   RV-­‐EF.	   Regression	   analysis	   shows	   a	  
good	   correlation	   between	   change	   in	   RV-­‐EF	   and	   ESV	   (Panel-­‐A)	   whereas	   there	   is	   no	  
discernable	  agreement	  with	  EDV	  (Panel-­‐B).	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6.3	  Long	  term	  follow	  up	  The	   patients	   involved	   in	   this	   study	   have	   been	   under	   continuing	   care	   with	   St	  Thomas’	  ACHD	  team.	  Unfortunately	  due	  to	  budgeting	  and	  time	  restraints	  during	  the	  research	  period	  it	  was	  not	  possible	  to	  follow	  up	  all	  patients	  with	  repeat	  CMR	  at	  a	  specific	  interval	  from	  their	  initial	  research	  CMR.	  The	  proposal	  at	  the	  start	  of	  the	  research	  period	  was	  to	  perform	  serial	  CMR	  at	  1	  year	  intervals	  if	  no	  PVR	  was	  performed	  and	  at	  6	  months	  post	  PVR	  then	  annual	  review	  if	  PVR	  was	  arranged.	  Although	   it	   was	   not	   possible	   to	   collect	   this	   data	   as	   anticipated	   it	   has	   been	  possible	  to	  review	  all	  patients	  over	  a	  5	  year	   interval	  to	  determine	  which	  of	  the	  went	  on	  to	  PVR	  and	  which	  have	  continued	  with	  medical	  management.	  Table	  20	  shows	  the	  patient	  follow	  up	  data.	  
Of	   the	   original	   28	   patients	   recruited	   into	   the	   study,	   11	   had	   PVR.	   The	   median	  interval	  for	  PVR	  following	  the	  DS-­‐MR	  protocol	  was	  3	  years.	  Of	  those,	  4	  patients	  completed	   the	   first	   stage	   of	   DS-­‐MR	   only	   due	   to	   mild	   side	   effects	   from	   the	  dobutamine.	  The	  remaining	  7	  completed	  both	  stages	  of	  the	  DS-­‐MR	  protocol	  with	  4	  of	  these	  patients	  falling	  into	  the	  “responder”	  category	  as	  determined	  by	  the	  RV-­‐ESV	  response	   to	  dobutamine.	   	  2	  patients	  had	  an	  abnormal	  RV-­‐ESV	  response	   to	  higher	   dose	   of	   dobutamine	   and	  were	   considered	   “non	   responders”	   (1	   data	   set	  was	  not	  included	  in	  the	  final	  volumetric	  analysis	  due	  to	  poor	  image	  quality).	  	  All	  PVR	  procedures	  were	  completed	  without	  significant	  cardiovascular	  morbidity	  or	  mortality.	  Within	  the	  group	  of	  patients	  who	  underwent	  PVR	  (i.e.	  the	  11	  patients)	  4	  had	  follow	  up	  CMR	  at	  6	  months	  post	  procedure	  and	  the	  	  results	  are	  shown	  in	  Figure	  30.	  There	  is	  a	  reduction	  in	  RV-­‐EDV	  and	  RV-­‐ESV	  in	  patient	  1	  and	  2	  but	  little	  change	  in	  volumes	  for	  patient	  3.	  Patient	  4	  only	  has	  a	  small	  reduction	  in	  RV-­‐ESV	  post	  PVR.	  Regarding	  the	  response	  to	  dobutamine	  pre	  operatively,	  patients	  1	  and	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4	  both	  had	  a	  normal	  RV-­‐ESV	  response	  at	  stage	  2	  DS-­‐MR	  and	  therefore	  considered	  responders.	   Patients	   2	   and	   3	   only	   completed	   the	   first	   stage	   of	   DS-­‐MR	   and	  therefore	  data	  for	  higher	  level	  of	  dobutamine	  is	  not	  available.	  	  
	  











1	   2	   Responder	   Y	  
2	   2	   Responder	   Y	  
3	   0	   	   	  
4	   2	   	   Y	  
5	   1	   	   Y	  
6	   2	   Responder	   	  
7	   1	   	   Y	  
8	   2	   Non	  responder	   	  
9	   2	   Non	  responder	   	  
10	   0	   	   	  
11	   2	   Responder	   	  
12	   0	   	   	  
13	   2	   Non	  responder	   	  
14	   2	   Non	  responder	   Y	  
15	   1	   	   Y	  
16	   2	   Responder	   Y	  
17	   1	   	   	  
18	   2	   Responder	   Y	  
19	   2	   Non	  responder	   	  
20	   2	   Non	  responder	   	  
21	   2	   Responder	   	  
22	   2	   Responder	   	  
23	   2	   Non	  responder	   	  
24	   2	   Non	  responder	   Y	  
25	   1	   	   	  
26	   1	   	   Y	  
27	   2	   Responder	   	  
28	   2	   Non	  responder	   	  	  
Table	  19:	  Follow	  up	  data	  for	  the	  TOF	  patients.	  The	  28	  patients	  are	  listed	  with	  level	  of	  
DS-­‐MR	   achieved	   i.e.	   stage	   1	   or	   stage	   2,	   whether	   they	   were	   considered	   to	   be	  
“responders”	   or	   non-­‐responders	   determined	   by	   RV-­‐ESV	   response	   and	   follow	   up	   in	  
terms	  of	  PVR	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Figure	  30:	  Pre	  and	  Post	  PVR	  Right	  Ventricular	  Volumes	  
Of	   the	   11	   patients	   who	   went	   on	   to	   PVR,	   4	   had	   follow	   up	   CMR	   with	   volumetric	  
assessment.	   The	   graphs	   above	   show	   that	   for	   these	   patients	   there	  was	   a	   change	  RV-­‐
EDV	  and	  RV-­‐ESV	   following	  PVR	   in	  patients	  1,2	  and	  4	  with	   little	   change	   in	  volumetric	  
parameters	  for	  patient	  3.	  
	  Nine	   of	   the	   patients	   who	   did	   not	   proceed	   to	   PVR	   had	   serial	   CMR	   assessment.	  Volumetric	   parameters	   at	   follow	   up	   scan	   are	   shown	   in	   Figure	   31.	   There	   is	   no	  change	  in	  the	  RV-­‐EDV	  or	  RV-­‐ESV	  of	  these	  patients	  on	  repeat	  CMR.	  Seven	  of	  these	  patients	  during	  DS-­‐MR	  stage	  2	  had	  an	  abnormal	  RV-­‐ESV	  response	  and	  therefore	  considered	   to	  be	   “non-­‐responders”.	   	  The	   fact	   that	   these	  patients	  have	   required	  repeat	   CMR	   compared	   to	   the	   other	   8	   non-­‐PVR	   patients	   suggests	   that	   they	  continue	  to	  be	  symptomatic.	   	   It	   is	  possible	   that	   these	  patients	  have	  a	  degree	  of	  restrictive	   RV	   physiology	   and	   that	   is	   what	   determines	   the	   abnormal	   RV-­‐ESV	  response.	  Whether	   restrictive	  physiology	  results	   in	  abnormal	   systolic	   response	  to	  dobutamine	  cannot	  be	  determined	  from	  this	  small	  study	  and	  it	  is	  hoped	  that	  with	  larger	  patient	  cohorts	  this	  hypothesis	  can	  be	  further	  explored.	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Figure	  31:	  Follow	  up	  CMR	  volumes	  for	  non-­‐PVR	  TOF	  patients	  
Right	  ventricular	  volumes	  at	  baseline	  during	  research	  protocol	  CMR	  and	  at	   follow	  up	  
CMR	  in	  patients	  who	  did	  not	  go	  forward	  to	  PVR	  (n=9).	  
	  
6.4	  Summary	  The	   normal	   haemodynamic	   and	   volumetric	   response	   to	   a	   staged	   dobutamine	  protocol	  has	  been	  demonstrated	  for	  the	  first	  time	  in	  healthy	  volunteers.	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CHAPTER	  7:	  DISCUSSION	  AND	  FUTURE	  DIRECTION	  	  The	   previous	   chapters	   have	   highlighted	   the	   importance	   of	   CMR	   assessment	   in	  repaired	   TOF	   patients.	   The	   roles	   of	   ventricular	   volume	   and	   arterial	   flow	  assessment	   have	   been	   explored	   together	   with	   the	   importance	   of	   accurate	  quantification.	   The	   results	   will	   now	   be	   put	   into	   the	   clinical	   context	   with	  particular	  reference	  to	  the	  timing	  of	  PVR	  and	  potential	  new	  strategies	  to	  evaluate	  TOF	  patients	  in	  the	  future.	  
7.1	  Stress	  magnetic	  resonance	  imaging	  in	  TOF	  One	  of	  the	  main	  aims	  of	  this	  study	  was	  to	  determine	  the	  haemodynamic	  effects	  and	  volumetric	  changes	  during	  dobutamine	  stress	  MR	  imaging	   in	  TOF	  patients.	  This	  was	  achieved	  by	  the	  direct	  comparison	  of	  DS-­‐MR	  in	  healthy	  adult	  volunteers	  and	  TOF	  patients	  with	  preserved	  biventricular	  function,	  moderate	  RV	  dilatation	  and	  severe	  PR.	  Overall	  a	  normal	  response	  in	  LV	  and	  RV	  volumetric	  response	  was	  found	   at	   a	   low	   level	   of	   dobutamine	   stress	   (10μg/kg/min)	   in	   the	   TOF	   patient	  cohort.	   The	   volumetric	   changes	   seen	   were	   similar	   to	   that	   seen	   in	   the	   healthy	  volunteer	  group	  and	  are	  in	  line	  with	  previously	  published	  data	  by	  Van	  de	  Berg	  et	  al,	  which	  also	  demonstrated	  normal	  systolic	  function	  in	  TOF	  patients	  during	  low	  dose	   dobutamine	   stress	   assessment	   106	   .	   Therefore	   this	   dose	   is	   unlikely	   to	  unmask	   systolic	   dysfunction	   compared	   with	   controls	   when	   using	   volumetric	  CMR	  On	   increasing	   from	  10	   to	   20	  μg/kg/min	   of	   dobutamine,	   changes	   in	  RV	   and	  LV	  systolic	   function	   were	   observed.	   There	   was	   a	   significant	   further	   reduction	   LV	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volumes	   (normal	   response)	  but	   the	   increase	   in	  LV-­‐EF	   in	  TOF	  patients	   failed	   to	  reach	  statistical	  significance.	  This	  may	  be	  due	  to	  the	  small	  sample	  size	  and	  in	  a	  larger	  cohort	  of	  patients	  this	  effect	  may	  become	  more	  prominent.	  Recent	  study	  has	  suggested	  that	  there	  is	  significant	  adverse	  ventricular-­‐ventricular	  interaction	  when	  TOF	  patients	  have	  greater	  RV	  volumes	  107	  and	  therefore	  in	  a	  larger	  cohort,	  especially	  one	  which	  included	  patients	  with	  significant	  RV	  dilatation,	  this	  effect	  may	  become	  more	  apparent.	  	  	  More	   impressive	   is	   the	   abnormal	   RV-­‐EF	   response	   observed	   in	   a	   sub-­‐group	   of	  TOF	  patients,	  who	  failed	  to	   further	   increase	  RV-­‐EF	  when	   increasing	   from	  10	  to	  20μg/kg/min	  of	  dobutamine,	  due	  to	  either	  failure	  of	  reduction	  or	  increase	  of	  RV-­‐ESV.	   The	   remainder	   of	   TOF	   patients	   had	   normal	   reduction	   of	   volumes	   at	  20μg/kg/min	   although	   the	   increase	   in	   RV-­‐EF	   did	   not	   reach	   statistical	  significance.	  The	  difference	  in	  incremental	  stress	  response	  within	  the	  TOF	  cohort	  could	   not	   be	   predicted	   by	   clinical	   or	   baseline	   CMR	  parameters.	   In	   comparison	  the	   healthy	   volunteers	   had	   a	   normal	   response	   to	   dobutamine	   throughout	   the	  clinical	   protocol	   and	   therefore	   a	   significant	   increase	   in	   bi-­‐ventricular	   EF	  demonstrating	  normal	  contractile	  reserve.	  
7.1.1	  Mechanics	  of	  impaired	  RV	  contractile	  reserve	  The	  response	  of	  RV-­‐ESV	  to	  stress	  contributed	  most	  to	  the	  degree	  of	  change	  of	  EF,	  (Figure	  29).	  The	  importance	  of	  RV-­‐ESV	  was	  highlighted	  recently	  by	  Uebing	  et	  al.	  
108	  using	  conductance	  catheter	  technology	  to	  analyze	  pressure-­‐volume	  relations	  under	  dobutamine	  stress	  in	  a	  similar	  cohort	  of	  TOF	  patients.	  They	  observed	  that	  increased	   RV-­‐ESV	  was	   associated	   with	   reduced	   end-­‐systolic	   elastance	   (Ees),	   a	  load-­‐independent	  marker	  of	  myocardial	  contractility,	  and	  that	  RV-­‐ESV	  correlated	  more	   closely	  with	   Ees	   than	   either	  RV-­‐EDV	  or	  RV-­‐EF	   108.	  Hence,	   although	   load-­‐
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dependent,	   RV-­‐ESV	   may	   still	   be	   regarded	   as	   a	   non-­‐invasive	   marker	   of	  contractility	  as	  it	  seems	  to	  reflect	  not	  only	  RV	  volume	  loading	  but	  also	  intrinsic	  myocardial	   contractility	   108.	   Moreover,	   a	   RV-­‐ESV	   >50	   ml/m2	   was	   a	   strong	  predictor	   of	  major	   adverse	   events	   in	   TOF	   in	   the	   study	   of	   Knauth	   et	   al	   103.	   For	  these	   reasons,	   the	   impact	   of	   RV-­‐ESV	   change	   on	   contractile	   reserve	   is	   a	  noteworthy	  extension	  of	  these	  previous	  findings	  highlighting	  the	  importance	  of	  RV-­‐ESV	  in	  the	  interpretation	  of	  systolic	  function.	  	  
7.1.2	  Clinical	  implications	  of	  volumetric	  changes	  seen	  during	  DS-­‐MR	  These	   findings	   are	   relevant	   as	   it	   has	   been	   reported	   that	   ventricular	   systolic	  function	   is	   of	   great	   prognostic	   importance	   in	   TOF	   patients	  with	   significant	   RV	  dilatation	   and	   chronic	   severe	   PR	   as	   even	   moderate	   ventricular	   systolic	  dysfunction	   (RV-­‐EF<45%,	   LV-­‐EF<55%)	   is	   associated	   with	   impaired	   clinical	  status	  104	  and	  can	  predict	  major	  adverse	  events	  103.	  If	  DS-­‐MR	  is	  able	  to	  provoke	  abnormal	  contractile	  reserve	  within	  a	  cohort	  with	  only	  moderate	  RV	  dilatation	  (126.4±27.2	   ml/m2	   BSA)	   and	   preserved	   biventricular	   function	   at	   baseline	   as	  observed	   in	   this	   study,	   then	   this	   pattern	   of	   response	   may	   identify	   those	   TOF	  individuals	   at	   higher	   risk	   of	   adverse	   long-­‐term	   outcome.	   Clearly	   this	  may	   also	  therefore	  elucidate	  which	  patients	  may	  require	  PVR	  or	  even	  which	  patients	  are	  being	  offered	  PVR	  too	  late.	  	  
7.2	  Relationship	  between	  Flow	  And	  Volumes	  during	  DS-­‐MR	  As	  has	  been	  previously	  discussed	   in	  chapter	  4,	  assessment	  of	  great	  artery	   flow	  and	   documentation	   of	   PR	   is	   an	   essential	   component	   of	   the	   clinical	   CMR	  assessment	   in	  TOF.	  All	  of	   the	  patients	   in	   this	   study	  had	  a	  degree	  of	  pulmonary	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regurgitation	   and	   one	   of	   the	   initial	   aims	   of	   the	   thesis	   was	   to	   document	   the	  changes	   in	   flow	   dynamics	   that	   occur	   during	   DS-­‐MR	   and	   also	   to	   look	   at	   the	  association	  between	  great	  artery	  flow	  and	  volumetric	  analysis.	  	  
7.2.1	  Response	  of	  pulmonary	  regurgitant	  flow	  during	  DS-­‐MR	  	  The	  study	  showed	  that	  there	  is	  a	  significant	  increase	  in	  total	  pulmonary	  forward	  flow	  at	  10μg/kg/min	  DS-­‐MR,	  which	  could	  not	  be	  maintained	  at	  20μg/kg/min	  DS-­‐MR.	   This	   is	   in	   agreement	   with	   the	   increase	   in	   RV-­‐SV	   seen	   by	   volumetric	  assessment	  during	  DS-­‐MR.	  The	  PR	  volume	  (PA-­‐BF)	   increased	  at	  stage	  1	  DS-­‐MR	  but	   then	  decreases	  at	   stage	  2	  DS-­‐MR	  possibly	  due	   to	  shorter	  diastole	  at	  higher	  heart	  rates.	  However	   these	  changes	   in	   flow	  dynamics	  were	  not	  reflected	   in	   the	  calculated	   regurgitant	   fraction,	   which	   remained	   constant	   throughout	   DS-­‐MR.	  Clinically	   in	   addition	   to	   other	   clinical	   and	   volumetric	   parameters,	   pulmonary	  regurgitant	  fraction	  remains	  one	  of	  the	  criteria	  used	  to	  determine	  PVR	  timing	  in	  TOF	  patients.	  However	  Wald	  et	  al	  have	  suggested	  that	   the	  use	  of	  PR	  expressed	  volumetrically,	   rather	   than	   as	   a	   percentage	   of	   antegrade	  MPA	   flow,	   is	   a	   more	  appropriate	  method	  for	  quantification	  in	  the	  assessment	  of	  TOF	  patients	  109.	  This	  would	  appear	  to	  be	  true	  in	  this	  TOF	  patient	  cohort	  as	  PR-­‐RF	  does	  not	  reflect	  the	  important	   changes	   in	   PR	   volume	   observed	   during	   flow	   imaging	   under	  dobutamine	  stress	  conditions.	  	  
7.2.2	  Disparity	  of	  flow	  vs	  volume	  during	  DS-­‐MR	  CMR	   flow	  assessment	   at	   rest	   is	   reproducible	   and	   in	   previous	   studies	   has	   been	  shown	  to	  correlate	  well	  with	  analogous	  volumetric	  parameters.	  However	  little	  is	  known	   about	   how	   robust	   and	   comparable	   these	   are	   relative	   to	   volumetric	  parameters	   110	   during	   stress	   imaging,	   particularly	   at	   higher	   doses	   up	   to	   20	  μg/kg/min	  dobutamine	  105.	  Therefore,	  simple	  parameters	  derived	  from	  flow	  and	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volume	  data,	  such	  as	  stroke	  volumes,	  and	  also	  more	  calculated	  parameters	  such	  as	   the	   absolute	   PA-­‐BF	   and	   PA-­‐RF	   were	   compared	   and	   the	   full	   results	   are	  available	  in	  Chapter	  4.	  
This	   study	   showed	   that	   for	   simple	   parameters,	   under	   resting	   conditions	   an	  excellent	  agreement	  of	  ventricular	  volumetric	  SV	  by	  CMR	  with	   their	   respective	  aortic	   and	   pulmonary	   total	   forward	   flow	   volumes	   by	   PC-­‐flow	   as	   is	   commonly	  reported	  83.	  This	  agreement	  however	  deteriorated	  markedly	  under	  dobutamine	  stress.	   For	   the	   calculated	   parameter	   PA-­‐RF,	   there	   was	   considerable	  disagreement;	  both	  at	  rest	  and	  during	  stress.	  As	  mentioned	  previously	  this	  again	  questions	   the	   utility	   of	   PR-­‐RF	   as	   a	   useful	   marker	   of	   pulmonary	   regurgitation	  severity.	   In	   this	   study	   the	   pulmonary	   regurgitant	   volume	   (PA-­‐BF)	   showed	  acceptable	  agreement	  at	  rest	  between	  the	  stroke	  volume	  difference	  method	  (RV-­‐SV	  minus	   LV-­‐SV)	   and	  pulmonary	   backward	   flow	  by	  PC-­‐flow	   (PA-­‐BF)	   but	   there	  was	  deterioration	  of	  agreement	  during	  stress.	  	  
Reasons	  for	  disagreement	  during	  DS-­‐MR	  These	   results	   clearly	   suggest	   that	   during	   stress	   flow	   and	   volumetric	  measurements	   cannot	  be	  used	   interchangeably.	  The	   reasons	  why	   there	   is	   such	  variability	  in	  the	  results	  are	  numerous.	  	  
During	  pharmacological	  stress	  motion	  artefacts	  may	  occur	  to	  some	  degree	  due	  to	  tachycardia,	   increased	   myocardial	   wall	   motion	   velocities	   and	   presence	   of	  ventricular	  ectopics.	  The	  volumetric	  images	  were	  quality	  scored	  and	  a	  moderate	  (albeit	   not	   significant)	   reduction	   in	   image	   quality	   score	   and	   slight	   increase	   in	  observer	   variance	   at	   stress	   was	   found.	   Another	   confounding	   factor	   may	   be	  differences	   in	   expiratory	   breath	   hold	   diaphragm	   positions	   as	   patients	   become	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more	   uncomfortable	   during	   dobutamine	   exposure.	   This	   may	   result	   in	  inconsistent	   coverage	   of	   the	   ventricles	   and	   slight	   bias	   in	   volumetric	   numbers.	  	  With	   flow	   imaging,	   the	   more	   important	   potential	   limitations	   include	   low	  temporal	   resolution	   at	   higher	   heart	   rates	   (up	   to	   160	   bpm)	   and	   increased	  turbulence	   and	   velocities,	   particularly	   in	   the	   main	   pulmonary	   artery,	   during	  stress.	  Turbulent	  flow	  may	  not	  be	  perpendicular	  to	  the	  imaging	  plane	  and	  lead	  to	  flow	  underestimation	  from	  intra-­‐voxel	  phase	  dispersion	  111.	  
In	  order	  to	  achieve	  sufficient	  temporal	  resolution	  in	  DS-­‐MR	  flow	  imaging	  a	  free-­‐breathing	   protocol	   was	   chosen.	   The	   PA	   flows	   would	   have	   been	   difficult	   to	  acquire	   within	   a	   reasonable	   breath-­‐hold.	   However	   there	   are	   disadvantages	   to	  free-­‐breathing	   scanning,	   namely	   propensity	   for	   arrhythmia	   affecting	  retrospective	   phase	   reordering,	   background	   phase	   offset	   errors	   112	   and	  susceptibility	  to	  irregular	  breathing	  patterns	  during	  stress111	  which	  may	  impact	  on	  the	  correlation	  between	  volume	  and	  flow	  measurements.	  	  
7.2.3	  Clinical	  impact	  of	  flow	  imaging	  during	  DSMR	  In	   repaired	  TOF	  with	  chronic	   severe	  PR,	  agreement	  between	  CMR	  PC-­‐flow	  and	  volumetry	  was	  excellent	   for	   stroke	  volumes	  and	  acceptable	   for	  absolute	  PA-­‐BF	  under	  resting	  conditions.	  Under	  stress	  there	  was	  considerable	  disagreement	  for	  all	  of	  these	  parameters,	  and	  for	  PA-­‐RF	  this	  was	  even	  true	  at	  rest.	  Although	  image	  quality	  suffered	  to	  some	  degree,	  there	  was	  little	  observer	  variance	  in	  volumetrics	  during	  increasing	  levels	  of	  dobutamine	  stress	  as	  intra-­‐institutional	  strict	  reading	  criteria	  were	  consistently	  applied.	  These	  results	  suggest	  that	  measures	  of	  RV	  and	  LV	   SV,	   absolute	   PA-­‐BF	   and	   importantly	   PA-­‐RF	   during	   DS-­‐MR	   should	   be	  interpreted	  with	  caution	  and	  should	  not	  be	  used	  interchangeably.	  For	  DS-­‐MR	  in	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TOF	   patients	   the	   focus	   should	   be	   on	   simple	   parameters	   such	   as	   response	   of	  ventricular	  end-­‐systolic	  and	  end-­‐diastolic	  volumes	  to	  dobutamine	  stress.	  	  
	  
7.3	  Reproducibility	  and	  observer	  variance	  
The	   difficulties	   seen	   when	   comparing	   volumetric	   and	   flow	   data	   highlight	   the	  importance	   of	   reproducibility	   of	   CMR	   measurements	   and	   how	   this	   may	   be	  affected	  during	  DS-­‐MR.	  The	  accuracy	  and	  reliability	  of	  resting	  CMR	  volumes	  has	  been	  well-­‐published	  94.	  However	  as	  seen	   in	   this	  study	  resting	   imaging	  may	  not	  truly	  reflect	  underlying	  ventricular	  dysfunction	  and	   there	   is	   increasing	   interest	  in	   the	  development	   of	   better	   determinants	   of	   ventricular	   systolic	   and	  diastolic	  function	  and	  contractile	  reserve	  through	  stress	  imaging	  especially	  in	  congenital	  conditions	   such	  as	  TOF	   65.	  Published	  data	   suggests	   that	   there	   is	   a	   risk	  of	   error	  when	  assessing	  ESV	  response	  during	  DS-­‐MR	  and	  this	  questions	  the	  utility	  of	  such	  a	  parameter	  in	  the	  assessment	  of	  ventricular	  systolic	  function	  61.	  
An	  additional	  aim	  of	  this	  thesis	  was	  to	  assess	  the	  reproducibility	  and	  accuracy	  of	  stress	   imaging	   analysis.	   Reproducibility	   was	   determined	   by	   coefficient	   of	  variance	  and	  image	  quality	  was	  also	  taken	  into	  consideration.	  The	  study	  showed	  that	   in	   TOF	   patients	   and	   the	   healthy	   volunteers	   inter	   and	   intra-­‐observer	  agreement	  of	  end-­‐diastolic	  volumes	  was	  excellent	  at	  all	  stages	  of	  DS-­‐MR.	  In	  the	  TOF	  patient	  group	  at	  20μg/kg/min	  of	  dobutamine	  there	  was	  abnormal	  RV-­‐ESV	  response	  in	  comparison	  to	  the	  normal	  volunteers.	  The	  inter-­‐	  and	  intra-­‐observer	  analysis	  of	   this	  parameter	  shows	  good	  agreement	  between	  observers	  and	  good	  reproducibility	  of	  this	  parameter	  at	  higher	  levels	  of	  stress.	  In	  comparison	  LV-­‐ESV	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in	   the	  TOF	  group	  has	  a	  greater	  COV,	  of	  14.9%,	  suggesting	   less	  good	  agreement	  between	  observers	  during	  stage	  2	  DS-­‐MR.	  There	  are	  2	  potential	  causes	   for	   this	  poor	  agreement.	  Firstly	  the	  ventricular	  end-­‐systolic	  size	  is	  much	  smaller	  at	  this	  higher	   level	   of	   DS-­‐MR.	   Small	   discrepancies	   between	   observers	   in	   volume	  measurement	  will	   be	   amplified	  when	   calculating	   the	   COV	   (as	   seen	   in	   previous	  study	   61)	   so	   even	   a	   small	   difference	   between	   observes	   will	   result	   in	   a	   much	  greater	   variance	   and	   suggest	   poor	   agreement.	   Secondly	   the	   images	   in	   TOF	  patients	   were	   acquired	   in	   the	   axial	   plane,	   which	  may	   result	   in	   partial	   volume	  effect	   in	   the	   most	   apical	   slices	   of	   the	   ventricle	   79.	   In	   comparison	   the	   normal	  healthy	  volunteer	  group	  have	  better	  agreement	  between	  observers	  at	  higher	  DS-­‐MR	   stages	   with	   a	   COV	   of	   10.5	   at	   stage	   2	   DS-­‐MR;	   these	   images	   were	   acquired	  using	   a	   short-­‐axis	   geometry,	   which	   is	   a	   more	   standardized	   method	   of	   LV	  assessment.	   Although	   volumetric	   assessment	   of	   the	   LV	   using	   transverse	   slices	  has	  been	  validated	  79,	  95	  and	  is	  thought	  to	  be	  comparable	  to	  short	  axis	  imaging	  at	  rest	  it	  is	  likely	  that	  the	  potential	  for	  error	  is	  greater	  during	  DS-­‐MR.	  
	  The	   RV-­‐ESV	   in	   both	   TOF	   and	   the	   normal	   volunteer	   group	   showed	   good	  agreement	  suggesting	  good	  reproducibility.	  In	  the	  TOF	  group	  this	  superiority	  in	  comparison	  to	  the	  LV-­‐ESV	  is	  likely	  to	  be	  due	  to	  the	  larger	  baseline	  ESV	  reducing	  the	  potential	  errors	  of	  small	  volumes.	  Additionally	  the	  transverse	  geometry	  used	  in	   the	   TOF	   allows	   better	   visualization	   of	   the	   valve	   planes	  which	  may	   improve	  accuracy	   when	   assessing	   volumes	   79.	   In	   comparison,	   the	   volunteer	   group	   also	  showed	   good	   agreement	   between	   observers	   in	   RV-­‐ESV	   assessment	   at	   higher	  stages	  of	  DS-­‐MR	  suggesting	  that	  both	  short	  axis	  and	  axial	  assessment	  of	  the	  RV	  yield	  reproducible	  results.	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Image	  quality	  should	  also	  be	  taken	  into	  consideration	  as	  it	  is	  anticipated	  that	  at	  higher	  heart	  rates	  this	  be	  will	  affected	  due	  to	  motion	  and	  respiratory	  artefacts	  61.	  Although	   image	   quality	   reduced	   marginally	   with	   increased	   DS-­‐MR	   stage,	   all	  images	  were	   of	   a	   high	   enough	   quality	   for	   analysis	   and	   this	   is	   unlikely	   to	   have	  caused	  significant	  error	  in	  analysis	  for	  either	  the	  TOF	  patients	  or	  the	  volunteers.	  	  
The	   data	   showed	   good	   agreement	   between	   observers	   for	   volume	   assessment	  during	   DS-­‐MR.	   This	   is	   only	   possible	   with	   good	   institutional	   training	   and	  adherence	   to	   strict	   reporting	   guidelines	   94.	   This	   should	   be	   taken	   into	  consideration	  when	  performing	  and	  analyzing	  DS-­‐MR	  volumes.	  
Overall,	  especially	  for	  the	  RV	  parameters	  the	  reproducibility	  was	  good.	  Previous	  work	  has	  suggested	  the	  ESV	  parameter	  to	  be	  most	  at	  risk	  and	  this	  appeared	  to	  be	  true	   for	   the	  LV	   in	  the	  TOF	  groups	  although	  the	  reasons	   for	   this	  have	  been	  well	  explained.	   The	   stress	   data	   suggested	   that	   changes	   in	   RV-­‐ESV	   at	   higher	  dobutamine	  concentrations	  may	  have	  clinical	  application	  and	  therefore	  the	  good	  reproducibility	  of	  this	  parameter	  supports	  its	  clinical	  utility.	  	  
7.4	  Safety	  Safety	   is	   paramount	  when	  performing	  DS-­‐MR	  and	   this	   study	  has	   shown	   that	   a	  dose	   of	   20mcg/kg/min	   is	   safe	   and	  well	   tolerated	   in	   this	   particular	   TOF	   study	  population.	   Only	   2	   patients	   experienced	  minor	   side	   effects	   and	   there	  were	   no	  documented	   serious	   adverse	   reactions.	   Major	   side	   effects	   although	   infrequent	  were	  reported	  from	  studies	  using	  higher	  doses	  up	  to	  40mcg/kg/min	  in	  patients	  with	  coronary	  artery	  disease	  50,	  whereas	  echocardiographic	  studies	  using	  up	  to	  40mcg/kg/min	  in	  TOF	  have	  only	  reported	  one	  case	  of	  non-­‐sustained	  ventricular	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tachycardia	  at	  a	  dose	  of	  20mcg/kg/min	  66,	   67.	  This	  potential	  risk	  of	  arrhythmias	  although	  rare	  has	  resulted	  in	  cautious	  dobutamine	  administration	  in	  congenital	  heart	  disease	  patients.	  Currently,	  a	  dose	  of	  7.5mcg/kg/min	  has	  been	  considered	  to	  be	  the	  safest	  and	  most	  effective	  61.	  However,	   the	  concern	  with	  this	   low	  dose	  approach	  is	  that	  there	  are	  potential	  changes	  in	  cardiac	  response	  to	  dobutamine	  as	  demonstrated	  in	  this	  investigation,	  which	  are	  not	  seen	  at	  low	  doses.	  
The	  higher-­‐dose	  protocol	  up	   to	  20μg/kg/min	  was	  well	   tolerated	   in	  all	   controls	  and	  our	  strictly	  selected	  TOF	  patients	  where	  only	  4	  of	  24	  patients	  were	  unable	  to	  proceed	  to	  full	  dose	  due	  to	  minor	  symptoms.	  It	   is	  mandatory	  that	  resuscitation	  equipment	  and	  trained	  staff	  are	  available	  when	  performing	  DS-­‐MR.	  	  	  
7.5	  Study	  Limitations	  
Due	   to	   very	   strict	   exclusion	   criteria	   for	   safety	   reasons,	   this	   exploratory	   study	  included	   a	   relatively	   small	   number	   of	   patients,	   and	   therefore	   the	   conclusions	  (including	   safety	   considerations)	   are	   not	   applicable	   to	   TOF	   with	   severe	   RV	  dilatation,	   arrhythmia,	   additional	   pulmonary	   stenosis	   and	   additional	   cardiac	  defects.	   Volunteers	   and	   TOF	   patients	   were	   not	   age-­‐matched,	   but	   this	   small	  difference	   in	   age	   is	   unlikely	   to	  have	   caused	   a	  major	  bias.	   Short-­‐axis	   volumetry	  was	  used	  for	  controls	  and	  transverse	  acquisition	  for	  TOF	  patients.	  However	  the	  two	   approaches	   have	   been	   shown	   to	   be	   comparable	   94,	   113	   and	   changes	   in	  parameters	  rather	  than	  absolute	  volumes	  were	  the	   focus	  of	   the	  study.	   It	  would	  however	  be	  beneficial	  to	  perform	  the	  DS-­‐MR	  protocol	  with	  both	  axial	  and	  short	  axis	   assessment	   in	   a	   TOF	   patient	   or	   volunteer	   group	   to	   get	   a	   better	  understanding	  of	  these	  potential	  limitations	  during	  DS-­‐MR.	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The	  limitations	  of	  a	  single	  centre	  study	  with	  limited	  number	  of	  patients	  must	  be	  acknowledged.	  However	  from	  this	  work	  the	  protocol	  has	  been	  adapted	  to	  form	  part	  of	  the	  assessment	  in	  TOF	  patients	  in	  a	  large	  multi-­‐centre	  study	  in	  Germany	  (German	  Competence	  Network).	  It	  is	  hoped	  that	  future	  results	  from	  this	  research	  will	   confirm	   the	   trends	   observed	   in	   the	   small	   TOF	   patient	   cohort	   described	   in	  this	  thesis.	  	  
7.6	  Future	  perspective	  This	  thesis	  has	  evaluated	  the	  safety	  and	  utility	  of	  dobutamine	  stress	  imaging	  in	  patients	  with	  TOF.	  The	  most	  important	  observations	  were	  that	  at	  higher	  doses	  of	  dobutamine	   RV	   contractile	   reserve	   is	   abnormal	   in	   some	   TOF	   patients	   due	   to	  abnormal	  change	  in	  RV-­‐ESV.	  How	  this	  change	  relates	  to	  clinical	  need	  for	  PVR	  is	  difficult	  to	  interpret	  in	  this	  small	  patient	  cohort.	  There	  are	  a	  number	  of	  questions	  that	   currently	   remain	   unanswered	   and	   through	   future	   study	   could	   reveal	  important	  features	  of	  early	  systolic	  dysfunction	  in	  this	  group	  of	  patients.	  
Load	  independent	  assessment	  
This	  study	  has	  focused	  on	  RV-­‐ESV	  and	  contractile	  reserve	  as	  potential	  markers	  of	  RV	   dysfunction.	   These	   are	   both	   load	   dependent	   parameters	   significantly	  influenced	   by	   regurgitant	   volumes.	   Other	   parameters	   may	   better	   reflect	   true	  myocardial	   dysfunction	   for	   example	   deformation	   imaging	   using	   tagging	   or	  speckle	   tracking	   and	   the	   relationship	  with	   strain	   and	   strain	   rate	   analysis	   from	  MR	   imaging	   could	   potentially	   offer	   load-­‐independent	   markers	   of	   ventricular	  dysfunction	  which	  may	  prove	  to	  be	  more	  predictive	  of	  outcome.	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Stress	  echo	  assessment	  The	   initial	   research	  protocol	  applied	   to	   the	  TOF	  patients	   included	  an	  extensive	  echo	   protocol	   including	   tissue	   velocity	   imaging	   and	   3D	   volume	   assessment.	   In	  the	   patient	   cohort	   3D	   volume	   assessment	   proved	   to	   be	   technically	   challenging	  due	  to	  the	  significant	  dilation	  of	  the	  RV	  in	  many	  cases.	  Post	  processing	  of	  these	  large	   volumes	   resulted	   in	   underestimation	   of	   volume	   measurements,	   this	   has	  also	  been	  observed	  in	  published	  data	  33.	  Therefore	  echo	  assessment	  could	  not	  be	  assumed	  to	  be	  comparable	   to	  CMR	  volume	  assessment.	  Although	  CMR	  remains	  the	   gold	   standard	   for	   volumetric	   assessment,	   with	   improvement	   in	   3D	   echo	  technology	  it	  is	  possible	  in	  the	  future	  that	  similar	  stress	  studies	  could	  be	  carried	  out	   with	   echocardiography.	   Benefits	   of	   this	   would	   include	   accessibility,	   faster	  acquisition	  of	   images	  and	  reduction	  of	  patient’s	  dobutamine	  exposure.	  It	  would	  also	   facilitate	   the	   study	  of	  patients	  with	   contraindications	   to	  CMR	   imaging	  and	  could	   be	   applied	   to	   exercise	   echo	   thereby	   removing	   the	   need	   for	  pharmacological	  agents.	  	  
Fast	  CMR	  scanning	  Chapter	  3	  reports	   the	  results	  of	  a	   faster	  3D	  ventricular	  assessment.	  The	  aim	  of	  this	  part	  of	  the	  project	  was	  to	  determine	  whether	  there	  are	  methods	  to	  achieve	  full	   ventricular	   assessment	   in	   a	   single	   breath	   hold.	   Because	   of	   the	   extensive	  imaging	   protocol	   undertaken	   by	   the	   patients	   and	   volunteers	   in	   this	   study	   this	  fast	   3D	   sequence	   was	   not	   examined	   under	   stress	   conditions.	   However	   future	  study	   could	   implement	   fast	   imaging	   methods	   such	   as	   this	   to	   minimize	   the	  duration	  of	  dobutamine	  exposure	  and	  improve	  image	  quality	  related	  during	  DS-­‐MR.	  Utilization	  of	  blood-­‐pool	  contrast	  agents	  may	  also	  reduce	  error	  by	  allowing	  better	  blood-­‐pool	  endocardial	  definition.	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DS-­‐MR	  Pre	  and	  Post	  PVR	  The	  observation	  that	  some	  patients	  have	  an	  abnormal	  RV-­‐ESV	  response	  during	  stress	  needs	  to	  be	  explored	  further	  in	  the	  context	  of	  ventricular	  function	  pre	  and	  post	   PVR.	   Repeating	   the	   stress	   protocol	   following	   pulmonary	   valve	   surgery	  would	  give	  a	  good	  insight	  into	  how	  the	  volumetric	  parameters	  change	  once	  the	  volume	   load	   of	   PR	   has	   been	   eliminated.	   It	   would	   also	   allow	   confirmation	   of	  whether	   abnormal	   RV-­‐ESV	   response	   during	   stress	   truly	   reflects	   systolic	  dysfunction.	   As	  mentioned	   previously	   this	   study	   is	   currently	   being	   performed	  using	   the	   protocol	   described	   in	   this	   thesis	   as	   part	   of	   a	  multi-­‐centre	   long	   term	  study	  created	  by	  the	  German	  Competence	  Network	  and	  the	  results	  are	  awaited.	  
Future	   study	   should	   also	   focus	   on	   more	   refined	   analyses	   of	   ventricular	   sub-­‐compartment	   response114	   and	   regional	   wall	   motion	   behavior115	   between	   rest	  and	  stress	  as	  this	  may	  add	  relevant	  information	  on	  the	  mechanics	  of	  ventricular	  dysfunction.	   Correlation	   with	   ventricular	   scarring116	   and	   fibrosis	   imaging117	  might	   further	   improve	   the	   understanding	   of	   progression	   of	   ventricular	  dysfunction	   and	   its	   association	   with	   major	   adverse	   events	   such	   as	   clinical	  dyssrhythmia	  and	  sudden	  cardiac	  death.	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7.7	  Conclusions	  In	   TOF	   patients	   with	   chronic	   PR	   and	   preserved	   baseline	   ventricular	   systolic	  function,	  DS-­‐MR	  at	  20	  μg/kg/min	  revealed	  abnormal	  RV	  contractile	  reserve	  in	  a	  proportion	  of	  patients.	  This	  was	  due	  to	  paradoxical	  change	  in	  RV-­‐ESV,	  leading	  to	  significant	   worsening	   of	   RV-­‐EF,	   whilst	   controls	   showed	   further	   reduction	   of	  volumes	   at	   this	   dose	   level.	   These	   differences	   in	   stress	   response	   were	   not	  predictable	   from	   baseline	   parameters.	   In	   contrast,	   low-­‐dose	   DS-­‐MR	   at	   10	  μg/kg/min	   demonstrated	   a	   normal	   biventricular	   contractile	   reserve	   compared	  with	  volunteers.	  Hence	  this	  dose	  is	  unlikely	  to	  unmask	  systolic	  dysfunction	  using	  volumetric	  CMR.	  Therefore,	  the	  staged	  higher-­‐dose	  DS-­‐MR	  protocol	  used	  in	  this	  study	  may	  have	  the	  potential	  to	  select	  those	  at	  risk	  for	  systolic	  dysfunction	  when	  baseline	  RV-­‐EF	   is	   still	  within	   the	  normal	   range	  and	   therefore	  determine	  which	  patients	  will	  benefit	  most	  from	  pulmonary	  valve	  replacement.	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Tel: 020 7188 7188
Department of Congenital Heart Disease                        
 
Cardiac Magnetic Resonance Imaging 
 
PATIENT INFORMATION SHEET 
Study Title: 
Comparison of tissue Doppler and magnetic resonance imaging for assessment of right 
ventricular function in patients with tetralogy of Fallot and pulmonary regurgitation 
 
TO THE PATIENT: 
You are being invited to take part in a research study.  Before you decide it is important for you to 
understand why the research is being done and what it will involve.  Please take time to read the 
following information carefully and discuss it with your friends, relatives and your GP if you wish.  
Ask us if there is anything that is not clear or if you would like more information.  Take time to 
decide whether or not you wish to take part. 
 
Consumers for Ethics in Research (CERES) publish a leaflet entitled ‘Medical Research and You’.  
This leaflet gives more information about medical research and looks at some questions you may 
want to ask.  Please ask us for a copy, or if you wish, a copy may be obtained from CERES, PO 
Box 1365, London N16 0BW. 
 
Purpose of the Study: 
You are invited to take part in a research study that is being done at Guy’s and St Thomas’ Hospital 
NHS Trust.  The reason for this research study is to compare the findings of MRI of your heart with 
those of echocardiography, in particular the function of your pulmonary valve, which over time may 
leak.  The aim is to try and establish if echocardiography and MRI can help define the timing of any 
future operations for repair of leaking pulmonary valves in patients with repaired tetralogy of Fallot.  
 
Why I have been chosen and what will happen if I take part in the study: 
You are due to have a routine cardiac MRI (Magnetic Resonance Imaging) to assess your heart.  In 
addition to this routine scan, we will perform a tissue Doppler echocardiogram and a stress MRI. This 
assessment will be performed in one sitting at Guy’s Hospital.  Images of your heart will be taken with 
MRI, you will then be removed from the MR scanner, have a tissue Doppler echocardiogram, and then 
be slid back in the MR scanner to complete the scan.  During this second MR scan you will be given a 
low dose of a drug called Dobutamine, which will make your heart work a little harder (stress).  This is 
a way of mimicking exercise within the MR scanner.  Dobutamine in low doses is a safe drug, though 
you may experience headache, flushing and palpitations.  The total time for both examinations would 
be about 1 hour. This is about 30 minutes longer than a standard scan would take if you were not taking 
part in this study. 
 
As you may know, MRI is a way of looking at your heart and blood vessels and is risk-free (except 
some patients who should not have scans because they have things like heart pacemakers).  The MRI 
would be made up of a number of scans each taking a few seconds (where you have to hold your 
breath) or a few minutes (where you won’t have to hold your breath).  As part of this examination you 
may be given an injection of a contrast agent (similar to a dye) called Gadolinium. 
Some people undergoing MRI scans (approximately 5%) develop feelings of claustrophobia (distress at 
being in an enclosed space).  If you feel claustrophobic then you can ask for the scan to be stopped. 
 
A tissue Doppler echocardiogram is a special way of looking at echo images, but the images will be 
taken in the same way as the echocardiograms you have had in the past.  
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Do I have to take part in the study? 
It is up to you to decide whether or not to take part.  If you do decide to take part you will be given this 
information sheet to keep and you will be asked to sign a consent form. If you decide to take part you 
are still free to withdraw at any time and without giving a reason.  This will not affect the care you 
receive. 
 
What if something goes wrong? 
If you are harmed by taking part in this research project there are no special compensation 
arrangements. If you are harmed due to someone’s negligence then you may have grounds for a legal 
action but you may have to pay for it. Regardless of this if you wish to complain about any aspect of 
the way you have been approached or treated during the course of this study the normal NHS complaint 
mechanism may be available to you. 
 
Will my taking part in this study be kept confidential? 
All information, which is collected about you during the course of the research, will be kept strictly 
confidential.  Any information or pictures about you which leaves the hospital, will have your name 
and address removed so that you cannot be recognised from it.  
 
What will happen to the results of the research study? 
The images collected will be stored on a computer system and, after your name and address has been 
removed, may be made available to researchers at other institutions or to the manufacturer of the 
scanner. 
We plan to publish the results of this study in a medical journal once the study has been completed and 
the results analysed. None of the patients will be identified in any report or publication.  
 
Who is organising and funding the research? 
This study is being organised by the cardiac MRI department of the department of congenital heart 
disease of Guy’s and St. Thomas’ Hospital.  
 
This study has been reviewed and approved by the Guy’s Hospital Research Ethics Committee. 




Contact for further information: 
Prof Reza Razavi        Dr Victoria Parish 
Division of Imaging Sciences                                          Division of Imaging Sciences 
Rayne Institute, 4th Floor Lambeth Wing,                   Tel: (+44)/(0)20 718 88382 
St Thomas' Hospital                                                       Fax: (+44)/(0)20 718 85442        
London SE1 7EH 
Tel:  (+44)/(0)20 718 85440 
Fax: (+44)/(02)0 718 85442 
 
Patient Information Sheet Version 2. 29 August 2006. 
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i)	  Ethics	  application	  	   	  
Guy’s	  Research	  Ethics	  Committee	   	   R&D	  NO:	  	  	  
	  
APPLICATION	  FORM	   	   	   	   	   	  
	  
	  
Application	  for	  approval	  of	  an	  investigation	  for	  teaching	  or	  research	  involving	  human	  
subjects	  
	  
1.	   Brief	  title	  of	  Project	   Comparison	  of	  Tissue	  Doppler	  and	  Magnetic	  Resonance	  Imaging	  for	  assessment	  
of	  right	  ventricular	  function	  in	  patients	  with	  Tetralogy	  of	  Fallot	  and	  Pulmonary	  
Regurgitation	  
2.	   Personnel	  involved	   	  
	   Department:	   Medical	  Imaging	  Science	  
	   Head	  of	  Department:	   Dave	  Hawkes	  
	   Applicant	  (main	  investigator)	  
name/appointment	  
Dr	  Reza	  Razavi	  
Honorary	  Consultant	  in	  Paediatric	  Cardiology	  
	  
	   Supervisor	  (if	  relevant)	   	  
	  
	   Principal	  assistants	  and	  their	  
responsibilities	  
	  
Dr	  Michael	  Vogel	  Senior	  research	  fellow	  in	  Congenital	  Heart	  Disease	  
Dr	  Derek	  Hill	  Reader	  Radiological	  Science	  
Dr	  Andrew	  Taylor	  Research	  Fellow	  in	  Cardiac	  MRI	  
3.	   State	  your	  personal	  
experience	  in	  this	  field	  in	  
terms	  of	  extent	  and	  duration	  
I	  am	  a	  paediatric	  cardiologist	  in	  charge	  of	  the	  cardiac	  MR	  service	  at	  Guy’s	  and	  St	  
Thomas’	  and	  direct	  and	  report	  the	  three	  weekly	  sessions	  of	  cardiac	  MR	  at	  Guy’s	  
(1	  for	  children,	  2	  for	  adults).	  I	  also	  perform	  diagnostic	  and	  interventional	  cardiac	  
catheterisations	  in	  children	  and	  adults	  with	  congenital	  heart	  disease.	  I	  have	  been	  
involved	  with	  acquisition	  and	  reporting	  of	  cardiac	  MR	  at	  Guy’s	  and	  St	  Thomas’	  
over	  the	  last	  6	  years	  and	  cardiac	  catheterisation	  over	  the	  last	  8	  years.	  I	  am	  part	  
of	  group	  of	  scientists	  and	  clinicians	  who	  been	  successful	  in	  obtaining	  over	  £3.8	  M	  
of	  funding	  from	  HEFCE,	  research	  councils,	  charities	  and	  industrial	  sources	  for	  a	  
research	  MR	  centre	  at	  Guy’s	  with	  a	  strong	  emphasis	  on	  cardiac	  MR	  and	  MR	  
guided	  intervention	  were	  this	  work	  is	  going	  to	  be	  carried	  out.	  	  
4.	   Are	  you	  a	  member	  of	  a	  
defence	  organisation	  
(MPS/MDU)?	  	  If	  so	  please	  give	  
registration	  number	  
	  
MDU	  	  	  232105J	  
	  
5.	   Contact	  numbers:	   Telephone	   Fax	   Email	  
	   	   020	  7955	  3196	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6.	   Purpose	  of	  investigation	  (please	  indicate	  
what	  information	  you	  hope	  to	  obtain,	  and	  
what	  you	  believe	  will	  be	  the	  benefits).	  
Patients	  with	  congenital	  heart	  disease	  who	  have	  had	  surgery	  to	  
their	  right	  ventricular	  outflow	  tract	  or	  pulmonary	  valve	  or	  who	  
have	  pulmonary	  homografts	  or	  conduits	  may	  develop	  
pulmonary	  incompetence.	  These	  patients	  may	  develop	  right	  
ventricular	  dilation	  and	  dysfunction,	  and	  be	  prone	  to	  
ventricular	  arrhythmias.	  They	  may	  therefore	  require	  
intervention	  to	  replace	  the	  regurgitant	  pulmonary	  valve.	  There	  
are	  currently	  no	  data	  on	  the	  optimal	  timing	  of	  intervention.	  If	  
the	  intervention	  is	  performed	  too	  early,	  there	  are	  concerns	  
about	  the	  requirement	  of	  future	  re-­‐interventions,	  as	  the	  life	  
span	  of	  currently	  used	  pulmonary	  homografts	  is	  limited	  to	  an	  
average	  of	  5-­‐7	  years.	  On	  the	  other	  hand,	  there	  is	  a	  limit	  to	  the	  
number	  of	  re-­‐operations	  that	  can	  be	  performed	  in	  a	  single	  
patient.	  Delaying	  the	  intervention	  carries	  the	  risk	  that	  the	  RV	  
dysfunction	  will	  not	  fully	  recover.	  The	  potential	  of	  recovery	  of	  
RV	  function	  is	  difficult	  to	  assess.	  Data	  from	  patients	  with	  
ischaemic	  heart	  disease	  suggest	  that	  evaluation	  of	  contractile	  
reserve	  is	  a	  good	  surrogate	  of	  recoverability	  of	  ventricular	  
function.	  However,	  this	  has	  so	  far	  not	  been	  assessed	  in	  patients	  
with	  pulmonary	  regurgitation.	  While	  echocardiography	  is	  most	  
commonly	  used	  for	  routine	  assessment	  of	  ventricular	  function	  
it	  has	  severe	  limitations	  in	  the	  RV,	  because	  of	  its	  difficult	  
geometry.	  Cardiac	  magnetic	  resonance	  allows	  accurate	  
assessment	  of	  right	  ventricular	  volumes	  and	  function.	  
However,	  this	  is	  load	  dependent	  and	  therefore	  has	  its	  
limitations	  when	  evaluating	  procedures	  characterised	  by	  rapid	  
changes	  in	  loading	  conditions.	  Recently,	  novel	  tissue	  Doppler	  
techniques	  have	  been	  shown	  to	  measure	  RV	  contractile	  
function	  independent	  of	  loading	  conditions.	  This	  is	  done	  by	  
measuring	  myocardial	  tissue	  acceleration	  during	  the	  iso-­‐
volumetric	  phase	  of	  ventricular	  contraction.	  The	  technique	  has	  
been	  experimentally	  validated	  but	  validation	  in	  a	  larger	  clinical	  
setting	  has	  not	  yet	  been	  performed.	  It	  is	  possible	  to	  measure	  
myocardial	  tissue	  acceleration	  by	  CMR	  tagging	  techniques.	  This	  
has	  not	  yet	  been	  used	  to	  assess	  load	  independent	  ventricular	  
function,	  however	  it	  has	  the	  advantage	  of	  allowing	  assessment	  
of	  myocardial	  tissue	  acceleration	  in	  3	  planes	  rather	  in	  a	  single	  
plane	  as	  obtained	  by	  tissue	  Doppler.	  	  
We	  will	  compare	  standard	  parameters	  of	  RV	  function	  by	  CMR,	  
pulmonary	  regurgitation	  by	  phase	  contrast	  flow	  and	  three-­‐
dimensional	  myocardial	  acceleration	  obtained	  by	  tagging	  with	  
the	  new	  tissue	  Doppler	  techniques.	  Tissue	  Doppler	  imaging	  has	  
the	  potential	  advantage	  of	  being	  applicable	  on	  the	  intensive	  
care	  unit,	  in	  the	  operating	  theatre,	  and	  outpatients.	  Data	  can	  
be	  acquired	  during	  routine	  echocardiographic	  examinations	  
within	  a	  few	  minutes	  without	  any	  extra	  discomfort	  for	  the	  
patient.	  
In	  addition,	  these	  load	  independent	  methods	  of	  measuring	  
ventricular	  function	  allow	  assessment	  of	  RV	  contractile	  
reserve.	  This	  can	  be	  achieved	  by	  acquiring	  data	  at	  rest	  and	  
during	  infusion	  of	  dobutamine.	  We	  will	  assess	  the	  ventricular	  
function	  and	  tissue	  doppler	  indices	  with	  MRI	  and	  
echocardiography	  at	  rest	  and	  whilst	  the	  patients	  are	  exposed	  
to	  dobutamine	  an	  intravenous	  cardiac	  inotrope.	  This	  will	  
enable	  accurate	  assessment	  of	  contractile	  reserve	  and	  may	  
unmask	  features	  of	  myocardial	  dysfunction	  which	  are	  not	  
detected	  during	  resting	  conditions.	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The	  principal	  goals	  of	  this	  project	  are:	  
to	  devise	  a	  technique	  for	  measuring	  load-­‐independent	  RV	  
function	  using	  MRI	  tagging	  
to	  assess	  the	  feasibility	  and	  safety	  of	  dobutamine	  stress	  MRI	  in	  
patients	  with	  Tetralogy	  of	  Fallot	  	  
Compare	  load-­‐independent	  techniques	  with	  more	  established	  
load-­‐dependent	  measures	  of	  ventricular	  function	  and	  the	  degree	  
of	  pulmonary	  regurgitation	  
To	  look	  for	  early	  markers	  of	  ventricular	  dysfunction	  in	  patients	  




7.	   Provide	  a	  concise	  description	  of	  what	  is	  to	  
be	  done	  (the	  protocol)	  
	  
Expand	  the	  box	  as	  necessary	  when	  giving	  
your	  description	  
This	  study	  will	  be	  carried	  out	  at	  the	  new	  MR	  research	  centre	  of	  
Guy’s	  hospital.	  Adults	  and	  adolescents	  will	  be	  studied.	  The	  
patient	  will	  be	  moved	  into	  the	  MR	  scanner	  and	  imaging	  of	  the	  
area	  of	  interest	  will	  be	  performed	  as	  per	  usual	  cardiac	  MR	  scan	  
of	  patient	  with	  congenital	  heart	  disease.	  The	  scans	  will	  be	  
performed	  with	  breath-­‐holds	  lasting	  10-­‐25	  secounds.	  
This	  will	  involve	  	  
1-­‐	  a	  plan	  scan	  	  
2-­‐	  a	  SENSE	  reference	  scan.	  
3-­‐	  an	  interactive	  real-­‐time	  scan	  to	  plan	  the	  planes	  of	  right	  
ventricular	  short	  axis,	  long	  axis	  and	  also	  a	  short	  axis	  plane	  
through	  the	  pulmonary	  artery	  and	  aorta.	  	  
5-­‐	  a	  phase	  contrast	  through	  plane	  velocity	  image	  in	  the	  short	  
axis	  plane	  through	  the	  pulmonary	  artery	  and	  aorta.	  
6-­‐	  3D	  Balanced	  Fast	  Field	  Echo	  short	  axis	  through	  the	  right	  
ventricle	  
7-­‐	  a	  series	  of	  spiral	  C-­‐SPAM	  tagging	  imaging	  in	  the	  short	  axis,	  and	  
long	  axis.	  
The	  cardiac	  MR	  examination	  will	  take	  30	  minutes.	  
Following	  the	  CMR	  acquisition	  patient	  will	  be	  moved	  out	  of	  the	  
scanner	  on	  the	  interventional	  table	  and	  the	  tissue	  Doppler	  
echocardiography	  will	  subsequently	  be	  performed	  in	  the	  same	  
room	  without	  moving	  the	  patient.	  (10	  minutes).	  
We	  will	  then	  start	  an	  infusion	  of	  Dobutamine	  10µg/kg/min.	  We	  
will	  repeat	  the	  phase	  contrast	  through	  plane	  velocity	  of	  the	  
pulmonary	  artery,	  3D	  Balanced	  Fast	  Field	  Echo	  short	  axis	  
through	  the	  right	  ventricle	  and	  spiral	  C-­‐SPAM	  tagging	  imaging	  in	  
the	  short	  axis,	  and	  long	  axis.	  (10	  min)	  The	  patient	  will	  then	  have	  
repeat	  tissue	  Doppler	  examination.(10	  min).	  We	  will	  increase	  the	  
Dobutamine	  to	  20µg/kg/min	  and	  repeat	  the	  cardiac	  MR	  (10	  min)	  
and	  tissue	  Doppler	  echocardiography.	  (10	  min).	  	  
	  
	  
8.	   (a)	   State	  potential	  hazards	  (if	  any),	  
including	  the	  degree	  of	  apprehension,	  pain	  
and	  disturbance.	  
MRI	  has	  been	  performed	  on	  millions	  of	  human	  subjects	  (and	  at	  
Guy’s	  specifically	  since	  1986)	  without	  ill	  effect.	  	  There	  are	  well-­‐
established	  contraindications	  for	  MRI,	  including	  pacemakers	  and	  
other	  implanted	  devices	  and	  metallic	  foreign	  bodies.	  	  Screening	  
procedures	  are	  in	  place	  in	  the	  MR	  unit	  to	  exclude	  such	  subjects,	  
and	  will	  be	  adopted	  in	  these	  studies.	  	  
	  
Dobutamine	  is	  routinely	  used	  as	  an	  agent	  to	  increase	  myocardial	  
contractility	  during	  imaging	  studies	  and	  with	  the	  low	  dose	  being	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used	  in	  this	  study	  and	  as	  the	  patients	  do	  not	  have	  ischaemic	  
heart	  disease	  we	  do	  not	  expect	  any	  problems.	  Patient	  however	  
will	  be	  monitored	  with	  ECG	  and	  BP	  monitoring	  and	  the	  infusion	  
will	  be	  stopped	  if	  there	  are	  any	  adverse	  effects	  or	  symptoms.	  	  
	   (b)	   State	  how	  the	  proposed	  protocol	  
would	  differ	  from	  the	  routine	  management.	  
Patients	  with	  tetralogy	  of	  Fallot	  routinely	  undergo	  MRI	  
assessment	  and	  echocardiography.	  However,	  in	  this	  study	  both	  
procedures	  will	  be	  performed	  concurrently	  and	  repeated	  
following	  the	  infusion	  of	  low	  dose	  dobutamine.	  




Where	  will	  the	  project	  be	  done?	   MRI	  research	  centre	  at	  Guy’s	  Hospital	  
	  
	  
11.	   What	  individual	  benefit	  (if	  any)	  will	  a	  patient	  
have	  if	  he/she	  participates	  in	  the	  study?	  
The	  MRI	  scan	  will	  be	  used	  for	  routine	  assessment	  of	  patient	  and	  
in	  deciding	  need	  for	  further	  treatment.	  There	  will	  be	  no	  
immediate	  individual	  benefit	  form	  the	  measurement	  of	  
contractile	  reserve	  and	  compression	  with	  Tissue	  Doppler.	  	  
	   	  
PATIENTS	  /VOLUNTEERS	  
	  
12.	   (a)	   State	  the	  number,	  age	  and	  type	  of	  
patients/subjects	  likely	  to	  be	  involved.	  	  Give	  
the	  size	  of	  any	  differences	  that	  you	  are	  
hoping	  to	  show	  between	  groups	  
We	  will	  study	  30	  patients	  with	  tetralogy	  of	  Fallot	  who	  are	  
referred	  for	  cardiac	  MRI	  assessment.	  	  
	   (b)	   Have	  you	  obtained	  statistical	  advice	  
on	  either	  of	  the	  following?	  	  
(Delete	  as	  applicable)	  
	  
The	  number	  of	  subjects	  required	  in	  order	  to	  
demonstrate	  results	  of	  clinical	  value	  
	  









	   	  
If	  YES,	  please	  indicate	  from	  whom:	  
	  
13.	   Do	  these	  include	  women	  who	  are	  pregnant	  
or	  likely	  to	  become	  pregnant?	  How	  will	  
pregnancy	  be	  excluded	  (if	  relevant)?	  
No,	  patient	  population	  is	  unlikely	  to	  include	  pregnant	  women	  
and	  pregnant	  women	  will	  be	  excluded	  by	  the	  MR/X-­‐ray	  
questionnaire	  filled	  in	  prior	  to	  scanning	  
	  
14.	   How	  will	  patients/volunteers	  be	  recruited?	   We	  will	  write	  to	  patients	  with	  tetralogy	  of	  Fallot	  on	  the	  waiting	  
list	  for	  cardiac	  MRI	  with	  an	  invitation	  letter,	  information	  sheet	  
and	  consent	  form.	  
15.	   Informed	  consent	  must	  be	  obtained	  in	  all	  
cases.	  	  Whether	  written	  or	  oral	  consent	  is	  
sought,	  written	  information	  should	  be	  
provided	  for	  the	  patient/volunteer,	  and	  this	  
must	  be	  included	  with	  this	  application.	  	  
Please	  indicate	  if	  consent	  will	  be:	  






	   	   b)	   Written	   Yes	  
	   	   c)	   Obtained	  in	  the	  
presence	  of	  a	  
disinterested	  third	  person	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COMMUNICATION	  
	  
17.	   Please	  indicate	  what	  (if	  any)	  information	  will	  
be	  sought	  from	  general	  practitioners,	  and	  
what	  information	  will	  be	  supplied	  to	  them	  
and	  in	  what	  form.	  	  Note	  that	  written	  
information	  should	  indicate	  how	  
experimenters	  can	  be	  contacted	  by	  
telephone	  in	  emergencies	  
N/A	  
18.	   When	  a	  drug	  is	  being	  administered	  will	  the	  
patient/subject	  have	  on	  his	  person	  some	  
means	  of	  this	  being	  known	  in	  case	  of	  a	  
sudden	  illness/accident?	  
N/A	  
	   	  
DRUGS	  
	  
19.	   Please	  state	  briefly	  the	  known	  
pharmacology	  of	  drugs	  to	  be	  used,	  
indicating	  activity	  and	  important	  side	  effects	  
Standard	  MR	  contrast	  agent	  if	  clinically	  indicated	  
Dobutamine	  is	  an	  inotropic	  agent	  which	  acts	  by	  increasing	  
myocardial	  contractility	  and	  arterial	  vasodilation.	  Side	  effects	  at	  
low	  dose	  may	  include,	  headache,	  flushing,	  palpitations.	  	  
20.	   Has	  approval	  been	  obtained	  from	  the	  
Committee	  for	  Safety	  in	  Medicine:	  
Yes	   No	   Not	  Applicable	  
	   	   	   	   N/A	  
21.	   Are	  radioactive	  substances/ionising	  








	   b)	   if	  the	  applicant	  is	  not	  a	  consultant	  radiologist	  or	  nuclear	  medicine	  physician,	  please	  append	  a	  letter	  
from	  radiation	  protection	  adviser	  or	  delegate;	  
	   c)	   has	  an	  ARSAC	  certificate	  been	  
obtained	  or	  applied	  for?	  	  (please	  append	  a	  copy	  
of	  the	  certificate	  to	  this	  application);	  
	  
	   d)	   is	  the	  investigation	  using	  ionising	  
radiation/radioactive	  substances	  intended	  to	  
benefit	  the	  patient?	  
	  
	   	  
SPONSORSHIP	  
	  
22.	   Is	  this	  study	  being	  performed	  with	  commercial	  
sponsorship,	  or	  sponsorship	  from	  some	  outside	  




23.	   If	  this	  project	  involves	  
participation/sponsorship	  by	  a	  pharmaceutical	  
company,	  has	  indemnification	  or	  no	  fault	  
liability	  been	  obtained?	  
N/A	  
	  
24.	   Is	  there	  any	  other	  form	  of	  indemnification?	   No	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ii)	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  Ethics	  Approval	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iii)	  Ethics	  for	  Fast	  3D	  Imaging	  	  The	   fast	   3D	   protocol	   (described	   in	   chapter	   2	   and	   3)	  was	   devised	   as	   part	   of	   a	  larger	  project	   looking	  at	  the	  utility	  of	  new	  contrast	  agents	   in	  the	  assessment	  of	  congenital	  heart	  disease.	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APPENDIX	  2	  
Echocardiography	  	  Echo	  data	  were	  collected	  for	  all	  TOF	  patients	  as	  part	  of	  the	  full	  research	  protocol	  and	  details	  of	  the	  measurements	  obtained	  are	  described	  in	  Chapter	  2.	  	  
With	  the	  utility	  of	  an	  XMR	  unit	  	  (combined	  X-­‐ray	  and	  CMR	  table)	  it	  was	  possible	  to	   perform	   echocardiography	  within	   the	   scanning	   room	   just	   prior	   to	   CMR	   and	  then	  also	  perform	  stress	  echocardiography	  whilst	  the	  dobutamine	  at	  peak	  dose	  of	  20ug/kg/min	  immediately	  after	  completion	  of	  the	  DS-­‐MR	  protocol.	  	  
Within	  this	  appendix	  the	  echo	  data	  will	  be	  described	  and	  documented.	  It	  has	  not	  been	  included	  within	  the	  man	  thesis	  as	  although	  baseline	  data	  is	  available,	  stress	  echo	  data	  was	  extremely	  difficult	  to	  achieve	  and	  therefore	  the	  data	  is	  relatively	  incomplete.	  3D	  data	  acquisition	  was	  collected	  in	  the	  majority	  of	  patients.	  At	  the	  time	   of	   performing	   the	   study,	   3D	   analysis	   software	   was	   still	   a	   relatively	   new	  entity,	  especially	  with	   the	  dilated	  right	  ventricle	  and	  volumetric	  measurements	  proved	  to	  be	  difficult	  to	  measure	  and	  assess	  accurately.	  	  
Echocardiography	  was	  not	  performed	  on	  the	  healthy	  volunteers.	  
Baseline	  Echo	  parameters	  Table	   20	   documents	   the	  mean	   baseline	   echo	   parameters	   acquired	   for	   all	   TOF	  patients.	   	  These	  results	  clearly	  show	  that	  the	  TOF	  patients	  had	  well	  functioning	  but	  dilated	  RV’s	  with	  at	  least	  moderate	  PR.	  All	  patients	  had	  good	  LV	  function	  on	  echo.	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PV	   V	   max,	   peak	   velocity	   through	   the	   pulmonary	   valve,	   TAPSE	   tricuspid	   annular	   plane	   systolic	  
excursion,	  TDI	  S	  wave,	  peak	  velocity	  of	  the	  systolic	  wave	  on	  tissue	  velocity	  imaging	  
	  
3D	  volumetric	  assessment	  Due	  to	  the	  technical	  problems	  already	  mentioned	  only	  twelve	  3D	  data	  sets	  were	  available	   for	   comparison	   with	   CMR	   volumes.	   	   The	   figures	   below	   show	   that	  although	   RV-­‐EDV	   measures	   tend	   to	   have	   modest	   agreement	   comparing	   CMR	  with	   Echo,	   there	   is	   poor	   agreement	   for	   RV-­‐ESV,	   RV-­‐SV	   and	   RV-­‐EF.	   In	   general	  echo	   volumes	   tended	   to	   be	   smaller	   than	   equivalent	   CMR	   volumes	   and	   this	   is	  likely	  to	  be	  due	  to	  poor	  endocardial	  definition	  of	  the	  lateral	  RV	  wall	  and	  RVOT	  on	  echo	  imaging	  (Figure	  32).	  
Stress	  echocardiography	  The	   focus	   of	   this	   aspect	   of	   the	   protocol	   was	   to	   acquire	   3d	   and	   TDI	   images	   to	  assess	   tissue	   velocity	  measurements	   using	   peak	   S	  wave	   at	   the	  RV	   lateral	  wall,	  septum	  and	  LV	  lateral	  wall	  (Figure	  33).	  	  Strain	  and	  strain	  rate	  was	  not	  calculated.	  3D	   data	  was	   collected	   at	   stress	   but	   due	   to	   high	   heart	   rates	   and	   significant	   RV	  dilatation	  many	  data	  sets	  were	  unsuitable	  for	  analysis	  	  
Parameter Mean ± SD 
LV End-diastolic dimension (cm) 4.4±0.5 
LV End-systolic dimension (cm) 3.1±0.5 
Estimated LV EF (%) 55±5 
RV End-diastolic dimension (cm) 4.7±0.7 
PV Vmax (m/s) 1.9±0.6 
PV Pressure Half Time (ms) 105±28 
TAPSE (cm) 19±3.0 
RV TDI S wave (m/s) 0.11±0.03 
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Tissue	  velocity	  imaging	  These	  data	  showed	  that	  during	  stress	  there	  is	  an	  increase	  in	  peak	  S	  wave	  velocity	  at	   the	   RV	   lateral	   wall,	   septum	   and	   LV	   lateral	   wall.	   It	   appears	   that	   there	   is	   a	  greater	   increase	   in	   peak	   LV	   S	  wave	   but	   the	   increase	   is	   significant	   in	   all	   three	  positions.	   This	   is	   in	   keeping	   with	   previously	   documented	   studies	   that	   have	  shown	   an	   increase	   in	   all	   TVI	  measurements	   during	   dobutamine	   stress	   in	   TOF	  patients.	  	  
Summary	  Echo	   remains	   an	   essential	   tool	   for	   assessing	   patients	   with	   TOF	   but	   direct	  comparison	   of	   echo	   parameters	   with	   CMR	   is	   difficult	   in	   these	   patients.	   CMR	  remains	   the	   gold	   standard	   for	   volumetric	   assessment	   due	   to	   the	   anterior	  position	  of	   the	  RV	   in	   the	   chest	  and	   the	  underestimation	  of	  volumes	  by	  echo	   in	  patients	  with	   dilated	  RV’s.	   As	   echo	   technology	   improves	   it	   is	   likely	   that	   image	  quality	   and	   therefore	   endocardial	   definition	   will	   improve	   and	   this	   will	   allow	  utilization	  of	  3D	  scanning	  in	  a	  variety	  of	  congenital	  heart	  disease	  patients.	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Figure	  32:	  Comparison	  of	  3D	  Echo	  and	  CMR	  parameters	  at	  rest	  
	  	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  
Figure	  33:	  TVI	  peak	  S	  wave	  during	  dobutamine	  stress	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